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SUMMARY  
Assay systems involving iodine-125 labelled iodothyronine substrates 
have been established which can detect deiodination with high sensitivity. 
A HPLC separation has also been established which complements the radio-
chemical assays. 
Using these assays, 5'-deiodinase enzyme activities have been 
localized to the plasma membranes, to the endoplasmic reticulum and to the 
lysosomes prepared from liver and kidney homogenates. A further activity 
in the cytosol of these tissues was also found, but evidence suggested, 
in part, that its presence there may be due to an artefact of the 
homogenisation procedures. 
Purification studies were performed on the cytosol 5'-deiodinase 
(because of its solubility) and on the combined microsomal 5'-deiodinase 
activity. Substantial purification (300 fold) of the 5'-deiodinase from 
cytosol was achieved using thyroxine as the ligand in affinity chromatography. 
Gel electrophoresis of this purified product suggested the presence of only 
a small number of proteins which combine in a regular fashion to produce 
aggregates of related structures. 
The combined plasma membrane and endoplasmic reticulum microsomal 
activity was significantly purified (3-10 fold) using iopanoic acid 
(which is a 5'-deiodinase inhibitor) as the ligand in affinity 
chromatography. The degree of purification compares favourably to that 
achieved by other workers. 
A model for deiodination of T4 is suggested in which the production 
of both T3 and rT 3 occurs predominantly at the plasma membrane. The r1 3 
produced is then subject to rapid catabolism by deiodination in the lysosome. 
The rate of rT 3 deiodination by lysosomes is controlled by the inhibition 
or stimulation of lysosomal autophagy or changes in the lysosomal membrane 
or both by drugs, hormones or aminoacids. This leads to alterations in 
the intracellular levels of rT 3 which in turn feeds-back negatively on the 
plasma membrane enzyme (and also perhaps the endoplasmic reticulum 
deiodinase) to inhibit the production of T3. 	This then leads to a rise 
in plasma rT 3 followed soon after by a fall in plasma 13. 
It is further postulated that the final common pathway for dietary 
changes of rT 3 /T 3 levels is via the intracellular levels of aminoacids 
in the liver, especially those (e.g. Asn, Gln, Leu) which are gluconeogenic 
or anabolic. 
Finally drugs which are known to be lysomotrophic and markedly 
affect the stability of lysosomes are predicted to have effects on the 
ratio of rT3 to T3 found in plasma. 
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CHAPTER 1  
Introduction to Thesis and Review of the Literature  
1.1 A Brief Review of the Development of our Understanding of  
Thyroid Physiology  
1.1.1. Historical Introduction  
The thyroid gland's ability to take up iodine from the blood and 
incorporate that iodine into the hormone released by the gland has long 
excited a wide range of medical and scientific interest. 
Medically, the thyroid gland has always been of great interest; 
both in the nature of the gland itself and in the effects of its secretions. 
Normal, elevated or low secretions are described in clinical situations as 
eu-, hyper- or hypo-thyroidism. Failure of homeostatic control of thyroid 
hormone levels leads to characteristic syndromes which in turn can be 
explained by the reduced or exaggerated effects of the changed levels of 
thyroid hormone on growth, metabolism, and the nervous system. 
The synthesis of thyroid hormone and its release represent many 
interesting features: the uptake and metabolism of a trace element 
present in the diet; the first described example of the incorporation 
of a halogen element into a biological compound; the synthesis within 
a very large protein of an unusual aminoacid; (and in retrospect) the 
first example of side chain (or post-translational) modification of a 
protein following its synthesis; and the first described example of the 
proteolysis of a protein to give an active hormone. 
Several good historical reviews exist on the development of our 
understanding of the nature of the thyroid gland and its functions, 
e.g. Kelly (1961), Stevenson (1963) and Trotter (1964). 
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The modern chemical study of thyroid function was initiated by 
the work of Baumann (1896 a, b) in which he •described not only the 
presence of iodine in the thyroid gland, but also that the iodine 
was contained predominantly in the protein fraction. This protein 
fraction after hydrolysis, yielded an iodine containing substance 
which he named in German: "thyrojodin" or in English "iodothyrin". 
Following Baumann's discoveries, Kendall (1915) reported that he 
had obtained "thyroxin" as a crystalline solid after hydrolysis of 
bovine glandular material. Harrington (1926a), improved the method 
of isolation of thyroxin so that larger yields could be obtained, and 
was thus able to characterise (1926b) and finally synthesize 
thyroxine (1927). 
The actual nature of the circulating hormone in the plasma remained 
controversial. It was thought that thyroglobulin or a thyroxine 
containing peptide was the circulating hormone because of the 
co-precipitation of thyroxine with plasma proteins. However the 
work of Taurog and Chaikoff (1948), Laidlaw (1949) and Rosenberg (1951) 
confirmed that it was the small molecular weight molecule thyroxine 
which was the iodine containing substance circulating in the bloodstream. 
The significant highlights of the debate for and against the 
possibility of free or non-covalently bound or covalently bound 
thyroxine have been succinctly reviewed by Pitt-Rivers (1978). The 
arguments have come eventually to favour a non-covalently protein-bound 
thyroxine with only a very small fraction of "free" or non-protein-bound 
hormone circulating in the plasma. 
The work of Harrington in elucidating the nature of the active 
principle in the colloid of the thyroid gland, was followed by Smith and 
Hypothalamus 
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FIGURE 1.1 The Control of Thyroid Hormone Secretion (Circa 1952). 
fellow workers who showed that there was an anterior pituitary principle 
which stimulated thyroid growth and secretion. This provided a further 
level of understanding of the thyroid gland (Sebert and Smith, 1930; 
Smith, 1930). 
The concept of feedback inhibition of thyroid secretion on the 
pituitary was proposed by Aron et al. (1931) and further refined by 
Hoskins (1949). Modification of the feedback concept came with the 
work of Green and Harris (1947) whose work implied that the hypothalamus 
could modulate the activity of the thyroid separately from the effect 
of the feed back control of thyroxine. This was confirmed by 
Greer (1951, 1955) who showed that the hypothalamus and hence, the then 
putative, TRH was necessary for the production of TSH and its trophic 
effect on the thyroid. 
So that by the early 1950's, most endocrinologists felt that 
thyroid physiology could be described (see Fig. 1.1) by the interaction 
of hypothalamus, pituitary and thyroid. 
1.1.2 The Role of Triiodothyronine  
A further level of control was then postulated by Gross and 
Pitt-Rivers (1953a)when they suggested that thyroxine (1 .4) was the 
precursor hormone activated outside the thyroid by deiodination to 
3,4,3', triiodothyronine (T 3 ). 
The evidence for their postulate was as follows: 
(i) T3 circulated in the blood (Gross and Pitt-Rivers, 1952; 
Roche, Lissitzky and Michel, 1952a, b). 
On a molar basis T3 was three to four times more potent 
than 14 (Gross and Pitt-Rivers, 1953a; Lerman, 1940). 
(iii) Injected radiolabelled 1311_T4  was converted to 131 I-T3 
(Gross and Pitt-Rivers, 1951, 1952a). 
(iv) 13 could completely alleviate myxoedema in people 
(Gross et al., 1952) and rats and mice (Gross and 
Pitt-Rivers, 1953b). 
This work was reviewed in retrospect by Pitt-Rivers (1978). 
1.1.3 The Loss of Interest in the Peripheral Conversion of  
Thyroxine to Triiodothyronine  
The postulate that triiodothyronine was the "effective" circulating 
hormone remained disputed on several points. Firstly, there were 
conflicting reports as to whether T4 could be converted to T3. 
Pitt-Rivers et al. (1955) had again found, by using paper chromatography, 
that 13 was derived peripherally from T4, but Lassiter and Stanbury (1958), 
from the same laboratory, were unable to show such conversion following a 
single injection of 131 I-T 4 when using an improved chromatographic separation 
of iodothyronines from serum. Secondly, the initial in vitro supporting 
evidence for peripheral conversion of T4 to 13 by Albright and Larson and 
co-workers (Albright, Larson and Tust, 1954; Larson, Tomita and Albright, 
1955; Albright and Larson, 1959) and by Sprott and MacLagan (1955) and by 
Cruchaude et al. (1955) was challenged by others who, although they were 
able to show deiodination of thyroxine by various in vitro systems, were 
unable to show formation of 13 (Etling and Barker, 1959; Galton and Ingbar, 
1961; Tata et al., 1957; Tata, 1957; Plaskett, 1961; Stanbury et al., 
1960; Wynn et al., 1962; Yamazaki and Slingerland, 1959). 
Tata (1959, 1960a, b, 1961) extended his work on deiodinases and 
partially purified (70-fold) from the soluble fraction of rabbit muscle, 
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an "enzyme" which required both Fe 2+ and a flavin and which was inhibited 
by chelating agents including EDTA, 8-hydroxy-quinoline, aasbipyridyl, 
atebrin, acriflavine, and chlorpromazine. The deiodinases of brain 
homogenates were also inhibited by mercurials (Tata et al:, 1957). The 
"enzyme" was assayed by using I 31 1-T 4 as a substrate and the products 
were separated by paper chromatography. Tata (1960b) found that whilst 
dehalogenation was occurring, non-specific protein in the reaction vessel 
could be "transiodinated" at the same time. This work on muscle 
deiodinase was confirmed by Lissitzky et al. (1961, 1962) who also 
showed that light was necessary for the flavin to have its effect on 
the deiodination. 
1.1.4 Non-enzymic Deiodination  
Lissitzky et al. (1961) and Galton and Ingbar (1962) then showed 
that deiodination of thyroxine by light and flavin could occur in a 
tissue-free reaction. These authors showed that boiled tissue at times 
markedly accelerated deiodination. This led Morreale de Escobar et al. 
(1962, 1963) to investigate the reaction using a miscellaneous 
selection of purified exogenous proteins and adding these fresh or after 
boiling to a mixture of FMN and T4 which were then exposed to light. 
The effects of these proteins were varied. Some would increase deiodination 
(e.g. lysozyme), others would have no effect (e.g. insulin and protamine), 
or would be inhibitory (e.g. albumin). After boiling, the properties 
of the proteins could change to cause increased deiodination (e.g. trypsin), 
or to have no effect (e.g. lysozyme), or to decrease deiodination 
(e.g. urease) or for deiodination to appear when the non-denatured 
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protein was inactive (e.g. ribonuclease and 0 lactoglobulins). 
Aminoacids tested had generally little effect except for histidine 
and tryptophane which markedly stimulated deiodination. 
The number of factors affecting non-enzymic deiodination were 
extended by Reinwein and Rall (1966a) who confirmed that labelled 
thyroxine and triiodothyronine could be deiodinated by light plus 
flavin mononucleotide (FMN) and showed that this phenomena could be 
accelerated by di- and tri-valent metals especially in the presence 
of some chelators of biological origin such as amino acids and proteins. 
This accelerating effect was however inhibited by stronger chelators 
such as quinoline-8-carboxylic acid. The effect of EDTA was variable; 
promoting deiodination when no metal was present and inhibiting when 
some cations, especially Fe 2+ were present in certain molar ratios. 
Most authors agreed that the action of light was probably via the 
generation of free radicals. 
Another possible source of non-specific deiodination was 
demonstrated by Galton and Ingbar (1963) in that T4 could be deiodinated 
by tissue peroxidases and the process inhibited by the exogenous 
addition of catalase, or activated by addition of Fe 2+ or haemoglobin. 
This deiodination could be stimulated in unboiled media by the 
addition of glucose and glucose oxidase (a known H 202 generating 
system). 
The same authors (Galton and Ingbar, 1966) later observed that 
the very active deiodination brought about with boiled liver homogenate, 
was not reproduced by boiled tissue slices unless the reaction was 
carried out in the preparation medium. They showed that a factor 
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responsible for deiodination was rapidly diffusible from tissue, readily 
dialysable and could be added back to the tissue to restore activity. 
This seemed to implicate a small molecular weight factor or factors. 
Reinwein and Rail (1966b) extended the observations on non-enzymatic 
deiodination of thyroxine by hydrogen peroxide in phosphate buffers by 
showing that light was not necessary if H202 and one of a set of 
certain metal ions were provided. A completely metal-free system was 
inactive. Metals varied in their action, some required EDTA for activity 
(e.g. Fe, Fe), others did not and were in fact inhibited (e.g. Cu). 
All these contributions to the study of non-enzymic deiodination 
led to a swing in opinion that favoured a non-enzymic process that was 
somehow associated with protein structure or aminoacid side chains per se 
and activated in the presence of metals and flavins, rather than being 
the effects of an active catalytic site of a true enzyme. These findings 
cast a great deal of doubt on those preceding papers showing deiodination 
as an enzymic process. This applied especially to those papers in 
which the authors could not show the presence of 13 or other intermediates, 
but had depended simply on measuring deiodination by the production of 
iodide. This doubt was so strong, that interest in the peripheral 
deiodination of T4 declined. 
The other (and perhaps more persuasive) line of evidence which 
discounted T3 was that the qualitative measurement of the total 
concentrations of the two hormones in serum showed that T4 was in 
very much higher concentration than T3; see for example Pitt-Rivers 
et al.(1955). The large amount of T4 relative to T3 was confirmed; 
when reasonably accurate quantitative estimates could be made. 
Pind (1957) and MacLagan et al. (1957) found that the circulating 
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concentration of T3 was between 50 and 100 times less than that of T4. 
So that, whilst most authors conceded the extra potency of T3 in 
bioassay, it was considered to be of much lesser importance relative 
to T. 
In retrospect, a more balanced assessment of the evidence for 
T4 to T3 conversion would have found great difficulty in dismissing 
the strong evidence that peripheral deiodination must occur: e.g. that 
exogenous 131 I-T4 led to the production of 131 1 - in the urine in vivo  
in man (Riggs, 1952; Pochin, 1951), in rats and or mice (Kalant et al., 
1955; MacLagan and Wilkinson, 1954; Flock and Bollman, 1955; and 
Gross and Leblond, 1951), and in the dog (Flock et al., 1956). 
In addition, Ford et al. (1957) had shown by the in vivo administration 
of 1311_ ,- 4  the formation of T3 from T4 in various tissues of the 
guinea pig by a careful, autoradiographic and chromatographic study. 
Other strong supporting evidence came from in vitro organ 
perfusion studies on the isolated rabbit kidney (Glitzer et al., 1956), 
and rabbit liver (Becker and Prudden, 1959) which showed that both organs 
would convert T4 to T3. 	These studies however lacked a quantitative 
measure of the specific activity of the radio-tracers and hence it was 
not possible to assess the importance of the T4 to 13 conversion. 
1.1.5 The Levels of Free or Non-Protein) Thyroid Hormones 
Other developments had been taking place in thyroid physiology 
which helped eventually to lead to a reconsideration of the role of T3. 
Recant and Riggs (1952) showed that it was the level of non-protein 
bound or free T4 which could maintain nephrotic patients in a euthyroid 
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state despite a lowered serum protein and a lowered PBI (i.e. total 1 - 4 ). 
These authors argued from the concepts of Goldstein (1949) who had 
reviewed drug action and found that the biologically effective 
concentration was the non-protein or "free" drug level and of McLean 
and Hastings (1935) who showed that ionized or "free" Ca 2+ was constant 
but that the protein bound Ca 2+ could vary considerably in vivo. 
Robbins and Rail (1957) calculated the free 14 levels in a large 
number of subjects with various hyper- and hypothyroid states and found 
that it correlated linearly with thyroid hormone degradation rates, 
and with the BMR. Later this argument was extended by Robbins and 
Rail (1960) who, when reviewing the literature, found that free T4 
levels correlated better than total T4 levels with euthyroidism in 
various states such as pregnancy, nephrosis, estrogen or androgen 
treated subjects, and in people with idiopathically raised TBG levels. 
They calculated that the concentration of free 14 was of the order of 
4 x 10 -11 M. 
Sterling et al. (1962) measured the binding constant of albumin 
for thyroxine (as it is one of the three binding proteins for T 4 ) and 
then calculated a value for free T4 of 0.6 x 10 -10 M based on the 
physiological concentration of albumin and the then accepted total 
T4 value. 
A better estimate of free T4 was later obtained by Sterling and 
Hegedus (1962) using a dialysis technique with serum to estimate the 
dissociation constant for T4 and this allowed an estimate of free T4 
of 1.3 x 10 -10 M in serum to be made. These values immediately 
suggested that the biological active fraction of 14 was only a minute 
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fraction of the total T. 	The other important observation that had 
been made by several authors was that T3 was less avidly bound than Ty 
by TBG and not at all by TBPA. These are the main thyroid hormone 
binding proteins. Albumin is thought to bind no more than about 10% 
of Ty. 	The binding of Ti. and T3 by plasma proteins was reviewed by 
Tata (1962) who obliquely made the point that as T3 was less tightly 
bound the free concentration could be comparable to that of T4 and it 
might after all be important even though the same author had dismissed 
the enzymic production of T3. 
1.1.6 The Renaissance of Interest in Triiodothyronine  
The renaissance of interest in T3 began with the work of Nauman eta]. 
(1967) who were able to measure serum 13 reasonably accurately by a 
chromatographic method and found a euthyroid value of 0.33 ± 0.07 pg/dl 
with a free T3 value of 1.51 ± ng/dl (or about 0.05%). Total T3 was 
found to vary more significantly in thyroid states than did T4 . 	Their 
calculated ratio of free T3 : T4 was 1:3 and was found to vary with 
hypo- and hyper-thyroidism showing a decrease in the ratio in hyper- 
thyroidism and an increase in hypothyroidism. Although Nauman et al. 
(1967) made no mention of the potency of T3 relative to T4, they 
discussed the metabolic clearance of T3 and its distribution value 
based on the work of Fisher and Oddie (1964) and suggested that the 
flux through this pool implied that there was preferential release of 
T3 by the thyroid. They thus concluded that T3 had an equal metabolic 
role to that of T4. 	Prior to Nauman et al. (1967), Shinaoka and Jansini 
(1965), although unable to measure absolute amounts, had accurately 
measured the ratio of T1,:T 3 in patients with thyrotoxicosis or thyroid 
tumour and concluded T3 might provide half the metabolic effect. 
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This work was extended by Sterling et al. (1969) who changed and 
improved the extraction and chromatographic method of Nauman et al, 
.(1967) which had overestimated the T3 level due to the formation of the 
methyl ester of T4 during the extraction with acid methanol. The 
methyl ester. of T 4 co-chromatographed with T3. 	However they confirmed 
qualitatively the observations of Nauman et al. on T3 and T4 in various 
'thyroid states although finding a lower level of T3 in euthyroid 
subjects (227 ± 27 ng/dl) and extended this work by finding in a series 
of clinically euthyroid patients, who had been treated for hyper-
thyroidism, a low T4 which seemed to be compensated for by a normal or 
high-normal T3. 	They also found in some rare cases, thyrotoxicosis 
apparently due to an elevation of T3 with a normal T. They pointed 
out that this 13 toxicity had been found in one case much earlier by 
MacLagan et al. (1957). 
Although not explicitly stated, I believe that these observations 
and those of Nauman et al. (1967) stimulated Sterling's group to re-
examine the question of whether peripheral deiodination of T4 to T3 
occurred in vivo. Sterling's group then found that athyreotic 
patients maintained on T4, had T3 in their blood. Then, rather than 
giving a single injection of 131 1-T4 as had been done by Lassiter and 
Stanbury (1958), they gave repeated multiple daily injections of 
125 I_T4  and showed that ' 25 1-T3 was formed from T4 in vivo (Braverman 
t al., 1970). 
Similar findings were made with normal subjects and using 
techniques to exclude deiodination of T4 to T3 during chromatography 
(Sterling et al., 1970; Pittman et al., 1971) and were confirmed in 
similar experiments using rats by Schwartz et al. (1971). 
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Following these papers, peripheral deiodination of T4 to T3 
was accepted as an important physiological mechanism in providing T3 
in vivo. Thus the postulate of Gross and Pitt-Rivers (1953) was, 
at least in part, accepted again. The question of intrinsic activity 
of T4 was still under question and remains so at the time of writing 
this thesis. 
The whole body studies quoted above did not indicate the site of 
this deiodination. This led to a flurry of papers, and subsequently 
a reconsideration of the early work done after the time of Gross and 
Pitt-Rivers. This early work on peripheral deiodination is discussed 
below. 
1.1.7 A Reappraisal of Research into the Deiodination of Thyroxine by  
Peripheral Tissues. 
It is difficult to assess the often contradictory early papers 
which deal with in vitro deiodination that were published before the 
watershed paper of Braverman et al. (1970). Clearly deiodination had 
been shown to occur in the whole animal in vivo using I' 31 -thyroxine 
in physiological amounts. 
Pitt-Rivers and Tata (1959),Ingbar and Galton (1963) and Galton 
(1968) in extensive discussions written before the paper of Braverman 
et al. (1970), tackled the controversy over peripheral deiodination 
in two ways. Firstly, they examined the likely methodological 
weaknesses, in particular, the mis-identification of products and 
secondly, they examined likely or possible non-enzymatic mechanisms 
for deiodination which would or could have been operative in the 
published systems. In retrospect, their criticisms have not necessarily 
proved to be valid. 
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Pitt-Rivers and Tata (1959) made the point that deiodination of 
labelled compounds can only be said to have occurred if the presence 
of iodide is established by unequivocal methods and to this end 
listed the following criteria: 
(i) chromatographic identification of radioactive I -
I 
in more than one solvent in the presence of carrier 
iodide; 
(ii) extraction of 1 2 into CS 2 after oxidation with ferric 
ions; 
(iii) electrophoretic mobility; 
(iv) isotopic dilution to constant specific activity; 
(v) adsorption on suitable ion exchange resins; 
and suggested that false conclusions would be drawn if nonspecific 
tests such as water solubility were used; as in this case, a water 
soluble thyroxine glucuronide conjugate could be formed by liver and 
kidney homogenates which is not precipitated by acid conditions. 
Thus Pitt-Rivers and Tata (1959) criticised the work of Sprott and 
MacLagan (1955) who had extracted their iodide fraction into a water 
phase; even though the latter authors for part of their work with 
non-radioactive thyroxine had used a AgS/Ag electrode for the measurement 
of the iodide released. A stronger criticism of Sprott and MacLagan 
was made by Lissitsky et al. (1956) who believed that the "deiodinase" 
was entirely non-enzymic because deiodination occurred equally in 
boiled and unboiled preparations, and was most active at the extremes• 
of pH; viz 3.5 and 9.5. The work of Morreale de Escobar et al. (1962, 
1963) on boiled proteins would also tend to discredit the claim by 
Sprott and MacLagan (1955) on the prolonged heat stability of the 
enzyme. 
One should note in passing, however, that more modern work of 
Hesch eta]. (1976) has shown a similar, but not as extreme, bimodal 
pH optima for the deiodination of thyroxine as determined by RIA. 
Pitt-Rivers and Tata (1959) also criticised the work of Albright 
et al. (1954) and Larson eta]. (1955) on the grounds that their 
chromatographic solvent used to separate T4 and its products after 
incubation with kidney slices did not distinguish between T3 and TA 4 
and did not measure iodide. The former authors felt that production 
of TA 4 to be a more likely product. However Allbright and Larson 
(1959) showed,with an improved solvent system which adequately 
separated T4, T3, TA 4 and TA 3,that kidney slices did produce T 
Taurog (1963a, b) had shown spontaneous deiodination of 
131 I-thyroxine and other iodophenols during the drying period when 
applied in aqueous buffers or in butanol to filter paper or silica 
plates. The deiodination was markedly inhibited by whole serum, 
albumin, ethanol or propylene glycol but not butanol. It was 
partially inhibited by propylthiouracil and by non-radioactive 
carriers. No decrease was observed with added iodide, EDTA or 
methimazole. Paper electrophoresis did not cause deiodination. 
With this work Taurog cast doubt on all the previous studies with 
131 I-T 4 and paper chromatography. 
Further, Morreale de Escobar et al. (1963) had shown that the 
deiodinase activities isolated by Tata (1963) and by Lissitzki eta]. 
(1962) were most likely a non-enzymic photochemical deiodination of 
of thyroxine catalysed by iron and flavin. So that, in her review 
Galton (1968) could not accept that there had been any convincing 
demonstration of in vitro deiodination. 
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In retrospect it seems to me that only the whole cell preparations 
of Albright, Larson and co-workers and Becker and Prudden (1959) and 
the pituitary homogenates of Volpert et al. (1966) gave a valid 
demonstration Of enzymic deiodination but quantitatively; were likely to 
be in error in view of Taurog's work, 
1.2 A Review of Recent Studies on the Peripheral Deiodination of  
Thyroxine  
1.2.1 Background  
Following the unequivocal demonstration by Braverman et al. (1970) 
that 1. 4 could be converted to T3 in vivo, there has been an explosion of 
interest in peripheral deiodination. Many early papers were concerned 
with the identification of the organ(s) responsible for this transformation. 
In vitro 13 production was shown using human fibroblasts in culture 
(Refetoff and Matalon, 1970), with the perfused rat heart (Rabinowitz 
and Hercker, 1971), and using cultured human kidney and liver cells 
(Sterling et al., 1973). Woeber et al. (1972) showed by paper 
chromatography, that intact leucocytes, when stimulated to phagocytose, 
would deiodinate thyroxine using hydrogen peroxide to produce I - and an 
iodinated protein material at the origin. This reaction was thought to 
be by a different mechanism than that of other tissues. Haibach (1971) 
showed that thyroid and kidney minces would deiodinate T4 to 13 by using 
an enZyme which was not iodotyrosine deiodinase. 
It should be noted that all these preparations consisted of whole, or 
a mixture of whole and broken cells. It was some time before the first 
convincing evidence of T4 to 13 production was demonstrated by Hesch et al. 
(1975) and Visser et al. (1975) using the broken cells of rat liver 
homogenates. To do so, they employed sensitive and specific 
radioimmuno-assays (RIA). 
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The development of RIA for thyronines was the final factor which 
has allowed the renewed interest in metabolism of thyroid hormones 
both in vitro and in vivo to be so quickly productive since 1970. 
A final impetus for the development of RIA for thyroid hormones had 
come from Larsen (1971) and Fisher and Dussault (1971) who, when 
using the Sterling (1969) procedure for measuring serum 13 found that 
the paper chromotographic step still led to a small but significant 
artefactual deiodination of 14 as had been first observed by Taurog 
(1963a, b). Thus, the work of Brown et al. (1970) in showing that 
specific antibodies could be raised to 13 led many laboratories to 
raise their own specific antibodies to T4 and to 13 and developed RIA 
to these thyronines. The early development of the radioimmunoassays 
with a comparison to the Sterling technique are reviewed by Larsen 
(1972a)and again by Burke and Eastman (1974). 
The sensitivity of RIA for 13 allowed Larsen (1972b)to confirm 
Sterling's clinical findings for 13 but lowered the normal value of 
total 13 from 2.2 ng/dl to 1.1 ng/dl. Larsen also reported that 
levels of 13 in newborn cord blood appeared to be in the hypothyroid 
range (0.5 ng/d1) whilst pregnant women were in the normal range. 
Sullivan et al. (1973) reported selectively low 13 and elevated 
free T4 levels in the serum of dying patients who had low 13 in tissues 
at necropsy. Carter et al. (1974) reported a wide range of patients 
who had chronic liver, lung, or kidney illnesses or who had desseminated 
carcinoma in whom blood concentrations of 13 were low. Since these 
, early reports, many different conditions and drugs have been shown 
to be associated with low plasma 13 (see Table 1.1). 
TABLE 1.1  
(Modified from Chopra et al., 1978) 
Clinical Situations with Low-Serum Total and/or Free T3 and 
Normal Total T4 and/or Normal or High Serum Free T4 
(Low T 3 Syndrome) 
1. Age related 
Fetus and the neonate at the time of birth 
Advanced age 
2. Caloric deprivation states 
Complete fasting 
Protein-caloric malnutrition 
Anorexia nervosa 
3. Systemic illnesses 
Febrile states 
Hepatic cirrhosis 
Renal failure 
Miscellaneous illnesses 
Toxaemia of pregnancy 
Burns 
4. Surgical operations 
5. Drugs 
Dexamethasone 
Radiocontrast agents for cholecystography 
Antianginal Agent (Amiadarone) 
Propylthiouracil 
Propranolol 
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Pharmaco-kinetic studies of metabolism of T3 and T4 have been 
conducted in some of these situations where T3 levels were low, 
e.g. sheep fetus (Chopra et al., 1975a), complete fasting (Portnay 
et al., 1974a; Suda et al., 1977), and hepatic cirrhosis (Nomura 
et al., 1975, Chopra, 1976a). These studies suggest that the low 13 
is due to a decreased production of T3 whilst that of T4 is normal, 
implying an inhibited peripheral conversion of T4 to 13 rather than 
an increased loss. This mechanism is thought to apply to many states 
of low plasma T3. 
1.2.2 Reverse T3  and the 5-Deiodination of Thyroxine  
The work of Chopra (1974) in developing a radioimmunoassay for 
3,3',5' triiodothyronine (termed by that author "reverse*" and variously 
abbreviated as RT 3 or rT 3 ) has opened up a much more extensive viewpoint 
on peripheral thyroid hormone metabolism. Chopra was able to show 
that r1 3 could be found and measured in human blood thus confirming and 
extending the early chromatographic work of Roche et al. (1956a, b) who 
had found rT 3 in rat thyroid and blood. Chopra found that the ratio 
of rT 3 to 13 or to T4 was markedly in excess to the ratio found in 
proteolytic or Pronase hydrolysates of thyroid glands. Also, hypo- 
thyroid and athyretoic patients receiving T4 were found to have normal 
levels of r1 3 suggesting that like 13, a large proportion of r1 3 was 
derived by peripheral deiodination of T4, although some direct secretion 
by the gland was not excluded. Chopra et al. (1975d, 1976a) using 
their RIA for r1 3 made the further discovery that total and free rT 3 
levels were elevated in most disease states having a low 13 and was 
normally elevated in the cord blood of newborn humans and sheep. 
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This workof Chopra was the first to show that thyroxine could be 
deiodinated from either the beta ("phenolic" or "outer") ring or from 
the alpha ("tyrosyl" or "inner") ring in an apparently controlled 
and reciprocal manner. Alpha or 54deiodination converted the thyroxine 
to T3 and beta or 5-deiodination converted thyroxine to rT 3 which is 
/ 
,inactive on bioassay as a thyroid Ormone (Stasilli et al., 1959; 
Money et al., 1960; Goldfine et a(T.,11976) but may have activity in 
other cell systems (reviewed by Chopr4 et al., 1978; 1980). 
These discoveries have led Chopra and other workers to look for 
other lesser-iodinated iodothyronines in plasma (see Fig 1.2) which 
would potentially be derived by the sequential deiodination of both 
rings of thyroxine. These have all now been identified in blood 
although their respective levels are disputed (Chopra, 1980; Burger, 
1980). The rate of metabolism through various pathways is not clear, 
nor is it clear whether various products have inherent biological roles 
or merely represent metabolic breakdown products. 
1.2.3 The Control of In Vivo Deiodination  
Surks and Oppenheimer (1971) performed studies using exogenous 
T4 labelled in either ring in normal humans and rats and suggested 
that the deiodination of thyroxine was random. In fact, peripheral 
production rates to 13 and rT 3 may approach equality in normal 
euthyroid subjects (see data Chopra et al., 1978). However it is now 
clear that the production of T3 and rT 3 and their subsequent metabolism 
are not random events but are in fact controlled in some fashion. 
Thus our overall view of the thyroid axis has been extended from 
Fig. 1.1 to that in Fig. 1.3. 
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FIGURE 1.2 The Successive Steps in the Complete Deiodination of 
Thyroxine (redrawn from Cody, 1981). 
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FIGURE 1.3 Control of Thyroid Hormone Secretion (Circa 1980). 
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What is not clear is how all the factors known to affect T 3/rT 3 
ratios exert their effects at the peripheral tissues to cause the 
altered levels of T 3/rT 3 and how they are adjusted to ensure 
euthyroidism in normal subjects. 
The modifying effect of food intake has been particularly studied 
since it was shown by Vagenakis et al. (1975) that a total fast led 
to a measurable increase in rT 3 with depressed T3 levels within 24 hours, 
reaching a maximal effect at about 5 days. A similar pattern was soon 
found in other calorie deprived states including protein-caloric 
malnutrition (Chopra et al., 1975d) and anorexia nervosa (Nicod et al., 
1976). Refeeding restored thyronine levels to normal (Chopra et al., 
1975d). In most reports T4 was little changed. Refeeding after total 
starvation with as little as 100 Kcal of carbohydrate caused a partial 
return to normal with 800 Kcal of carbohydrate causing a complete return 
to normal (Azizi, 1978). Fructose is just as effective as glucose 
(Burman et al., 1979). Westgren et al. (1977) have reported that oral 
carbohydrate but not intravenous glucose is effective in restoring the 
ratio. Pure protein refeeding does not restore T3 to normal but 
substantially returns rT 3 to normal (Azizi, 1978). In fact rT 3 may 
return to almost normal after about four weeks despite continuing 
a partial fast (300 Kcal/day), whilst T3 remains low (Visser et al., 
1978). Otten et al. (1980) found that fasting per se was not necessary 
• since a diet completely devoid of fat but isocaloric to a normal diet 
may cause a fall in T3 and rise in rT 3 . Danforth et al. (1979), 
conversely, have shown that voluntary overeating of carbohydrate is 
associated with elevated T3 and low rT 3 although a rise in T3 was not 
found when the diet contained the extra calories as fat. Studies in 
diabetes tend to confirm the link of thyroid hormones with carbohydrate 
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metabolism. Firstly, untreated insulin-dependent diabetic patients 
show a low plasma T3 (Suda eta]., 1977). These values return to 
normal sometime after treatment with insulin. Richmond et al. (1980) 
have shown in bacterial sepsis that total parenteral nutrition but not 
i.v. glucose can reverse the change in T 3/rT 3 ratio back to normal. 
(However the work of Westgren et al. (1977) on i.v. versus oral glucose 
mentioned above needs to be borne in mind). Richmond eta], suggest 
that in many sick patients the low T 3/high rT 3 ratio might be due to 
inadequate nutrition and not necessarily to the disease state per se. 
In this regard the finding that high doses of synthetic glucocorticoids 
such as dexamethasone also induce this change in ratio (Duick et al., 
1974; Chopra et al., 1975c; and Burr et al., 1976) is of great interest 
since it is well known that in many serious illnesses both the levels 
and the need for endogenous glucocorticoids rise (Selye, 1946). 
The information linking levels of T3 and to a lesser extent rT 3 
to carbohydrate ingestion suggest that it may be the hormones 
(e.g. insulin, cortisol glucagon) or the substrates (e.g. glucose, 
aminoacids) mobilized during gluconeogenesis that lower the T 3/rT 3 
ratio and not pituitary TSH. However the finding of Visser et al. 
(1978) and Otten et al . (1980) that plasma rT 3 levels often correlate 
well with plasma urate levels but not as well to creatinine suggests 
that factors other than carbohydrate metabolism may be operative. 
The changes in rT 3 and T3 appear not to be always truly reciprocal 
nor synchronous. As mentioned above, Visser eta]. (1978) showed 
a long term effect in partial fasting whereby protein refeeding 
restored rT 3 but not 1 3 . McLarty et al. (1976) showed that some patients 
with severe illness and who subsequently died had very low or absent T3 
and elevated rT 3 levels that decreased one or more days before death. 
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Loos et al. (1980) repeatedly sampled the blood of six thyroidectomised 
patients who were receiving constant infusions of T4 over a 24 hr 
period. This study showed that T3 and rT 3 levels have a circadean 
rhythm induced by peripheral mechanisms. Both T3 and rT 3 levels show 
two maxima and two minima which were not reciprocal in time nor 
proportional in change. 
1.2.4 In Vitro Studies on Deiodination 
The demonstration by Visser et al. (1975) and of Hesch et al. 
(1975) that liver homogenates could deiodinate T4 to T3 has been 
followed by a large number of papers documenting the properties of 
in vitro deiodination. 
1.2.4.1 Comparison of the In Vitro Deiodination by Various Tissues 
Albright and Larson (1959) showed that in vitro human 
kidney slices were the most active of all tissues in the 
deiodination of T4 to T3 with possibly some activity in the 
liver and heart. Similar findings had been made in the rat 
by Albright et al. (1954) but had been subsequently challenged 
by Tata (1959) who felt Albright et al. had misidentified 
T4 -glucuronate as iodide. 
Chopra (1977a) surveyed the tissues of the rat for deiodinase 
activity and found that kidney and liver were far more active 
than all the other tissues tested (muscle, heart, spleen, lung, 
brain, gut) which had showed little activity. The thyroid 
gland was not tested. 
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• Galton (1975) using phosphate homogenising buffers, found 
that the rat pituitary would deiodinate 14 but not produce T3. 
The chromatography system employed however did not resolve r1 3 
and 14 nor any of the diodothyronines. Galton appears to have 
overlooked the work of Grinberg et al. (1963) and Volpert 
et al. (1966) who had shown the conversion of T4 to T3 by 
mouse and human pituitary tumors could be demonstrated using 
Eagles' medium for incubation rather than using phosphate 
buffers which lead to a high deiodination rate without T3 
production. 
Newer studies from Larsen's laboratory have confirmed 
that the rat pituitary can convert T4 to 13 both in vivo and 
in vitro (Silva and Larsen, 1977, 1978; Silva et al., 1978; 
Larsen et al., 1980; Kaplan, 1980). This work implies that 
the anterior pituitary may need to be considered as a 
peripheral tissue in Fig 1.3. It is of interest that, in 
this new work, T4 to 13 deiodination by pituitary in vitro  
could only be shown in the presence of 5mM dithithreitol. 
This concentration is much higher than had been used by 
Visser et al. (1976) to obtain maximal-activity with liver 
microsomes. Deiodination of 14 to 13 by pituitary has been 
confirmed in vitro by El-Zaheri et al. (1980) in neonatal rats 
and in vivo by Lewis et al. (1980) and ObregOn et al. (1980). 
Recent work by Kaplan and Yaskoski (1980) has confirmed 
and extended the observations that the brain is a site of 
deiodination. These authors found that both cerebral and 
cerebellar homogenates would deiodinate both rings of T4 but 
required from 10 to 100 mM DTT for full activity, depending 
on the thyroid status of the rats. There was little or no 
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activity between 1-5 mM DTT. This explains the previous 
inability of Chopra or Kaplan (Chopra, 1977a; Kaplan and Utiger, 
1978; and Kaplan, 1980) to show deiodination by brain homogenates. 
Early work by Tata et al. (1957) had shown brain homogenates to 
deiodinate T4 to I - without forming T3. 	It was however 
considered by Tata and Pitt-Rivers (1959) and Galton (1968) as 
photochemical rather than enzymic activity even though it was 
inhibited by mercuric chloride and heat labile; properties 
which suggest a sulphydryl-requiring enzyme. 
The deiodination of T4 to T3 in thyroid minces has been 
shown by Haibach (1971) and confirmed by Erickson et al. (1980). 
Using a 100,000g pellet of thyroid homogenate, the latter 
authors showed a requirement of 5 mM DTT for activity. 
In summary liver, kidney, anterior pituitary, thyroid, 
and brain,broken-cell preparations all cause deiodination of 
T4 but require DTT or other sulphydryl compounds to show 
activity. 
1.2.4.2. The Sub-cellular Localization and the Co-factor  
Requirements  
Both Hesch et al. (1975) and Visser et al. (1975) in their 
original papers found 5'-deiodinating (T 4 to T 3 ) activity to 
be associated with the microsomal fraction of liver cell 
homogenates. Visser et al. (1976) extended their observations 
to show that a sulphydryl compound from the cytosol was 
necessary for maximal activity of the microsomes. Cytosol 
could be replaced by dithiothreitol and to a lesser extent 
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mercaptoethanol. The deiodinase was not inhibited by CN - 
thus distinguishing it from the possible enzyme systems 
described by Stanbury et al. (1960) which had required 
Fe 2+ , 02 and a sulphydryl compound but were inhibited by CN - . 
Production of reverse T3 from T4 in subcellular fractions 
was not shown until Cavalieri et al. (1977) found a cytosolic 
enzyme with an alkaline pH optima (8.5) in rat liver. It was 
thought to be a distinct enzyme from the microsomal T4 to T3 
deiodinase of Hesch et al. (1975) or of Visser et al. (1975). 
Huffner et. al. (1977) and HUffner and Grussendorf (1978) 
suggested that r1 3 production might not be easily detected as 
it was very rapidly deiodinated in vitro. The latter authors 
found rT 3 formation in the 100,000g pellet and not in the 
soluble fraction. Huffner et al. (1977) found a rT 3 
producing system in microsOmes with a pH otpimum of 8.5 and 
a T3 producing system in the same preparation at a pH optimum 
of 6.5. 
Sinsheimer et al. (1978) using model, iodinated-ring 
compounds (not true thyroid hormones) found three deiodination 
systems: a minor component in the microsomes and two systems 
in cytosol; one was dependent on gluththione, the other was 
independent of sulphhydryl compounds. 
Leonard and Rosenberg (1978a) extended the microsomal 
findings by showing with studies of "marker" enzymes associated 
with various cell fractions, that the T4 5'-deiodinase seemed 
to be a plasma membrane enzyme in rat kidneys. This work 
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prompted a re-examination by several groups of the 
sub-cellular site of the deiodinating enzymes because until 
Leonard and Rosenberg (1978a), most workers had depended 
predominantly on sedimentational criteria to specify their 
sub-cellular localization of the deiodinase. 
Chopra and co-workers (Maciel et al., 1979) confirmed 
Leonard and Rosenberg's finding that most T3 forming activity 
was associated with the plasma membranes of liver but there 
was still significant separate microsomal activity. On the 
other hand, Auf dem Brinke et al. (1979) found T4 to T3 
activity associated only with endoplasmic reticulum and not 
plasma membranes of rat liver. This was supported by Fekkes 
et al. (1979) who also found that liver deiodinase activity 
for both the inner and outer rings was present only in rat 
liver parenchymal cells and not Gpfer cells' and that after 
sub-cellular fractionation, the deiodination was associated 
with the endoplasmic reticulum and not the plasma membranes. 
They pointed out that the activities from microsomes were 
very much higher than those found by Cavalieri et al. (1977) 
in their cytosolic r1 3 -forming reaction and for this reason 
implied that the latter's work might not be rele vant. 
In summary, most authors feel that both 5- and 5'-deiodinase 
activities are associated with the endoplasmic reticulum in 
rat liver but there is strong evidence for an alternative 
plasma membrane localization in rat kidney. Difficulty has 
been' found in showing 5-deiodination in any viscus in vitro  
because of the rapid deiodination of rT 3 . Both 13 and rT 3 
formation seems to have been clearly shown to occur in the 
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brain by Kaplan et (1981) who used paper chromatographic 
methods. 
1.2.4.3. The Role of Glutathione 
The work of Visser et al. (1976) directed attention to 
a cytosolic factor which was necessary for the enzymic 
conversion of T4 to T3. This factor could be inhibited by 
Hg 2+ ions and p-chloromercuriphenylsulphate and replaced by 
thiol compounds such as dithiothreitol and mercaptoethanol. 
Chopra (1978) showed that foetal tissues were not as active 
in T4 to T3 conversion but the activity could be brought up 
to adult levels by the addition of thiol compounds. The 
activity in adult liver homogenates could be inhibited by 
thiol reagents (HgC1 2 , N-ethylmaleimide and diamide) and 
activated by reduced thiols (dithiothreitol, mercaptoethanol, 
and reduced glutathione). Kaplan (1979), Balsam and Ingbar 
(1979) and Harris et al. (1979) found that fasting led to a 
decrease in the cytosolic thiol compounds of rat liver and 
these were restored by prior administration of oral glucose 
before killing. Several authors have suggested that activity 
of the pentose shunt by producing NADPH and in turn reducing 
G-SS-R to GSH may be a mechanism for controlling T4 to 13 
production (Visser, 1978; Harris et al., 1979a). In support 
of this assertion, Balsam and Ingbar (1979) found that the 
activity of cytosol derived from starved liver or kidney on 
liver microsomes could be increased by adding NADPH or GSH 
to the cytosol. However NADPH when added directly to 
microsomes had no effect whereas GSH was active. Imai (1980) 
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by assaying extracts of cytosol, separated by column 
chromatography, has produced strong confirmatory evidence 
that the endogenous thiol which activates deiodination is 
glutathione. 
The question of whether changes in reduced glutathione 
levels are associated with in vitro states of reduced 13 
formation has been re-investigated in the light of its 
probable importance as a cofactor. Chopra (1978) has 
found decreased non-protein sulphhydryl groups (NPSH) in 
the foetal sheep with decreased in vitro deiodination of T4 
which is restored by in vitro addition of thiols. Harris 
et al. (1979) found that in starved foetal, neonatal or 
thyroidectomised rats, as well as in the hypopituitary dwarf 
mouse, the levels of liver NPSH were all reduced, as were 
the levels of production of 13 from T4 in vitro. Further 
the addition of thiols in vitro only partially restored liver 
deiodination of T4 to 13 in the foetal and neonatal liver up 
to day 5, but after day 5 activity was completely restored. 
Dithiothreitol did not restore deiodination activity in vitro  
from livers taken from rats thyroidectomised 60 days previous 
to the in vitro experiment. Deiodination of T4 to T3 activity 
in these livers was restored to normal by administration of 
13 in vivo for 10 days prior to assays. This treatment did 
not restore liver NPSH levels. Kaplan (1979) also found only 
partial restoration of deiodinase activity by DTT in vitro 
using livers from fasted rats. 
These findings have in part been confirmed and extended 
by Chopra (1980) who noted that NPSH in rat liver fell quickly 
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after a day of fasting and returned to normal over 4 days. 
The whole period of fasting was associated with decreased 
in vitro deiodination of T4 and rT3 (but not of 1 3 ) which 
could be restored fully by DTT only On day 0 and day 1, 
and then only partially on the remaining days of the fast. 
Chiraseveenuprapund eta]. (1975, 1978) were unable to 
show an increased deiodinase activity in renal homogenates 
•by the addition of thiols, but thiol blocking agents 
(e.g. N-ethylmaleimide) inhibited the reaction. Later work 
on kidney microsomes showed that DTT would increase the 
activity (Leonard and Rosenberg, 1978b). However Kaplan 
eta]. (1979) and Balsam and Ingbar (1979) have shown no 
decrease in deiodinase activity of the kidney in the 
fasting rat. 
1.2.4.4. Sex Differences in Tissue Deiodination  
Harris et al. (1979b) have shown T4 to 13 production by 
liver homogenates derived from both male or female were 
similar from days 1-24. However at age 30 days, a significant 
decrease in T3 production was observed in the female rat. 
This decrease reached approximately 50% by day 90 and remained 
constant thereafter. In vitro addition of thiols, e.g. DTT 
did not eliminate the difference Castration of females 
before puberty prevented these differences and if performed 
after puberty led to a gradual restoration to male values 
over about 40 days. 
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1.2.4.5 Effects of Hypo- and Hyperthyroidism  
Albright et al. (1954) showed that kidney slices from 
thyroidectomised rats had decreased T4 to 13 production 
whereas there was an increase in T3 production following 
prior administration of exogenous T. Kaplan and Utiger 
(1978), after prior administration of T4 to rats in vivo, 
found an increase in deiodination of T4 to T3 and rT 3 to 12 
in homogenates from liver but they observed no such change 
in kidney homogenates. Thyroidectomised rats showed reduced 
deiodination of T4 and rT 3 in both liver and kidney homogenates. 
Balsam et al. (1978), using liver and kidney slices from 
either hypophysectomised or thyroidectomised rats, found very 
similar decreases in deiodination of T4 to 13, and in the 
kidney decreased formation of TA4. The changes after 
removal of either gland were fully restored by administering 
13 in the diet but not by giving adrenal or sex steroids. 
1.2.4.6 Inhibitors and Enzyme Mechanism  
Various substances inhibit peripheral deiodination both 
in vivo and in vitro in both man and rat. Examination of 
their structures and of their reaction kinetics has given 
insight into the possible reaction mechanisms of deiodination. 
Chopra et al. (1978) found that T4 to 13 deiodination in rat 
liver was not inhibited by large doses of sodium iodide, 
iodotyrosines, 3,5,-T 2 , methylated, brominated or chlorinated 
analogues of 13and rT 3 nor by methimazole (methylmercapto- 
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imidiazole); however it was inhibited in a dose dependent 
manner by rT3, TA, 3,3'T2, 6-propylthiouracil, 
iodoacetic acid and some iodinated X-ray contrast agents, 
in particular ipodate and iopanoic acid. Other substances 
known to inhibit in vitro deiodination are propanalol and 
quinidine on isolated rat kidney tubules (but not homogenates) 
(Heyma et al., 1980) and sodium salicylate (Chopra and 
Solomon, 1980; Chiraseveenuprapund et al., 1978). 
• In vivo inhibition of deiodination is found with PTU and 
other six membered thionamide derivatives but not methimazole 
or other five membered thionamides (Hershman and Van Middlesworth, 
1962; Geffner et al., 1975; and Saberi et al., 1975). 
Propranalol (Wiersinga and Tauber, 1976), X-ray contrast agents 
Bergi et al., 1976; Wu et al., 1978), and dexamethasone 
(Duick et al., 1974; Chopra et al., 1975c) also inhibit 
in vivo; often with a rise in rT3. Infusion of rT3 in 
pharmacoloclical quantities to rats (Coiro et al., 1980), 
but not in physiological doses to man, inhibits T4 to T3 
deiodination. 
Recent studies by Visser (1979, 1980a, 1980b), using a 
rat liver preparation, have indicated that the 5'-deiodination 
of iodothyronines of both T4 and rT 3 follows a ping-pang 
mechanism implying the formation of an enzyme-sulfenyl iodide 
(E-SI) intermediate. The function of thiols (cofactor) is 
to regenerate free enzyme by reduction of this intermediate. 
Thiouracils inhibit deiodination by forming a mixed disulfide 
(dead-end complex) by reaction with the -SI group. Thus, 
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binding of thiouracils to the 5Hdeiodinase with the concomitant 
loss of enzyme activity only occurs under conditions where. 
enzymic deiodination has taken place and therefore requires 
the presence of substrate. Similar findings have been made 
by Leonard and Rosenberg (1980) in rat kidney who have further 
observed that the binding of PTU to enzyme prevents denaturation 
by sulphhydryl reagents, e.g. iodoacetamide and the activity 
can be later restored by adding high levels of DTT which reduce 
the enzyme-PTU mixed disulphide. 
1.2.4.7 Multiplicity of Enzymes  
There is strong evidence that there are at least two 
deiodinase enzymes which each act on the different rings of 
thyroxine. In vivo evidence is derived firstly from sick 
and fasting subjects where 13 and rT 3 levels alter 
independently of each other (or at least not synchronous nor 
reciprocal). Secondly, patients who have been given PTU 
have depressed T3 levels and elevated rT 3 levels which 
suggests a differential sensitivity of the two putative 
enzymes to the inhibitor and thirdly, the changes at birth; 
when 13 levels rise rapidly but those of rT 3 fall much more 
slowly, this suggests at least two enzymes. 
In vitro evidence for more than one deiodinase comes from 
their different properties in solution. Liver homogenates 
when incubated with T4 at pH 6.5 produce predominantly T3 and 
at pH 8.5 produce rT 3 with much less or no T 3 . It is possible 
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that rT 3 is produced at lower pH although this is not 
certain, since exogenous r1 3 is extremely quickly deiodinated 
below pH 8.0 in liver homogenates (Hiifner and Grussendorf, 1978). 
The differential effect of PTU and of fasting, both of 
which inhibit T3 production far more than rT 3 by in vitro  
microsomal enzyme preparations, is circumstantial evidence of 
more than one enzyme (Visser, 1980). Auf dem Brinke et al. 
(1979) have suggested that liver microsomes show kinetics 
and bimodal pH dependence which might be explained by the 
existence of two 5'-deiodinases and that there might also 
be a third activity associated with the lysosomes of liver. 
Visser et al. (1979) have examined the sequential 
deiodination of T4 to 3,3'T 2 via either T3 or rT 3 . They 
concluded the simplest explanation was that there were only 
two enzymes, one each for the 5 and 5' positions, which could 
act in sequence. They also concluded that the reason for 
the variation in the reported pH optimum for 5' deiodination 
of T4 was due in part to the alteration of Km and Vmax with 
pH and the use of non-saturating substrate conditions by 
previous authors including themselves. Most authors have 
concluded that proof of the existence of one or more enzymes 
awaits their eventual isolation and study. 
1.2.4.8 Purification of Deiodinases  
Several authors have described attempts at purification. 
Because the enzyme is probably membrane bound a major difficulty 
has been in the adequate solubilization of the enzyme, together 
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with its lability once solubilized. Takaishi et al. (1979) 
have used deoxycholate (DOC) for solubilization with a small 
increase in specific activity, Fekkes et al. (1980b) used 
cholate and W 1 ether and then applied the enzyme to either ion 
exchange or thiol covalent chromatography but again obtained 
only 2 to 3 fold increase in specific activity. Kiihrle et a . 
(1980) have also used DOC or cholate. They discarded the 
detergents acetyl-sulphate, SDS, Triton X-100 as unsatisfactory.. 
since they caused either loss or inhibition of enzyme activity. 
The use of CM or DEAE ion exchange cellulose did not improve 
specific activity nor did it separate the T4 and rT 3 
5'-deiodinases. 
1.3 Conclusion and Aims  
This survey of the literature includes some reported work 
which is contemporaneous with my own part-time research undertaken in 
the period from 1976 to 1981. The work is included because of the 
rapid advances made in this field of research during the last five years. 
Not to do so, would leave an unbalanced introduction with many deficits 
when compared with current knowledge. 
The overall aim of this work was, if possible, to separate 
and purify to homogeneity from kidney or liver, any of the enzymes 
catalysing the deiodination of the iodothyronines. The subsequent 
study of the separated or purified enzymes might then provide valuable 
information in that: 
(1) it might well answer the vexed question of how many 
enzymes catalyse deiodination; 
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(2) it might clarify the role of sulphydryl compounds 
either as co-factors or as substrates or both; 
(3) it would allow investigation of potential activators 
and inhibitors and their molecular mechanism; 
(4) it would allow studies on the size and structure of 
the enzyme; 
(5) it would allow kinetic studies on the enzymes and 
provide knowledge on the reaction mechanisms. 
CHAPTER  2 
Measurement of  Iodothyronine Deiodination 
2.1 Introduction  
For the purpose of monitoring the purification of an enzyme, a 
rapid method of measuring activity is desirable even if it is not as 
accurate as another more accurate assay but which is slower, or more 
difficult to perform (Dixon and Webb, 1962). 
However if such a rapid method is approximate or if it does not 
discriminate between possible products, it is necessary to have an 
additional assay which measures in an accurate and unambiguous manner 
any product formed. This is relevant to thyroxine as a substrate, 
as deiodination might occur from either of its two rings leading to 
two different sequences or pathways as shown in Fig. 1.2 (reviewed 
by Chopra et al., 1978). 
Potentially there could be attack on the inner or on the outer 
ring (alternative nomenclature: tyrosyl or phenolic; 5- or 5'- 
deiodination). 
Consideration of the reaction mechanism for deiodination of 
thyroxine: 
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(2.1) 
T4 4- rT 3 + I - (2.2) 
shows that at least two lesser iodOthyronines could be formed, 
namely T3 or r1 3 and I - , although the possibility needs to be 
considered that 11 2 might 'be formed. This is unlikely however 
-• 
as Visser et al. (1976, 1978) have shown that T4 to 13 deiodinase 
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activity in liver homogenates and fractions in vitro is dependent on 
the presence of a reduced sulphydryl compound. In vitro, 
dithiothreitol (DTT) is the most effective sulphydivl cofactor or 
substrate (section 1.2.4) but it is thought that glutathione (GSH) is 
the active compound in vivo (Visser, 1976, 1979; Imai et al., 1980; 
Chopra, 1978). 
Thus equations 2.1 and 2.2 may be written as: 
T4 + 2RSH T3 + R-S-S-R + HI (2.3) 
T4 + 2RSH rT 3 + R-S-S-R + HI (2.4) 
Other enzymic mechanisms of deiodination may exist which do not 
require a reducing compound as a cofactor or substrate. Sinsheimer 
et al. (1978),using synthetic iodinated ring compounds as models, 
found that they were deiodinated in vitro by rat liver cytosol by one 
of two mechanisms. The first, similar to the mechanism in equations 
2.3 and 2.4 required glutathione (GSH) but the second mechanism not 
only did not require GSH, it was inhibited by GSH. 
As was discussed in Chapter 1, the early workers studying the 
peripheral deiodination of thyroxine had great difficulty in showing 
that deiodination by cell fractions was the result of enzyme action 
rather than a non-enzymic (e.g. photochemical) reaction. 
It was therefore essential to establish that the assays devised 
in Sections 2.2 and 2.3 for the measurement of iodide-125 reflect the 
enzymic production of iodide-125 from the substrate rather than 
non-enzymic processes. 
To show that incubations with enzyme preparations are revealing 
enzymic rather than non-enzymic deiodination it was necessary to 
establish a suitable control. 
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In general, the in vitro determination of any enzyme activity 
requires a number of conditions to be met before meaningful results 
are obtained. 
(1) A source of enzyme must be found, e.g. a tissue 
or tissue fraction. 
(2) An appropriate reaction medium, e.g. one with 
defined pH, salt concentration, temperature. 
(3) The timed commencement of reaction by the addition 
of sufficient substrates. 
(4) The use of controls to measure the non-enzymic 
reaction rate. 
(5) The measurement of change in substrates or products 
or both, either by continuous measurement or by 
stopping the reaction in aliquots at a predetermined 
time and then measuring the changes. 
(6) The extraction and separation of substrates or 
products or both may be necessary before their 
measurement. 
The experimental evolution of such as assay however, usually 
proceeds in the reverse order of the above points. That is, a means 
is established for the measurement of the substrates or of the products 
and then the means of fulfilling the other criteria listed above are 
experimentally verified. Hence the development of the assays used 
will be discussed in approximately the reverse order in the subsequent 
sections, beginning with estimation of iodide and then of thyronines. 
The establishment of an assay for deiodination became a problem 
of the measurement of individual iodothyronines and of the 1 - ions 
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produced by deiodination .. A less suitable alternative for the 
measurement of deiodination is the increase in the amount of oxidized 
sulphydryl compound formed. However it would be less specific having 
a iow signal to nbise ratio. That is, the likely concentration of GSH 
utilized of approximation .10-8 mo1/1 when compared to that of the total 
GSH in the reaction mixture of 10 -9 mo1/1. 
The physiological concentration range of thyroxine in plasma in 
man is about 10 -7mo1/1 and that of T3 10-9 mo1/1 and rT3 0.5 x 10 -9 mo1/1 
(reviewed by Di Stefano and Fisher, 1976). The two in vitro methods 
which seemed capable of use were: 
(i) saturation analysis, e.g. radioimmunoassay of 
T4 and its products; 
chromatographic separation of radiolabelled 
1251 -T4 and its products followed by measurement of 
the radioactivity of the separated iodothyronines. 
Other workers, for example Hesch et al. (1975), Chopra (1977) 
and Visser et al. (1975) chose to employ RIA in measuring T4 disappearance 
and 13 production by enzyme action without measuring the production of 
I - and that of other lesser iodinated thyronines. Although 
subsequently diiodo- and monoiodothyronines have excited much interest 
by many workers, e.g. Chopra et al. (1978). 
The overwhelming advantage of RIA is its simplicity in performance 
(but not necessarily in its development) and its sensitivity and 
suitability to the very low levels of iodothyronine for both in vivo 
and in vitro studies. RIA of thyronines has several requirements. 
It needs an antibody of sufficient sensitivity and specificity and a 
labelled hormone (tracer), usually labelled with iodine-125. 
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At the time of the commencement of my investigations, only T to 
T3 and later rT 3 were commercially available as radiochemicals either 
as 1251 (or 131 1) labelled chemicals, and as animal facilities were 
not then available to me for raising antibodies. I therefore 
decided not to try to use RIA but to employ 1251 labelled thyroxine 
or other labelled iodothyronines incubated with in vitro systems and 
, separate the products formed by chromatography. This would have 
two advantages, firstly, the I - (which is not measurable by RIA) and 
the iodothyronines liberated,would be radioactively labelled, thus 
allowing measurement of very small concentrations (depending on specific 
activity of starting material) but far below the 10 -9 mo1/1 limit. 
Secondly, it would potentially allow the measurement in the one assay 
of all of the products formed, given that they could all be separated 
chromatographically and the iodine -125 measured by a gamma-counter 
which was available. The counter was a Packard Model 3001 Tricarb 
Scintilation Spectrometer which gave for iodine-125 an apparent efficiency 
of 70%. The use of aqueous solutions, chromatographic paper, or TLC 
backing sheets of plastic or aluminium foil, had no significant effect 
on the efficiency of the counting by the counter. 
Therefore the problem of measurement was readily solved, the major 
problem remaining being the one of separation of iodine and the 
iodothyronines to allow their measurement. 
There were many published methods for the separation and 
measurement of iodide and iodoaminoacids, for example using paper 
chromatography (Roche et al., 1964), thin layer chromatography 
(Osborn and Simpson, 1969; Cahnmann, 1972), ion exchange column 
chromatography (Sorimachi and Ui, 1975) and gas-liquid chromatography 
(Richards and Mason, 1966). 
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None of these methods, except perhaps for gas chromatography, 
would separate all of the iodothyronines of interest in a single run, 
but almost all these compounds could be resolved by the use of two-
dimensional chromatography, especially TLC (West et al., 1965). 
However when I came to use the methods of Roche et al. (1964), 
I was unable to reproduce any of their published separations of T4 
and rT 3 , nor of the diiodothyronines. This was confirmed by 
Dr H. Rokos of Henning GMBH, Berlin (personal communication) 
who was also unable to reproduce the separations of Roche et al. (1964). 
In a review, Plaskett (1964) has pointed out that highly variable R f 
values had been obtained by various authors using apparently the same 
chromatographic systems in separating the iodoamino acids on paper. 
He further suggested that very small changes in the physical 
dimensions of tanks or of their vapour concentrations, especially that 
of ammonia, were in part responsible for the wide variations noted 
and which had sometimes led to the non-reproducible results between 
different laboratories. Pitt-Rivers and Tata (1959) also mention 
the great variability of solvent systems on the migration of 
iodothyronines. 
Because of the variability in paper and thin layer chromatograhy 
it was necessary to devise other methods for the measurement of 
iodide and iodothyronines. This work is described in the 
subsequent sections. 
2.2 Ion Exchange Chromatography  
Backer et al. (1967) introduced the use of sulphonated polystyrene 
cation-exchange resins (e.g. Dowex 50W) for the extraction of thyroxine 
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from serum samples which at the same time allowed the removal of 
inorganic iodide. This ion-exchange method was modified by Tajuddin 
and Elfbaum (1973) for the extraction and clean up of serum 
iodothyronines prior to their derivatization for gas chromatography. 
This ion-exchange method was then combined with an ethanol precipitation 
and extraction for the assay of the 125J.  enzymically from 
125 I-iodothyronines (see Fig. 2.2). 
The same method allows separation of iodothyronines as a group 
suitable for their separation by HPLC. Recoveries can be estimated 
by counting both I - and thyronine fractions. 
2.3 Butanol Extraction  
Although the ion exchange method is reliable it is slow, so that 
another more rapid method is desirable. The use of butanol as a 
separating agent was examined in the following experiments because of 
its long history in improving the specificity of PBI (protein bound 
iodide) as the BEI (butanol extractable iodide) from serum in the 
estimation of circulating thyroxine. 
I felt that a hydrophobic solvent, when added to butanol or 
another solvent, would help to exclude water and hence I - from the 
solvent phase. The protocol is shown in Fig. 2.2 and the extraction 
data is displayed in Table 2.1 and Fig. 2.3. 
Table 2.1 shows that a good retention of iodide in the aqueous phase 
occurs with several solvents, and that this separation is improved by 
the addition of petroleum spirit as a strong hydrophobic solvent. 
In particular, the combination of BuOH/Pet.Spt. between 50/50 to 25/75 
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FIG. 2.1 Ion-Exchange Extraction for Iodide and Iodothyronines. 
Stop enzyme reaction with 4 vols Et0H 
Centrifuge 
1 
Supernatant (SN1) Sediment 
Wash with 2 mls 80% Et0H 
Centrifuge 
1  
1 
SN2 Sediment 
 1 discard 
1 
Combine supernatants 
Add 0.1 ml 4M HC1 
Load onto 1 ml of 
AG 50W-X2 (H+ form, Cahnmann, 1972) 
Rinse container with 1 ml 80% Et0H 
and add to load fluid 
Elute slowly Combine the column effluents 1 	f ollowing load fluid and first 4 mls of the acetate buffer. 
Elute with 4 ml Count as 125-iodide. 
0.15 M NH 4 CH 3C00 pH 8.5 
Wash with further 20 mls 
of NH 4 CH 3 C00 and discard 
Slowly elute iodothyronines with 
10 ml methanol/NHOH 97/3 (v/v) 
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FIG. 2.2 Protocol for Solvent Extractions. 
1 ml of buffer 250 mM 
KC1 100 mM 
(
IL Sucrose 
HEPES 25 mM  
15 mM ) EDTA 
DTT 1 mM 
Add 25 pl* of 1251  -thyroxine to make 10 -7 M and mix. 
Then add 100 pl of 75% w/v CC1 3 COOH 
Add 1 ml butanol mixture, or other solvent, 
mix thoroughly in vortex mixer, allow to separate, 
then aspirate and discard upper phase. 
Repeat once. 
Count aqueous layer as iodide-125. 
*This sample of 25 pl of [3 1 5 1 - 125 I] thyroxine contained a total of 
220,000 cpm of which ion-exchange determinations showed 51,579 ± 5667 cpm 
present as free iodide'anion. 
48 
TABLE 2.1 Iodide Separation by Solvent Extraction. 
Solvent Composition 
(parts by volume) 
Iodine-125 in Aqueous Layer 
(% of total radioactivity added) 
Mean s.d. (n) 
n-butanol (BuOH) 100 16.0 1.2 7 
/Pet.Spt.(60°-80°) 75/25 19.9 2.2 5 
50/50 20.6 1.5 5 
25/75 25.1 2.7 5 
0/100 81.2 5.5 5 
/Pet.Spt.(80°-100°) 75/25 17.9 2.3 5 
50/50 17.7 2.0 5 
25/75 18.9 2.1 5 
0/100 82.5 6.4 5 
benzyl alcohol 100 72.8 10.4 10 
/Pet.Spt.(60°-80°) 75/25 31.4 3.6 5 
/Pet.Spt.(80°-100°) 75/25 34.6 2.6 5 
isoamylalcohol 100 20.3 2.6 10 
/Pet.Spt.(60°-80°) 50/50 19.1 3.4 5 
/Pet.Spt.(80°-100°) 50/50 21.2 3.1 5 
t-amylalcohol 100 19.6 3.4 10 
/Pet.Spt.(60°-80°) 50/50 20.8 1.6 5 
/Pet.Spt.(80°-100°) 50/50 20.3 2.3 5 
Total cpm added for each extraction 212,282 ± 20,807 cpm (100 ± 9.8%) 
and when assayed by ion-exchange indicated 
that T4 was 160,703 ± 20,021 cpm (75.7 ± 9.4%) 
and I - was 51,579 ± 5,667 cpm. (24.3 ± 2.7%) 
49 
appears best in this regard. However inspection of a plot of this 
set of data for BuOH/Pet.Spt. in Fig. 2.3 suggests that some 
thyroxine may be excluded by the petroleum spirit and remain in the 
aqueous phase. This certainly occurs with 100% Pet.Spt. The 
addition of petroleum spirit also markedly improved the speed at which 
the two phases separated after mixing. By itself, butanol often 
needed centrifugation to separate the two phases. Butanol/Pet.Spt. 
has a further advantage of being a cheaper solvent mixture than the 
other alcohol mixtures which give equivalent separations. 
The possibility of thyroxine being retained in the aqueous phase 
was investigated in the following experiment. A sample of 125 1 - was 
prepared from an old batch of 125 I-thyroxine by the ion-exchange method 
and then diluted to give 4474 cpm/ml. As well, 10 pl of 125 I-thyroxine 
(containing 70,058 cpm of which 13,420 cpm were shown to be 125 1 - ) was 
added to 1 ml of water. Multiple samples of both I - and thyroxine 
containing I - were then extracted using Butanol/Pet.Spt. combinations. 
The data is presented in Fig. 2.4 and the calculated aqueous distribution 
of T4 is shown in Fig. 2.5. The two figures suggest that using 
butanol/Pet.Spt. (50/50 v/v) gives 86% I - and 5% T4 in aqueous phase. 
The value of 5% T4 in aqueous phase might be of concern if the 
degree of deiodination were of that order, however in practice more than 
80% of T4 is protein bound after TCA precipitation (Nakagawa & Ruegamer, 1967) 
so that in an actual assay it would be anticipated that T4 will be 
markedly decreased by its affinity for the precipitated protein which 
occurs on stopping the reaction and less than 1% of T4 will be present in the 
aqueous layer. This was tested by employing the protocol in Fig. 2.6 
using a 10% w/v renal homogenate in TRIS buffer pH 7.4. Five 
determinations of each group were made and the data is shown in Table 2.2. 
100 
1=4 
eti 
0 	50 
	
100 
Pet. Spt. 10) 
FIGURE 2.3 The Effect of Pet. Spt. on the Butanol Extraction of 
T4 and I - . 
The data plotted is taken from Table 2.1. 
100 
..•••••% 
• 
• ••■• 
0 	50 	100 
Pet. Spt. CYO 
FIGURE 2.4 Distribution of T4 and I - between Water and Butanol/ 
Pet. Spt. Mixtures. 
100' 
a 
• 
0 	50 
Pet. Spt, (0/s) 
100 
FIGURE 2.5 Corrected Data for the Distribution of T4 between Water and 
Butanol/Pet. Spt. Mixtures. 
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FIG. 2.6 Protocol for Butanol/Pet.Spt. Extraction in the 
Presence of Protein. 
To 1 ml tissue fraction 
add: either 25 j.il 1251-  or. 125 I-T4 
add: 0.1 ml 75% w/v TCA mix 
centrifuge 
S.N. ppt 
discard 
Wash with 1 ml BuOH/Pet.Spt. (50/50 v/v) 
the aspirate upper layer. Repeat once. 
Count aqueous layer for 125 1 - 
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TABLE 2.2 Radioactivity CO in Aqueous Layer and Protein Precipitate 
after Butanol/Pet.Spt. Extraction. 
Fraction 
Buffer Homogenate 
1251- 1251-T4 125r- 1251-T 4 
Aqueous 
layer 
93 ± 3 ' 2 ± 0 80 ± 3 1 ± 0 
Protein 
precipitate 
Not Applic. Not Applic. 27 ± 1 66 ± 1 
As the data in Table 2.2 have not been corrected for endogenous 
I - present in the 125 I-T 4 used, it indicates that <1% of T4 will be 
found in the aqueous layer when the extraction is used on protein 
solutions, and that a likely extraction efficiency for 125 1 - will be 
about 80% which is an acceptable figure for routine assay of the enzyme. 
The above method was also tested for effects of strong salt 
(0-1000 mM KC1), detergents (0.1% Triton X100 and 0.1% SDS) and 
sucrose (250 mM), all had an effect of <5% on the extraction of iodide, 
and had <1% effect on residual aqueous T. 
In conclusion, the butanol/petroleum spirit extraction method 
gives a rapid, cheap, and reproducible method of separation of iodide 
from thyroxine. It has about 80% recovery of iodide with <1% contamination 
by thyroxine in the aqueous layer under the conditions of assay. 
It therefore fulfils the requirement for a rapid assay (Dixon and 
Webb, 1962). However it does not discriminate between various 
iodothyronine products. The separation and measurement of iodothyronines 
is discussed in the next section. 
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2.4 Separation of Iodoaminoacids by High Performance Liquid  
Chromatography (HPLC)  
2.4.1 Introduction  
High performance liquid chromatography (HPLC) is also known 
as high pressure liquid chromatography (HPLC) or as high speed  
liquid chromatography (HSLC). These terms are synonyms for the 
same sort of general chromatographic system. Such systems are 
all characterised by the above adjectives, viz: speed, performance 
and pressure. The latter condition of high pressure being needed 
to achieve the former two. HPLC is in fact no different in 
principle to any other form of chromatography. It does, however, 
often possess the advantages of speed or resolution. 
The fundamental theory for HSLC was developed by Giddings 
(1965) and Hamilton (1966) and has since been improved and 
extended by many workers (reviewed by Kirkland, 1971; and by 
Brown, 1973). It has been widely introduced in the mid 1970's 
with continuing improvement in performance, especially of pumps 
and column packings, and in reliability and ease of use (see 
reviews by Perry et al., 1972; Done eta]., 1974; Johnson and 
Stevenson, 1972, 1978; and Simpson, 1976). 
A marked increase in the use of stationary hydrophobic 
("reversed-phase") packings through which a more polar mobile phase 
is pumped, has occurred and such systems now provide the majority 
of HPLC separations being reported (reviewed by Karger and Giese, 
1978; and by Brown and Krstulovic, 1979). 
t- 6 
2.4.2 Application to Iodoaminoacids  
The use of HPLC to separate both derivatized (De Vries 
et al., 1975; Bollet and Caude, 1976) and non-derivatized aminoacids 
(Hancock et al., 1976) has been rapidly developed. Many of these 
approaches are therefore relevant to the separation and quantitation 
of the thyronines as they are phenolic iodoaminoacids. In fact, 
the two manufacturers, Waters and Merck, have both published 
instructions for using their reversed phase (C 18 ) column packings 
to separate and quantitate the T4 and T3 in thyroxine tablets. 
Both systems employed aqueous methanol. Waters used KH 2 PO 4 
and Merck used proprionic acid as the polar solvent modifiers. 
Karger et al. (1974) published a normal phase separation of T4 
and T3 using perchlorate ions pairs bound to a silica column. 
However none of these systems adequately separate other 
iodothyronines, especially the two pairs rT 3 and T4, and 
3,3'-T 2 and 3'5'-T 2 . Hancock et al. (1978) introduced 0.1% 
phosphoric acid in methanol or acetonitrile mobile phases with 
C13 reversed phase packings which could separate rT3 and T4 but 
not 3,3'-T 2 and 3'5'-T2 . The phosphoric acid provides a counter-ion 
or ion-pair of opposite polarity to the molecule of - interest and 
it is this "ion-pair" that is separated, leading to improved 
separation, sharpened peaks and reduced retention times (Hearn and 
Hancock, 1979). 
The detection of iodoaminoacids is possible by their light 
absorption in the U.V. range. They have the generalised maximum 
common to aminoacids in the low U.V. range at about 210-220 nm 
with additional specific maxima (depending on ionization state of 
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phenolic ring) between 280 and 330 nm (Robbins and Rail, 1967). 
However the sensitivity is insufficient to measure less than 
about 10-6 M when using a mercury lamp detector at 254 nm. 
Nachtmann et al. (1978) have coupled a post column 
detection system to a RPLC separation using the redox reaction 
between cerium (IV) and arsenic (III) catalysed by trace amounts 
of iodine. This method,although troubled by an erratic baseline, 
has a very high sensitivity and may eventually allow detection of 
physiological concentrations of T4 and 13 of 10-9 - 10-7M. 
Another detection system suitable only for in vitro work 
is to use labelled (1251)  iodothyronines and collect the column 
effluent into fractions and count these in a gamma-counter. 
The thyronines are hydrophobic in nature, being quite 
insoluble in water, but soluble in alcohols and strong bases. 
Solubility is often reduced by the formation of insoluble chelates 
with divalent cations (Kendall and Osterberg, 1920). Because of 
these properties, together with the preliminary separations 
established by Waters and by Merck, it was decided to attempt to 
improve the separations using reversed-phase HPLC (RPLC). 
The potential of this approach has been confirmed by 
Hearn et al. (1978) who have established separations of the 
thyronines but who failed to adequately separate 3,3'-T 2 and 
3'5'-T2. 
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2.4.3 Basic Theory of HPLC Separations  
The theoretical basis for establishing a separation and 
subsequent measurement of band height on HPLC is well discussed 
by Snyder and Kirkland (1974) and Karger et al. (1973), from whom 
the following condensed treatment is taken. 
The resolution of two bands on a chromatogram is 
defined as 
   
Rs 	t2 - t i 
 
(2.5) 
•(twi + tw2 ) 
and can be measured on the chromatogram (see Fig. 2.7) 
 
To control the resolution of two bands in an empirical 
sense, resolution can be shown to be related to measurable variables 
on the chromatogram so that for two closely migrating bands 
= (i14-) - 1) A (-k-d5.--; 1 ) 
(i) (ii) (iii) 
where ' (the capacity factor) is given by 
(2.6) 
k' = 
tx 
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tx - to 
 
and a (the selectivity factor) is given by 
k2 	where k 1  and k are the capacity a 2 
factors for bands 1 and 2. For two 
close bands k' = k 1 = k 2 
and N (the theoretical plate count) of a band is given by 
N 	= 	16 
(t.
x 
tw 
) 2 
The concept of N or theoretical plate count was introduced by 
Martin and Synge (1941) who showed that 
where L is length of column and H is height equivalent of 
theoretical plates, a concept which in turn was derived from 
distillation theory. 
Equation 2.6 is a fundamental relationship in HPLC which 
allows the empirical control of resolution by manipulating the 
three terms a, N, k which are essentially independent of each other. 
This means that it is possible to optimise these variables one after 
the other. 
The separation selectivity as measured by a in term (i) is 
varied by changing either the composition of either the moving or 
stationary phase or both. The separation efficiency as measured 
by N is varied by changing the column length or solvent velocity. 
The capacity factor k' is varied by changing solvent strength to 
increase k' (weaker solvent) or decrease k (stronger solvent). 
These manipulations are shown diagramatically in Fig. 2.8. 
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Vary k' 
Increase 
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cc 
t 
FIGURE 2..8 The Effect on Resolution of Manipulating the Chromatographic 
Parameters for HPLC. 
2.4.4 Chromatographic Equipment and Solvents  
A Waters Assoc. (Milford, Mass., U.S.A.) HPLC system was 
used which consisted of two M-6000 A solvent delivery pumps, 
a U6K universal liquid chromatograph injector and a M-660 solvent 
programmer coupled to a series 440 uv absorbance detector (254 nm) 
and a Linear Instruments double channel pen recorder. 
A pBondpak C18 (10 pm) of 300 x 3.9 mm was used for all 
separations. 
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The column material consists of 10 micron diameter 
porous silica particles, the silanol groups of which have been 
reacted as follows (reviewed by Grushka and Kikta, 1977): 
--SiOH + C1Si(CH 3 ) 2 (CH 2 ) 17CH 3 Si(CH3)2(CH 2 ) 17 CH 3+ HC1 (2.7) 
1 
for steric reasons not all silanol groups will react (<45%), the 
silica surface thus consists of a mixture of silanol and bonded 
groups. The free silanol groups can then be reacted with 
trimethylchlorosilane to block them and prevent their interference 
with column reactions. 
The use of the pBondpak C18 column of constant length 
virtually fixes N for any separations using the column except 
for variations in flow rate. However k' and a can be varied 
widely. These experimental variations in k' and a are discussed 
in the following sections. 
Iodoaminoacids were all purchased from Henning GMBH, Berlin 
except for 3,5-7 2 (Koch-Light, Haverhill, U.K.) and MIT and DIT 
(Sigma, St. Louis, U.S.A.). KH 2 PO4 (Ajax, Sydney). Methanol 
either Merck (AR) or Waters (HPLC grade), n-propanol (AR) (Ajax, 
Sydney). Ethanol (nominally 95%, Berri Cooperative, Adelaide) 
and redistilled over ferrous sulphate through a 30 cm column packed 
with glass-wool to remove ultraviolet absorbing material. This 
meant that each batch of ethanol varied slightly. 
As alcohol-water mixtures shrink on mixing, mixed solvents 
were always made by adding the aqueous component last to bring 
the solution to the final volume. All the solvents were filtered 
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through a 0.5umTeflon filter (Millipore, Sydney) and degassed 
under partial vacuum before use. 
Standards (25 pg/m1) were prepared in either 50% v/v 
methanol or 30% v/v ethanol and then filtered and degassed similarly. 
The standards were kept at -5°C in the dark to prevent deiodination. 
When in use, the standards were kept at room temperature in the 
dark near the apparatus. 
2.4.5 Manipulations of the Mobile Phase  
Methanol is an often used solvent for the mobile phase 
in reversed phase HPLC, and as discussed earlier, has been used 
in the separation of thyronines. Accordingly, aqueous mixtures 
of methanol with 0.05 M KH 2 PO4 in various proportions were tried, 
the best separation, in terms of k' and R s , was obtained with 
55% methanol (see Fig. 2.9). Table 2.4 lists tx (elution time) 
and t (band width duration) for each thyronine when Chromatographed 
separately under these conditions. Most thyronines are resolved, 
but the triplet TA 2/3,3 1 -T2 /3 1,5'-T2 and the pair TA 3 /T4 are not 
resolved. Of these, the most important in terms of deiodination - 
reactions is the pair 3,3'-T 2 and 3',5'-T 2 which are not resolved 
at all. • By further reducing the proportion of methanol in the 
mobile phase it is possible to partially separate 3,3'- -T and 
3',5'-T2 but at the expense of prolonged elution time (t x ), 
increased k', markedly reduced band height, and increased band 
width and tailing (see Fig. 2.10). Table 2.4 compares the 
separation of 3,3'-T 2 and 3',5'-T2 at 55% and 40% methanol., 
3b 210 1 10 	min 
Column: Waters 1 Bondpak C18 30 x 0.39 cm. 
Eluant: Methanol/KH 2 PO 4 0.05 M (55/45 v/v). 
Pressure: 3000 PSI 
Flow Rate: 2 ml/min. 
Sample: 140 pl containing 10 pl of each thyronine. 
Detection: UV 254 nm 
DIT 
TA 2 
3512 
FIGURE 2.9 The Optimum Separation of Iodothyronines Obtained with"Methanol. 
2b 
	1 	
L;ci 
min 
FIGURE 2.10 Partial Separation of 3',5'-T 2 and 3,3'-T 2 by Methanol. 
Column: Waters p Bondpak C I 8 30 x 0.39 cm. 
Eluant: Methanol : KH 2PO 4 0.05 M 40:60 
Pressure: 3000 PSI 
Flow Rate: 2 ml/min 
Sample: 20 pl of each. 
Detector: 254 nm. 
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TABLE 2.3 Elution of Thyronines by Methanol 55/45 (v/v) 
KH 2 PO4 0.05M. 
Thyronine/ 
Iodoaminoacid 
Chromatographic Variable 
tx 
(time of elution; 
min) 
tw 
(width of band 
in time; min) 
-t 
k'( 
 o ) 
tx 
MIT 1.6 0.15 0.45 
DIT 2.05 0.15 0.86 
To 2.05 0.15 0.86 
3T 1 3.1 0.2 1.81 
3'1. 1 3.6 0.3 2.27 
3,5-T 2 3.9 0.3 2.54 
3,3'-T2 6.4 0.5 4.81 
3'5'-T2 6.5 0.4 4.91 
3,5,3'-T 3 7.75 0.55 6.05 
3,3'5'-T 3 (rT ) 11.75 0.95 9.68 
3,5,3'5'-1. 4 14.3 0.8 12.00 
DIAC 6.15 0.45 4.59 
TRIAC 13.9 0.8 11.64 
TETRAC 25.8 1.4 22.45 
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TABLE 2.4 
 
Alteration of Methanol Concentration and R s of 
3',5'-T 2 and 3,3'-12. 
Methanol 
(vol. %) 
Chrom. 
variables 
3,1 5 1 -T2 3,3 1 -12 
55% 
tx (mins) 
k' 
a 
6.5 
4.91 
6.5 
4.91 
1.00 
0.00 
40% 
t (mins) 
x 
k' 
a 
Rs 
30.1 
19.07 
33.45 
21.30 
1.12 
0.67 
The use of 40% v/v methano1/KH 2PO 4 although partially 
resolving 3,3'-T 2 and 3',5'-T 2 would at the same time so prolong 
the elution times (and k') for other iodothyronines such as 
T3, rT 3 and T4 that their band height would approach the baseline 
as predicted by N = 16( tx 2 . 
tw 
Instead, an alteration in a is required without markedly 
affecting k'. This can be achieved, as noted in the introduction 
by altering either the column packing or the solvent. It was 
decided to try alterations of solvent as the first approach. 
Various strengths of aqueous solutions of acetonitrile were 
tried but failed to separate 3,3'-T2 and 3',5'-T2. Such mixtures 
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were, however, able to markedly reduce elution times and hence 
k' when tompared to aqueous methanol mixtures. 
Ethanol and propanol are not often used in HPLC because 
of the difficulties firstly, in getting spectroscopically clean 
ethanol and secondly, the increased viscosities of both,when 
compared to methanol, require higher pump pressures. Nevertheless 
I felt that they might be useful solvents to vary a and allow the 
separation of the diiodothyronines. 
In order to allow comparison of ethanol and propanol with 
methanol, various aqueous mixtures of each were used to separate 
3,3'-T 2 and 3',5'-T 2 . Solvent strengths were chosen to give 
overlapping solvent polarity index values (Snyder, 1974). The 
separation achieved with varying ethanol concentration is shown 
in Fig. 2.11. No resolution was obtained with n-propanol. 
The chromatographic variables for both solvents are shown in 
Table 2.5. 
Ethanol is obviously the superior solvent in terms of 
higher selectivity (a) and resolution (R s ). Thus the alcohols do 
not form a series of increased resolution with increased molecular 
weight. Ethanol is fortunately higher in its selectivity for 
3,3'-T2 and 3',5'-T 2 . 
Manufactured columns may vary in performance both between 
columns initially and during their lifetime of use so that 
empirically for each column, the separation must be optimised. 
This became particularly apparent during this work, for example, 
the Rs for 3,3'-T2 and 3',5'-T 2 was initially 1.25, one month later .  
FIGURE 2.11 The Separation of 3,3'-T 2 and 3',5'-T 2 by Ethanol Mixtures. 
Column: 
Eluant: 
Pressure: 
Flow Rate: 
Sample: 
Detector: 
Waters p Bondpak C18 39 x 0.30 cm. 
Et0H/KH2PO4 0.05 M (v/v) (i) 38/62; (ii) 32/68; (iii) 25/75. 
4000 PSI 
2 ml/min 
20 pl each of 3,3'-T 2 and 3',5'-T 2 
254 nm 
1 15 
min 
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TABLE 2.5 Effect of C2 and C3 Alcohols on the Separation of 
3,3'-T2 /3',5'-T2 . 
% Solvent/KH PO 4 
3',5'-T2 3,3'-T2 Ethanol 
38% t
x 
(mm) 
k' 
R
s (min) 
3.65 
4.21 
4.65 
5.64 
1.34 
1.25 
32% t 
x 
k' 
R
s 
6.85 
8.78 
8.9 
11.7 
1.33 
1.37 
25% t
x 
k' 
a 
R
s 
18.1 
24.9 
26.05 
36.21 
1.45 
2.86 
Propanol 
23.5 t
x 
k' 
a 
R
s 
3.90 
2.90 
3.90 
2.90 
1.00 
0.00 
19.6 t
x 
k' 
7.00 
6.00 
7.00 
6.00 
a 1.00 
0.00 
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it had dropped to 0.81 and the next day 0.30 with marked skewness 
and band trailing. The column was discarded and a new one installed. 
The optimal separation for all the iodothyronines using ethanol is 
shown in Fig. 2.12 and the chromatographic variables tabulated in 
Table 2.6. However R s for 3,3'-T 2 and 3',5'-T2 is much reduced 
when compared to the previous column but because the peaks are 
sharp and have very low skew, the resolution is more than 
adequate for band height determination. 
TABLE 2.6 Separation of Iodothyronines with 39%v/v Ethanol/KH2PO4 0.025 M. 
t x k' Rs 
To 19.0 1.11 
3.56 
3T 1 31.0 2.44 
0.93 
3'T 1 34.5 2.83 
1.23 
3,51 2 40.5 3.5 
3.29 
3',5 1 12 61.5 5.83 
0.37 
3,3'T 2 64.0 6.11 
2.56 
13 87.0 8.67 
3.17 
rT 3 127.5 13.2 
1.66 
T4 153.75 16.1 
( 
The plate value N, N = 16 tx 2 is in part a measure 
tw 
of band broadening. Its value, especially for the later bands, 
can be improved by means of a gradient as shown in Fig. 2.13. 
However, although the bands are sharpened and the N value is 
improved, the use of a gradient creates several problems. 
Firstly a long period of equilibration is needed to obtain stable 
conditions and if injection occurs before true equilibrium is 
_ 	3T2 
1351T2 T, 14. 
,3°51T2 
13 rT,3 
juv 
lb 
	
20 
min 
FIGURE 2.12 The Separation of the Iodothyronines by Ethanol. 
Column: 
Eluant: 
Pressure: 
Flow Rate 
Sample: 
Waters p Bondpak C18 30 x 0.9 cm. 
Et0H:KH 2 PO 4 0.05 M (38/62 v/v) 
4000 PSI 
2 ml/min 
50 ul containing 125 ng of each thyronine. 
• 	 3,4T2 
3T2 f .  
3512 
2‘0 
m n 
FIGURE 2.13 Gradient Elution of Iodothyronines. 
Column: 
Eluant: 
Pressure: 
Flow Rate: 
Sample: 
Waters p Bondpak C18 30 x 0.9 cm. 
35/65 linear gradient over 60 min to 50/50 Et0H/KH 2 PO 4 0.05 M. 
3800 ± 4000 PSI. 
2 ml/min. 
50 pl containing 125 ng of each thyronine. 
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obtained, the variation in elution time alters band heights, 
making their quantitation difficult. A rising baseline also 
makes band height measurement difficult. Isocratic conditions 
are usually preferred for these reasons. 
Potassium dihydrogen phosphate (0.05 M) was used in all 
separations following the separation devised by Waters Association 
for T4 and 13 and the work of Hancock and Hearn (1976) who found 
that 0.01% v/v phosphoric acid improved resolution, band height 
and reproducibility with many peptides. However the low pH of 
0.1% H3PO4 in solution is not recommended by Waters Associates 
(personal communication) who suggested that a pH <2 attacks the 
silicon-carbon bands of the reverse phase packing. I therefore 
continued to use KH 2PO 4which has an approximate pH of 4.0, instead 
of H 3 PO4 . The effect of KH 2PO4 on k' was assessed by measuring 
the resolution (Rs ) of 3,3'-T 2/3',5'T 2 in the absence of KH 2 PO4 
whilst varying the proportion of Et0H. The results are shown 
in Table 2.7. This data is graphically compared to the presence 
of 0.05 M KH 2PO 4 (Table 2.5) in Fig. 2.14 which suggests that 
similar resolutions may be obtained with or without KH 2 PO 4 but 
that in the absence of KH 2 PO 4 equivalent resolution is achieved 
at lower ethanol concentrations. However, Fig. 2.14 suggests 
that separation with KH 2PO 4 is less critically dependent on the 
concentration of ethanol; i.e., the curve of Rs between 1.0 - 1.5 
is flatter than the very steep curve for ethanol alone. 
The added KH 2PO4 was varied between 0 and 0.05M and the 
resolution of 3,3'-T2 and 3',5'-T2 was measured keeping the 
proportion of Et0H at 35% and a flow rate of 2 ml/min 
(see Table 2.8). 
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TABLE 2.7 Separation of 3,3' and 3',5' Diiodothyronines by Et0H Without 
KH 2PO4. 
Et0H % v/v 
, 
3'5'-T2  
35 
t
x 
k' 
a 
R
s 
(mins) 
94.5 
9.5 
134 
13.9 
146 
2.52 
37.5 
t
x 
k' 
a 
R
s 
77 
7.56 
. 
96 
9.67 
1.28 , 
1.56 
41.25 
t
x 
k' 
a 
R
s 
59 
5.56 
64.5 
6.17 
1.11 
0.7 
42.5 
1 54 
5.00 
58 
5.42 
tri 
ts 	
c4 
1.08 
0.56 
40 
2 
Rs 
1 
3 
• 
\o 
o
v 3 '
3T
2 
\o 0 
3,512 
0 .■•••10 
* mom' 
No KH2PO4 
0.05 M KH2PO4 
0 
20 	30 	40 	50 
Et0H 	v/v) 
FIGURE 2.14 The Effect of KH 2PO 4 in the Mobile Phase on the k' and 
Rs for the Separation of 3,3'-T 2 and 3',5'-T 2 by HPLC. 
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TABLE 2.8 Effect of KH 2PO 4 on the Resolution of 3,3'-T 2 and 3',5'-T 2 . 
KH2PO4 
(mo1/1) 
Elution time (tx ) 
3'5'-T 2 
Elution time (t x ) 
3,3'-T2 
R5 :3,3'-T 2/ 
3',3'-T 2 
0 6.9 7.9 1.7 
0.01 6.9 7.9 2.0 
0.025 6.9 7.7 1.6 
0.05 7.0 8.0 2.0 
Table 2.8 shows that there is very little effect of KH 2PO 4 
on retention time. However the addition of KH 2PO 4 may allow 
greater variations in solvent composition without deterioration of 
resolution. 
Deming and Turoff (1978) made a systematic study of the 
effects of pH on the mobilities of weak organic acids, adapting 
the graphical "window" technique of Laub and Purnell (1975, 1976) 
who had devised their method for the optimization of the separation 
of complex mixutres by gas-liquid chromatography. The "window" 
method is quite simple; all the components of interest are run 
at three or more variations of the mobile phase (in this case pH) 
and a plot (for every pair of chosen substances) of the relative 
retention a = k1 is made against the change in mobile phase 
k2 
(i.e. pH). The method is particularly useful in allowing one to 
choose conditions for maximising the resolution of all the bands, 
especially those which migrate across each other with change in 
mobile phase. 
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The pH of the mobile phase was therefore adjusted in the 
aqueous component by adding sufficient orthophosphoric acid to 
make it 0.01 M and then adjusting the pH with KOH (5M). The 
range was kept between 2.5 and 6.0 to prevent damage to the silica 
based packing. The aqueous phase was then degassed and combined 
with degassed ethanol to give a final concentration of 39% v/v 
which was run at 2 ml/min. The void time was 0.9 min. The k' 
for all iodothyronines and the R s for adjacent pairs are plotted 
against pH in Figs. 2.15 and 2.16. 
It is in fact not necessary to plot a window diagram as 
the components all maintain the same relative position as shown 
by Fig. 2.15. The difficult pair 3'5'/3,3' have the lowest 
resolution (R
s
) and were unaffected by changes in pH. 
However pH does have effects on retention time, especially 
of the later components rT 3 and T. 	So that, for processing a 
large number of samples a pH of about 3.0 would give the fastest 
elution time for the whole chromatogram of about 14 min. compared 
to 18 min. at pH 2.5 or pH 6.0. 
In conclusion, for best resolution of T4 and all its 
potential iodothyronine products, the optimal system is 39% v/v 
ethanol in 0.01 M H 3 PO4 adjusted to pH 3.0 with KOH. 
The linearity of response and calibration for each 
iodothyronine was checked by the injection of a constant volume 
(20 pl) containing various amounts of each compound (Fig. 2.17). 
A linear response is obtained for all thyronines. 
FIGURE 2.15 The Effect of pH on k' for the Separation of the 
Iodothyronines by HPLC. 
35/j5' 1-2 
T3 ,/ r T3 
rT3/ T4 33T2/ T3 
• ---- • 
 
-5'/33T2 
FIGURE 2.16 The Effect of pH on R s for Adjacent Pairs of Iodothyronines 
Separated by HPLC% 
0.10 
E254 
005 
0 •00 
0 	1 
	
2 
thyronine nmol) 
FIGURE 2.17 The Detector Response at E254 with Varying Amounts of 
Iodothyronine Injected onto HPLC. 
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2.4.6 Internal Standard and Extraction of Thyronines from  
Incubations. 
To improve the validity of peak measurement derived from 
tissue extracts the synthetic thyronine 3'-isopropyl-3, 
5-diiodothyronine (gift from Dr,E.C. Jorgenson) was used. It had 
a retention time between that of rT 3 and T4 (see Fig. 2.18). 
The internal standard was added at the end of the incubation. 
The incubation was then extracted as in section 2.2 and the methanol/ 
ammonia eluant dried under air at 40°C in dim light. It was then 
taken up in 120 pl of mobile phase and 100 pl injected into the 
HPLC. 
2.5 Preparation of Radioactive Substrate  
The detection of deiodination by the methods in section 2.2 and 
2.3 requires the use of iodine-125 labelled thyroxine (or other 
thyronine). In this study the thyroxine (and other thyronines) were 
obtained commercially with the iodine-125 only in the outer ring of 
the thyronine so that the thyroxine was labelled as follows: 
[3.,5.-1251 ]-thyroxine, rT 3 was labelled in the same positions, and 
13 was labelled as [3'- 1251]-3,3,51_  triiodothyronine. 
These substrates were purchased from the Radiochemical Centre, 
Amersham and from the New England Nuclear Corporation, Boston. They 
were supplied at different times in 50% aqueous 1,2 propanediol, 
50% ethanol or 50% propanol. 
For use, each substrate was diluted with 50% aq. propanediol and 
non-radioactive thyroxine (or other thyronine) was added so that 
3512 
1 31q2 
c., 
3312 	___., FT >, 
1 13 	T3 oc3- ri (- 
3- 
T4 
0 	10 
	20 
min 
FIGURE 2.18 The Migration of Isopropyl Diiodothyronine (internal std.) 
on HPLC. 
Conditions were the same as in Figure 2.12. 
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25 pl of the substrate when added to a 1 ml reaction volume contained 
between 50,000-300,000 cpm and a final concentration of T4 of 10 -7 mo1/1 
(or for T3, rT 3 10-8 mo1/1). These values were chosen to be close 
to physiological serum concentrations, and still provide an adequate 
specific acitivity of the substrate to allow detection of deiodination. 
As the radioactive iodine-125 atoms are present at the 3' or 5' 
positions in the outer (or phenolic) ring of the thyronines, they allow 
only the detection of deiodination from this outer ring. For brevity, 
this deiodination is described as 5'-deiodination. However this assumes 
that in solution the steric hindrance due to the bulky iodine atoms 
is overcome, and the phenolic ring is able to rotate around the angled 
oxygen bridge and allow the 3' and 5' iodine atoms to become equivalent 
substitutes for the enzyme (reviewed by Cody, 1981). Of course, 
"5'-deiodination" of T3 is not really a correct description as a single 
iodine atom in the outer ring is, by convention, always in the 3' position. 
2.6 The Selection of Buffer Conditions  
2.6.1 Introduction to the Selection of Buffer Components  
As was reviewed in Chapter 1, early workers had used 
radio-chemical techniques to demonstrate T4 deiodination by 
peripheral tissues. Later however, many instances of deiodination 
were shown to be non-enzymically induced either by flavin 
nucleotides activated by light or by hydrogen peroxide. 
Characteristic of many of these non-enzymic deiodinations, was 
their authors' inability to demonstrate any products of T4 
deiodination other than the end product iodide. Thus the assays 
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in sections 2.2 and 2.3, which depend on the measurement of 
iodide released from T4 or other thyronine, must be shown to 
maximise the enzymic deiodination rate and to minimise the 
non-enzymic rate. 
Recent workers on thyroxine deiodination have used a 
variety of buffer components; for example, Hesch et al. (1975) 
used triethanolamine or Krebs-Ringer bicarbonate; Visser et al. 
(1976) used TRIS/EDTA; Chopra (1977) used phosphate buffers; 
as did Leonard and Rosenberg (1978). 
Although the exact pH optima for T3 production from T4 
varies between authors, all have found the pH optimum to lie 
between 6.5 and 7.5. Hence a neutral pH (7.2-7.4) was chosen 
for initial studies. Of the potentially suitable buffers, HEPES 
(N-2 hydroxyethylpiperazine-N'-2-ethane sul phonic acid, Calbiochem, 
Sydney) pKa 7.55, IRIS (tris(hydroxymethyl) aminomethane, Sigma, 
St. Louis) pKa 8.1 and Na2HPO4 (Ajax, Sydney) pKa 7.2 were chosen 
as appropriate substances to buffer at pH 7.4. 
With respect to other components of the incubation medium, 
Visser et al. (1976) using liver cell homogenates and microsomes 
have shown that DTT is the most active of the essential sulphydryl 
compounds required in stimulating the conversion of 14 to T3 in vitro. 
Conversion was further stimulated by the addition of EDTA with DTT 
but not by EDTA alone. 
These observations on EDTA are of great interest as 
Kobayashi et al. (1966) found that metal chelators including EDTA 
are very effective in the prevention of trace-metal induced non-enzymic 
deiodination. On the other hand, Reinwein and Rall (1966) had 
78 
shown that non-enzymic deiodination by metal ions was either 
stimulated or inhibited by EDTA and which depended on the 
concentrations of both the EDTA and the cation (e.g. Fe 2+ ). 
Other cations which induced deiodination (e.g. Cu 2+ ) were only 
inhibited by EDTA. These authors showed a similar increased 
or decreased deiodination with different aminoacids, particularly 
those that would chelate metal ions. 
With respect to non-enzymic deiodination, those authors 
who have used thiol compounds to stimulate T4 to T3 conversion 
(e.g. Visser et al., 1976; Chopra, 1978; and Imai et al., 1980) 
do not record if they have investigated whether the reduced thiol 
compounds have an effect on deiodination not mediated by enzymes 
as catalysts; their published works used as a control the omission 
of the sulphydryl compound. However, of relevance is that 
cysteine is known to inhibit the rapid non-enzymic deiodination 
of radiolabelled thyroxine on storage (Braverman et al., 1970). 
Nevertheless, a priori it seemed possible that if the 
thiols were substrates in the reductive enzymic deiodination of 
thyroxine, then they may cause deiodination at an appreciable rate 
without the catalytic enzyme being present. Also, as HEPES and TRIS 
are amino compounds, they might have similar actions to the amino acids, 
in either stimulating or inhibiting non-enzymic deiodination. 
2.6.2 The Interaction of Buffer Components on the Non-Enzymic  
Deiodination of Thyroxine  
_The effects of EDTA, OTT, GSH, HEPES, TRIS, and NaH 2 PO 4 
were examined both singly and in combination, to determine their 
effects, if any, on non-enzymic deiodination. The data and 
experimental method are shown in Table 2.9 and its caption. 
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TABLE 2.9 The Effect of Buffer Ions and Sulphydryl Compounds on the 
Non-Enzymic Production of Iodide (1251-  ) from 125 I-Thyroxine 
in the Dark. 
Buffer 
Component 
Addition 
of TCA 
(420 mM) 
Addition 
of EDTA 
(15 mM) 
Sulphydryl Addition 
None GSH (10 mM) OTT (1 mM) 
NONE -0.4 4.8 2.1 
+ -1.3 1.3 10.4 
+ 1.4 •2.8 2.3 
-0.3 1.1 1.8 
HEPES -0.7 4.5 2.3 
(50 mM) + -0.3 1.3 7.2 
+ 0.1 2.3 4.0 
+ 0.3 1.1 0.9 
TRIS -0.6 2.1 1.7 
(50 mM) + -1.3 1.1 1.4 
+ -0.7 2.3 1.8 
+ -1.4 0.8 0.8 
NaH2PO4 0.2 4.1 2.0 
(50 mM) + -1.5 1.2 9.2 
+ 0.5 1.9 0.9 
+ + -0.4 0.6 1.3 
• Each value shown is the mean value of 5 determinations of 125 1 - liberated 
from 125 I-T4 and is expressed as the percentage of the total radioactivity 
added with correction for 1251-  already present. To simplify presentation, 
standard deviations are not shown but were all less than 15% of their 
respective means. The observations were made as follows. To a series 
of glass tubes at 0°C, concentrated solutions prepared from glass distilled 
water, were added to make, in a volume of 1 ml, the final concentrations 
shown in the table. All the solutions, except the water and the 
trichloracetic acid, were adjusted to pH 7.2 with either HC1 or NaOH before 
dispensing. The 125 I-T4 (10-10 mol and 322,500 cpm) in 25 pl was then 
added just prior to the transfer of the tubes for 2 hours into a 37°C 
water bath in the dark. After which time, 100 pl of TCA was added to the 
tubes not already containing 0.42 M TCA. 1251- was then measured after 
butanol extraction (Section 2.3). 
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From Table 2.9 it can be seen that in the presence of 
either TCA or EDTA or both, there is no measurable deiodination. 
This remains true when HEPES, TRIS or NaH 2PO 4 are present. 
The only statistically significant (t-test >95% c.1.) 
increase in deiodination occurs when sulphydryls are present 
as follows. Glutathione is associated with a small increase 
in non-enzymic deiodination in neutral (pH) conditions in the 
absence of EDTA and TCA, but not when either EDTA or acid 
conditions (TCA) or both are present. HEPES and NaH 2 PO4 have 
no effect on this deiodination but TRIS inhibits the GSH associated 
effect. 
Dithiothreitol on the other hand is associated with a 
marked increase (7-10%) in non-enzymic deiodination in acid 
conditions (TCA) but not when EDTA is also present nor in neutral 
conditions with or without EDTA. HEPES and NaH 2 PO 4 have little 
or no effect, but IRIS again inhibits the non-enzymic deiodination. 
In summary, glutathione stimulates non-enzymic deiodination 
in neutral conditions and DTT in acid conditions. Both processes 
are inhibited by EDTA and TRIS. 
2.6.3 The Effect of Light on Non-Enzymic Deiodination  
The effect of light on the non-enzymic deiodination of 
thyroxine was examined in the presence of HEPES buffer with 
additions of DTT, EDTA and KC1 singly and in combination. The 
methods and results are shown in Table 2.10 and its caption. 
KC1 was chosen as potassium and chloride ions are the predominant 
intracellular ions and might conceivably have an effect on 
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TABLE 2.10 Effect of Light on the Non-Enzymic Deiodination of 
1251 -Thyroxine in HEPES Buffer. 
Lighting TCA 
present 
Additions to HEPES (50 mM) buffer pH 7.4 
(420mM) None EDTA KC1 DTT EDTA/KC1/DTT 
(15mM) (100mM) (1mM) (15/100/1mM) 
DARK 2.0 0.4 2.1 2.3 2.4 
1.8 0.3 2.0 2.7 4.2 
LIGHT 1.1 0.0 1.9 2.4 2.4 
1.5 -1.0 2.0 2.4 3.0 
Each value shown is the mean of duplicate determinations of the 
percentage 1251  liberatedfrom 125 I-T4 during the incubation of two 
identical sets of tubes either in the light or in the dark for 2 hours. 
The methods used were the same as is described in the caption to 
Table 2.9. The tubes were prepared using HEPES as the buffer with 
the added components and their final concentrations as shown in the 
table. 
non-enzymic deiodination either by chemical exchange of chloride 
for iodide or because K  not complexed by EDTA. 
It is apparent from Table 2.10 that light does not 
increase the non-enzymic deiodination in the buffers tested, in 
particular, there is no additive effect with OTT. 
2.6.4 The Deiodination of 125 I-Thyroxine by Renal Homogenates  
The percentage of iodide released from thyroxine (10 -7M) 
by the kidney homogenates in the different buffers is shown in 
Table 2.11. The method is described in the caption to Table 2.11. 
Consideration of Table 2.11 in comparison with Tables 2.10 
and 2.9 shows that in the presence of trichloracetic acid, the 
denatured homogenate protein has no effect on deiodination which 
82 
TABLE 2.11 Deiodination of 125 1 - Thyroxine by Renal Homogenates. 
Lighting Presence 
of TCA 
Homogenising Buffer 
(420 mM) HEPES(50mM) HEPES-EKD TRIS(50mM) TRIS-EKD 
DARK 19.2 33.1 15.2 27.2 
+ 2.0 1.1 1.2 1.3 
LIGHT 23.2 31.6 16.5 25.9 
+ 1.7 1.6 2.5 1.0 
Each value shown is the mean of 5 determinations of 125 1 - liberated from 
1251_T4 and is expressed as the percentage of the total radioactivity 
added with correction for 125 1 - already present. Standard deviations 
were all <15% of their respective means. 
Homogenates were prepared first as a paste by passage of 8 rat kidneys 
through a Harvard Press. Weighed portions were then mixed with each 
buffer at 0°C to give a 10% (w/v) homogenate. The buffers were HEPES 
or IRIS 50mM pH 7.2; EKD is EDTA/KC1/DTT of 15/100/1 mM and pH 7.2. 
Incubation was for 2 hours in either the light or in the dark and 
followed the methods described in Table 2.9. 
cannot be ascribed to the non-enzymic deiodination by the buffer 
components in acid conditions. On the other hand, the homogenates 
at pH 7.2 show . a considerable excess of deiodination over that of 
their respective TCA-denatured homogenates. The deiodination in 
homogenates is further increased, by at least half, by the addition 
of EDTA/KC1/DTT to each buffer. 
Light gives a small and statistically non-significant 
(t-test <80%) increase with either TRIS or HEPES but this difference 
disappears with the addition of EDTA/KC1/DTT. Overall HEPES is 
a marginally better buffer than TRIS. 
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2.7 Conclusion  
In conclusion: 
(1) Assays for either iodide-125 or 125 1- iodothyronine 
production from 125 1- thyroxine have been established. 
(2) Buffer compositions have been found which have minimal 
non-enzymic deiodination rates and which, at the same 
time, promote enzymic deiodination by employing DTT 
and EDTA. 
(3) The addition of trichloracetic acid to homogenates 
at zero time provides an adequate control for the 
measurement of non-enzymic deiodination. 
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CHAPTER 3  
Cell Fractionation and the Intracellular  
Location of the Deiodinases  
3.1 Introduction  
In any attempt at purification of an enzyme, both a reasonably 
concentrated source of enzyme and a reasonably large quantity of 
starting material is desirable (Dixon and Webb, 1964). In this regard 
a number of kidneys, from normal Landrace pigs, was made available by 
Dr K.D. Rainsford of my department so that initially parallel studies 
on both pig and rat tissues were conducted. As discussed in Chapter 1, 
kidney tissues were chosen because the kidney has proportionately the 
highest in vitro T4 deiodinase activity of those tissues tested in the 
rat (Albright et. al., 1954; Larson et al., 1955) and in man (Albright 
and Larson, 1959). The high activity in rat kidney was confirmed more 
recently by Chopra (1977). 
Cellular fractionation of kidney and liver homogenates was performed 
primarily as a step in protein purification and secondly as a procedure 
to localise the intracellular sites of activity. 
As reviewed in Chapter 1, different authors, using RIA to measure 
the products T3, rT 3 or 3,3'-T 2 , identified different intracellular sites 
for deiodination. There was general agreement on a microsomal site for 
both 5- and 5'- deiodinating processes, however there was disagreement 
between the further possibility of deiodination at either , plasma membrane 
or endoplasmic reticular components of the microsomes. Thus the use of 
a different and sensitive chromatographic technique to measure deiodination 
might also provide useful information on the intracellular sites of 
deiodination. However the prime purpose of fractionation was as a step 
in the purification of the deiodinases. 
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3.2 Preparation and Properties of Homogenates  
3.2.1 Homogenisation  
Before examining the subcellular location of the deiodinases, 
preliminary studies on homogenates were made. However as the 
deiodinase activity of homogenates has been extensively investigated 
by many workers (reviewed in Section 1.2), only that work will be 
presented which is either relevant to my later studies on 
purification of the deiodinases or which is necessary to show that 
my results obtained with the assays in Sections 2.2 and 2.3 are 
comparable with those obtained by others using RIA. 
The available Methods of cell breakage prior to cell fractionation 
have been reviewed by Potter (1955) and more recently by Evans (1978). 
Initially Teflon in glass Potter-Elvehjem homogenisers having 
capacities between 25-100 ml were used. The largest had sufficient 
capacity to hold a whole rat liver or 6 rat kidneys. However.when 
pig kidneys were used, the kidney was cut into segments with a knife 
and homogenised first in a Waring Blender for 2 min at top speed. 
Unless otherwise stated, rat kidney homogenates were prepared 
from a local strain of male hooded Wistar rats of 180-220 gm. 
The rats were killed by stunning and cervical dislocation. The 
kidneys were rapidly removed and chilled in an ice-cold buffer. 
The kidneys were then homogenised by five passages of the Teflon 
piston in a Potter-Elvejhem homogeniser. 
3.2.2 Homogenising Buffer  
The composition of the homogenising medium was examined to see 
if the deiodinase activity of the homogenate would be improved by 
using constituents other than those described in section 2.6.4. 
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As the HEPES or TRIS buffers are not iso-osmotic, the addition 
of sucrose to maintain cellular organelle integrity was examined 
for any effect on homogenate deiodinase activity. Experimental 
details and results are given in Table 3.1 and its caption.. 
TABLE 3.1 The Effect of Sucrose on Thyroxine '-Deiodinase 
Activity in Rat Kidney Homogenate. 
Homogenising 
buffera 
Control Expt. 
Without sucrose 2.3 + 0.2 12.4 + 0.7 
With sucroseb 2.2 + 0.2 11.7 + 2.5 
a HEPES/EDTA 50/15 mM pH 7.4 
b sucrose 250 mM 
Comparable homogenates (10% w/v) were obtained by homogenising 
one kidney taken from each of two rats in the two buffers. 
The added substrate gave 122,000 cpm and a final concentration 
of T4 of 10 -7M. Incubation was for 2 hours at 37°C. Iodide 
values were measured by the butanol method and are uncorrected 
for iodide already present in the substrate and are expressed as 
percent of radioactivity liberated as mean ± S.D. for five 
determinations. 
Table 3.1 shows that the presence of sucrose has no measurable 
effect on the activity of •the renal homogenate. Nevertheless, it 
was decided to incorporate sucrose into the homogenising buffer or 
buffers to facilitate the later cell fractionation studies. 
Proteins and polymers such as albumin or polyvinyl pyrolidine (PVP) 
can be added to homogenising buffers to improve yields of enzyme 
activity in homogenates (reviewed by Crabtree et. al., 1979). 
To test this possibility, rat kidney homogenates were prepared in 
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sucrose-HEPES buffer alone or with either 1% w/v of bovine serum 
albumin (Sigma, St. Louis) or 1% w/v PVP (Sigma, St. Louis) and 
deiodinase activity measured as before. The effect of both these 
substances on the non-enzymic deiodination was measured at the 
same time. Experimental details and results are given in 
Table 3.2. 
TABLE 3.2 The Effect of Albumin or Polyvinyl pyrolidine on the 
Deiodination of Thyroxine in Buffer or in Kidney 
Homogenate. 
Assay Medium 
Addition to Buffera 
None Albumin b PVP b 
Buffer alone a Control 6.3 3.0 3.2 
Expt. 4.9 3.0 3.3 
Homogenate Control 2.9 2.8 3.1 
Expt. 24.6 4.2 16.8 
a Buffer: Sucrose/HEPES/EDTA/DTT (250/25/3/1 mM) 
Final concentration of 1% w/v 
The three homogenates were rapidly prepared in the ice-cold buffers 
from 6 rat kidneys each of which was sliced into three equal portions 
one each of which was added to each buffer and homogenised as 
described in section 3.2.1. Incubation conditions and the added 
concentration of substrate were the same as in Table 3.1. The values 
for percent iodide released are the means of triplicate determinations. 
Table 3.2 shows that both PVP and albumin decreased, rather than 
increased, the apparent activity of the homogenate. This result 
was not unexpected as both substances are known to bind thyroid 
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hormones and thus would reduce the activity in solution of thyroxine 
relative to its total concentration. Of interest also was the 
reduced control values in the buffers and in the homogenates. 
This suggested that there might be a concentratiOn of albUMin Which 
inhibited non-enzymic deiodination but not enzymic deiodination. 
This possibility was examined and the results and methods are given 
in Figure 3.1. 
It is apparent from Figure 3.1 that whilst increasing albumin 
concentration slowly reduces the non-enzymic deiodination, there is 
a markedly decreased enzymic activity, probably caused by the binding 
of the substrate to the albumin. Thus, the use of albumin in 
homogenates is not warranted. 
3.2.3 The Effect of pH on Thyroxine 5'-Deiodinase Activity in  
Rat Kidney Homogenates  
The effect of pH on thyroxine 5'-deiodinating activity in rat 
kidney was determined and the data and methods are shown and 
described in Fig. 3.2 There is a broad distribution of enzyme 
activity which appears to have several maxima at pH 6.0, 7.5 and 
9.0. 
3.2.4 The Effect of pH on Thyroxine 5'-Deiodinase Activity in  
Pig Kidney Homogenates  
A reasonably large amount of starting material is desirable in 
any purification attempt. In this regard a number of pig kidneys 
became available through the courtesy of Dr K.D. Rainsford of this 
Department. 
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FIGURE 3.1 The Effect of Albumin on 5'-Deiodination of T4 and T3 
by Rat Kidney Homogenate. 
Four rat kidneys were homogenised in buffer consisting of 
sucrose/HEPES/EDTA/KC1/DTT 250/50/15/100/1 mM pH 7.4 and then 
aliquots were mixed with an equal volume of one of a range of 
concentrations of bovine serum albumin (Sigma, St. Louis) in the 
same buffer to give the final concentrations shown on the abscissa. 
The mixtures were allowed to stand at 0°C for 30 min before 
incubation. 
Released iodide after 2 hours at 37°C was measured by butanol 
extraction in duplicate control and experimental samples after 
addition of substrate which contained either T4 (144,000 cpm and 
final concentration 10 -7M) or T3 (292,000 cpm and final concentration 
10 -8 M). Values were converted to p mol iodide released but were 
not corrected for iodide already present in either substrate. 
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FIGURE 3.2 The Effect of pH on Rat Kidney Homogenate Thyroxine 
5'-Deiodinase Activity. 
Rat kidneys were homogenised in ice-cold sucrose/EDTA 250/5 mM 
buffer pH 7.4. Portions of homogenate were then mixed with an 
equal volume of the same buffer to which had been added one of the 
following additional buffer ions: Morpholine-ethanesulphonic acid 
(MES), pKa6.0; HEPES, pKa 7.55; and Glycine, pKa 2 9,6; to give 
final concentrations of 50 mM. The pH of these latter buffers 
was adjusted with either HC1 or NaOH before mixing to give the pH 
range shown on the abscissa. 
The values shown for iodide production were measured in duplicate 
by the ion exchange method after incubation for 2 hours at 37°C. 
The substrate contained 156,000 cpm and gave a final concentration 
of 10-7M T4. 	Control values have been subtracted which provides 
correction for both iodide already present in substrate but also 
for any non-enzymic iodide production. Protein was measured 
using biuret reagent with bovine albumin as standard. 
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The pigs were killed by the use of a captive bolt pistol, 
followed by exanguination. The kidneys were rapidly removed, 
dissected free of connective tissue and sliced once longitudinally 
and cortex and medulla dissected free and immersed separately in 
ice-cold buffer. Less than 30 minutes later the kidneys were 
transferred to fresh cold buffer and homogenised in a Waring Blender 
to give an approxinate concentration of 16 g wet weight/d1. The 
effect of varied pH on 5'-deiodinase activity was then measured 
in both cortical and medullary homogenates. The results are 
shown in Figure 3.3. The cortical homogenate shows a similar plot 
to that obtained with rat kidney homogenate with a maxima of pH 8, 
but the presence of other maxima is less obvious. The medullary 
homogenate however shows a much flatter curve of less specific 
activity than that of the cortical homogenate. However the amount 
of medulla present in the kidney when compared to the cortex is 
very much smaller (< 5% wet weight), so that in any homogenate of 
the whole gland, the contribution of the medulla would be small. 
At pH .9 the activity would almost be exclusively due to the 
cortical deiodinase. 
3.3 Cell Fractionation of Kidney  
Fractionation of either rat or pig kidney was performed as shown 
in Figure 3.4. Arising out of the data shown in Figures 3.2 and 3.3, 
the fractions were assayed forT4 5'-deiodinase activity at pH 7.4 using 
the same incubation conditions as described in those figures. Results 
for rat and pig kidney are shown in Tables 3.3 and 3.4 respectively. 
The 5'-deiodination of the triiodothyronines by rat kidney cell 
fractions was also assessed using T3 and rT 3 and Ompared to that of 
Cortex 
" 
° Medulla 
0 0 
	
MES 	HEPES 	I 	Gly 
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pH 
FIGURE 3.3 The Effect of pH on Pig Kidney Homogenate Thyroxine 
5'-Deiodinase Activity. 
The values shown are the means of duplicate determinations of 
iodide released over the four hour incubation as measured by the 
ion-exchange method. Other procedures were the same as described 
in Figure 3.2. 
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FIGURE 3.4 Flow Chart of Cell Fractionation by Centrifugation  
Homogenate 
1000 g, 20 min 2°C 
sed. 1 SN 
(nuclei/unbroken cells) 
10,000 g, 20 min 
sed. 2 SN 
(mitochondria/lysosomes) 
30,000 g, 25 min 
sed. 3 SN 
('heavy' microsomes) 
260,000 g, 45 min 
sed. 4 
('light' microsomes) 
SN 
(cytosol) 
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TABLE 3.3 Thyroxine 5'-Deiodinase Activity in tell Fractions of 
Rat Kidney  
Cell Fractioh a VolUme Total Protein 5'-Deiodihase Activity 
.(m1) Protein Conc. 
(9) (g/l) Specific Total 
Activity Activity 
(pmol/ (nmol/ 
2hr/mg) 2hr) 
Homogenate 185 0.80 4.3 6.3 5.0 
10,000 g sed. 
(mitochondria/ 
lysosomes) 
165 0.71 4.3 6.3 4.5 
260,000 g sed. 
(microsomes) 
18.5 0.06 3.4 13.3 0.8 
260,000 g sn 
(cytosol) 
162 0.62 3.8 0.9 0.6 
a Preparation of a 30,000 g sediment was omitted in this preparation. 
TABLE 3.4 Thyroxine 5'-Deiodinase Activity in Cell Fractions of  
Pig Kidney Cortex  
Cell Fraction Volume 
(ml) 
Total 
Protein 
(g) . 
Protein 
Conc. 
4g/1) 
, 
5'-Deiodinase Activity 
Specific Total 
Activity Activity 
(pmol/ (nmol/ 
2hr/mg) 2hr) 
Homogenate 
10,000 g sed. 
mitochondria/ 
lysosomes) 
30,000 g sed. 
(heavy microsomes)
,n 
260,000 g sed. 
(light microsomes) 
260,000 g sn 
(cytosol) 
333 
233 
" 
I  21 
184 
11.36 
5.55 
0.86 
0.41 
3.61 
34.1 
23.8 
. 
17.2 
19.7 
19.6 
2.3 ± 0.3 
4.1 ± 0.7 
6.0 ± 1.4 
7.3 ± 1.0 
3.8 ± 0.7 
26.2 ± 2.3 
22.1 ± 2.1 
 
4.9 ± 1.0 
3.0 ± 0.2 
13.0 ± 2.2 
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thyroxine. The method and results are shown in Table 3.5. 
TABLE 3.5. Iodothyronine 5'-Deiodinase Activity Of Cell fractions  
Cell Fraction T4 
Sp.Act. a Tot.Act. b 
rT 3 
Sp.Act. Tot.Act. 
13 
Sp.Act. Tot.Act. 
Homogenate 61 6.9 15 1.7 3.1 0.4 
1,000 g sed 40 1.4 15 0.5 1.1 0.04 
10,000 g sed 55 1.5 15 0.4 1.0 0.03 
30,000 g sed 37 1.9 17 0.9 1.0 0.05 
260,000 g sed 56 2.3 17 0.7 1.9 0.08 
260,000 g sn 1.4 0.2 3.2 0.4 0.2 0.03 
_ 
a Specific Activity pmo1/2h/mg 
Total Activity in mo1/2h 
Cell fractions were prepared as described in the caption to Figure 3.4 
from 4 male rats (180 g) and incubated with T4 (10 -/ M), r13, 
T3 (10 -8 M) for four hours. The values shown are the means of 
duplicates. 
The concentrations of 10-7 M (T4 ) and:10 -8 M (rT 3 and T 3 ) and the 
2 hour incubation period were chosen to indicate physiologically relevant 
5'-deiodinase activity and at the same time to obtain sufficient iodide 
release at this concentration for easy measurement of the reaction. 
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However the use of these two conditions which provide neither 
maximal nor initial velocities, as defined for enzyme kinetics, means 
that maximal enzyme activities are not necessarily obtained and thus 
the recovery of activity, when all fractions are summed, may exceed 
that of the homogenate. As well, when the protein concentration is 
less in a particular fraction, there will be less non-specific binding 
of the substrate present which then leads to a proportionately higher 
enzyme activity. 
3.4 Discussion  
The data obtained for the pH optima of 14 5'-deiodinase in rat kidney 
homogenates is consistent with the results obtained by HOffken et al. 
(1977) who found'a maximum conversion of 14 to T3 at pH 6.5 and of T4 
to rT 3 at pH 9.5 in rat liver homogenate. A maximum at a higher pH of 
7.0 to 7.5 was found by Chopra (1977) and by Cavalieri et al. (1977) 
for 14 to T3 conversion by rat liver homogenates. Hiiffner and 
Grussendorf (1978) found in the same preparation that 14 to T3 conversion 
was maximal at pH 6.5 and that any rT3 formed from T4 by homogenates was 
rapidly further deiodinated to 3,3'-T2. Both these sequential reactions 
were found to be maximal at about pH 8.0-8.5. The latter deiodination 
(rT 3 to 3,3'-12) would explain how T4 labelled only in the outer ring 
might also indicate inner ring deiodination to form rT3 from T4 because 
the rT 3 formed is then subsequently rapidly deiodinated in the outer ring 
to form 3,3'-T2 with liberation of 125 1 - and thus the activity is detectable 
in the butanol or ion-exchange assay which depends only on the measurement 
of 1251- release. Thus in a sense, reverse 13 synthesis and degradation 
provide a coupled enzyme assay. 
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Consideration of the cell fractionation data for both pig and rat 
kidney suggests that the distribution of the T4 5'-deiodinase activities 
over the various fractions is different in each species. For pig, the 
microsomal fractions have the highest specific activity but the order 
for total activity is: crude mitochondria > cytosol > microsomes. 
For rat, the combined microsomal fraction has the highest activity but 
the order for total activity is: crude mitochondria > microsomes > 
cytosol. 
. Confirmation of the rapid deiodination of rT 3 at pH 7.4 in homogenates 
is given in Table 3.5. This is especially so as the concentration of 
r1 3 is one tenth that of T. 	The table also shows that rT3 is 
deiodinated by all those cell fractions which deiodinate T. 	13 is only 
slowly deiodinated by homogenates and by all cell fractions. 
The widespread T4 5'-deiodinase activity found in the kidney cell 
differed from the results of others who have found a predominant microsomal 
localisation of T4 5'-deiodination (reviewed in Chapter 1) and this made 
the decision difficult as to which of the cell fractions to further purify 
for T4 5'-deiodinase activity. Consequently, cytosol, microsomes and the 
crude mitochondrial fractions were all chosen for further study. 
The cytosol fraction was chosen because the activity was already in 
a soluble form and the cytosol had a significant total deiodinase activity 
particularly in the pig kidney. The microsomal fraction was chosen 
because of its large specific activity, its significant total activity 
and the work of others (section 3.1) which had localised 13 production to 
this fraction. The crude mitochondrial fraction was chosen because of 
its large total activity and because during the study of the cytosol, a 
possible link between the activity in the cytosol and lysosomes became 
apparent. 
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CHAPTER 4  
Purification and Properties of Cytosol  
Thyroxine 5'-Deiodinase  
4.1 Preparation and Properties of Thyroxine 5'-Deiodinase from  
Cytosol  
Repeated preparations of cytosol by the method shown in Figure 3.4 
were often found to have much lower 5'-deiodinase activity than shown 
in Table 3.5. Even lower or absent activity was found when the method 
for preparation of cytosol was abbreviated to that shown in Figure 4.1. 
This protocol was tried on the rationale that if the 5'-deiodinase was 
present and in solution in the cytosol, then a single high speed 
centrifugation step should suffice to remove all the organelles and 
membranes of the cell and thus prepare the cytosol in a much shorter time. 
In view of the reduced activity with the abbreviated preparation, 
it seemed possible that the 'cytosol' enzyme could be normally 
associated with either another compartment or membrane of the cell and 
was thus only found in the cytosol after the cell breakage and the 
centrifugations involved in the method shown in Figure 3.4. 
To test the possibility that the cytosolic 5'-deiodinase activity 
in the cell was being released by leakage from another cell compartment, 
cytosol was prepared from rat kidneys which had been homogenised in 
HEPES-TRIS/EDTA 25/10 mM pH 7.4 with and without 250 mM sucrose in the 
buffer. The data for the homogenate 5'-deiodinase activity is shown 
in Table 3.1. Cytosol was prepared in each buffer as shown by the 
method in Figure 4.1. On assay, both preparations had no detectable 
T 4 -5'-deiodinase activity. 
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FIGURE 4.1 The Abbreviated Method for Preparing Kidney Cytosol. 
homogenate 
centrifuge 1000 g 20 min 2°C 
sed. 1 SN 
unbroken cells/nuclei 
260,000 g, 60 min 
sed. 2 SN 
combined particulate (cytosol) 
fraction 
100 
Another possibility was that during the manipulations of the 
multistage centrifugation procedure, the material was not always 
kept at the same temperature as the ice-bath. Thus elevated temperature 
might in some fashion increase the enzyme yield in cytosol, for example, 
by the increased solubilisation of a lipoprotein membrane at the higher 
temperature or by a cathespin proteolysis liberating a more water 
soluble protein. Preparation at 4°, and at 20°C, with and without KC1 
in the homogenising buffer was examined and the method and the data 
obtained are shown in Table 4.1 and its caption. 
Table 4.1 shows that rat cytosol activity is much lower than in 
other cell fractions, but is slightly greater when prepared at 20°C 
than at 4°C but that in the presence of 100mM KC1 the value at 4°C 
is greater than at 20°C. Both warmer ambient temperature and KC1 
caused a decrease in homogenate and microsomal T 4 -5'-deiodinase 
activity. 
The possibility that proteolysis was taking place was examined by preparing 
homogenates at various temperatures and allowing them to stand for an 
hour before commencing fractionation. The method and data are shown 
in Table 4.2 and its caption. The table shows that for cytosol 
there is again low 5'-deiodinase activity which is probably at its 
highest when prepared at 20°C. For the other fractions, there is little 
difference between 20° and 4°C, but there is a definite decrease at 37°C. 
This suggests that autolysis of membrane activity does occur, but there 
is no subsequent increase in the cytosol activity suggesting that the 
membrane activity is being destroyed by tissue proteinases rather than 
being liberated into the cytosol. 
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TABLE 4.1 The Effect of Temperature and KC1 on the Preparation 
of 5'-Deiodinase Activity from Rat Kidney Cell 
Fractionations. 
Fraction 
KC1(100mM) 
in 
buffer 
Ambient Temperature during Preparation 
' 4°C 20°C 
Spec. Act. a Tot. Act)b Spec. Act. Tot. Act. 
Homogenate 62.6 1253 39.5 790 
+ 31.8 635 23.5 469 
Microsomes 48.7 584 30.3 364 
+ 27.7 332 21.6 259 
Cytosol 2.0 39 2.4 45 
4.1 78 2.6 49 
a
specific activity of 5'-deiodinase (pmol/mg/4h) as mean of 
duplicates. 
b
total activity of 5'-deiodinase (pmo1/4h) as mean of duplicates. 
Rat kidney cytosol was prepared by taking one half of each kidney taken 
from two male rats of equal weight (200 gm) and homogenising the four 
groups containing the four quarter kidneys in Sucrose/HEPES-TRIS/EDTA/ 
DTT 205/25/15/1 pH 7.4 with and without KC1 100mM and at either 4°C or 
20°C. The four homogenates were fractionated by the method shown in 
Fig. 3.3 and the 5'-deiodinase activity determined in each fraction 
using 10-7M T4 and butanol extraction. The values shown are the means 
of triplicates. 
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TABLE 4.2 	The Effect of Preincubation at Different Temperatures 
on the Yield of Thyroxine 5'-Deiodinase Activity from 
Rat Kidney Cell Fractions. 
Cell Fraction 4°C 20°C 37°C 
Sp. Act. a Tot.Act. b Sp. Act. Tot.Act. Sp.Act. Tot.Act. 
Homogenate 
Mitochondria 
(10,000 g sed) 
Microsomes 
(260,000g sed) 
Cytosol 
(260,000 SN) 
9.9 
42.8 
43.1 
0.8 
823 
304 
326 
31 
8.6 
43.1 
41.5 
3.1 
716 
288 
323 
87 
7.7 
32.8 
30.1 
1.8 
643 
219 
154 
61 
a
specific activity of 5'-deiodinase (pmol/mg/2h) as mean of duplicates. 
b
total activity of 5'-deiodinase (pmo1/2h) as mean of duplicates. 
An homogenate (6 kidneys/30ml) was prepared at 4°C in sucrose/ 
HEPES-TRIS/DTT 250/25/1 mM pH 7.4. It was divided into three 
aliquots each of which was then allowed to stand at 4°, 20° or 37°C 
for 1 hour. Each aliquot was then combined with an equal volume of 
sucrose/HEPES-TRIS/KC1/EDTA/DTT 250/50/100/15/1 mM pH 7.4 and each 
homogenate was then fractionated by the procedure as shown in 
Figure 3.3 at 20°C. Before assay, a 2.5 ml sample was taken from each 
homogenate and diluted to 5 ml, the microsomal and mitochondrial fractions 
were resuspended in 20 ml and the volume of cytosol was adjusted to 
22 ml with the buffer containing DTT. 
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Another possible reason for the variability was that an essential 
ion was not present in the preparation, so that various cations and 
other substances were examined for any effect on either the activity or 
stability of cytosol thyroxine 5'-deiodinase. 
In ,several experiments it appeared that K+ ion s in high) 
concentration were partially effective in preventing the loss of activity 
by rat kidney cytosol once prepared (see Figure 4.2), however the effect 
of KC1 as shown in the figure was not always reproducible. Sometimes 
the 5'.-deiodinase was Only slightly increased or not increased at all.. 
The other salts and substances tested for a stabilizing effect 
were shown to neither stabilise nor inhibit the cytosol 5'-dei6dinase 
in the concentration ranges listed in Table 4.3. The fact that it was KC1 
and not NaC1 which was sometimes effective, suggests that it is the 
K ion which is the active moiety. 
1 
In the light of the evidence that somewhat increased activity 
of 5'-deiodinase in cytosof Could be obtained by using 100 mM KC1 
andwas partially stabilised by 1000 mM KC1 and did not inhibit the 
5'-deiodinase activity, 'I was led to use KC1 in the homogenising 
buffer when preparing rat kidney cytosol. I also used 1000 mM KC1 
when the deiodinase activity could not be assayed immediately, for 
example after the running of a chromotographic column. 
In view of the in vivo studies of Oppenheimer et al. (1972) and 
1 
Saberi et al. (1975) and the in vitro studies of Chopra et al. (1978) 
with rat liver homogenates which have shown that propylthiouracil (PTU), 
but not methimazole, inhibits the conversion of thyroxine to triiodo-
thyroxine, these substances were tested on cytosol deiodinase activity 
• 	• 1-0M KC1 
0-1M KC1 
-15 • 
FIGURE 4.2 The Effect of KC1 on the Stability of Cytosol Thyroxine 
5'-Deiodinase at Different Temperatures. 
Cytosol was prepared at 4°C by the method shown in Figures 3.3 using 
Sucrose/HEPES-TRIS/KC1/EDTA/DTT 250/25/100/15/1 mM pH 7.4. It was 
divided in two. One half was made to 1000 mM by addition of solid 
KC1. Aliquots of the two samples were assayed immediately at 37°C 
and the remainder then divided into 1 ml aliquots which were stood 
at one of the following temperatures -15°, +4° or +20°C for the times 
indicated in the figure when they were assayed at 37°C after thawing 
if necessary. 
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TABLE 4.3 Compounds Tested for Effect on Rat Cytosol Thyroxine 
5'-Deiodinase Activity. 
Compound Concentration Range Compound Concentration Range 
NaC1 0-1000 mM Glycerol 0-30% 
NH 4 Cl 0-1000 mM Albumin a 0-0.01% 
(NH) 2SO 4 0-2,500 mM Polyvinyl- 
pyrolidinea 
0-0.01% 
MgC1 2 0-5 mM Heparin 0-1% 
CaC1 2 0-5 mM Protamine- 
sulphate 0-1% 
a
Both albumin and polyvinylpyrolidine will inhibit in higher 
concentration because of substrate binding. 
Compounds were tested as in Figure 4.2 except that EDTA was omitted 
for cytosol containing MgC1 2 and CaC1 2 during storage but added for 
assay. 
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as shown in Figure 4.3. The figure shows that the data for 5'-deiodinase in 
cytosol , is consistent with the reported finding that PTU inhibits the.deiodinase 
whilst methimazole has a slight stimulatory Or no effect at low 
concentrations but inhibits at high concentrations. 
In order that the optimal pH could be chosen to monitor 
5'-deiodinase activity during purification, the effect of pH on the 
cytosolic thyroxine 5'-deiodinase from pig kidney was determined. 
The method and data are shown in Figure 4.4 and its caption. 
The plot of 5'-deiodinase activity for pig cytosol shows a 
similar but sharper curve to that for the homogenate in Figure 3.2 
and indicates that pH 7.4 is appropriate for monitoring deiodinase 
activity during purification. There is however significant activity 
at low pH. 
4.2 Salt Fractionation of Cytosol Thyroxine '-Deiodinase Activity  
Table 4.4 shows the effect of (NH 4 ) 2 50 4 on the precipitation 
of thyroxine 5'-deiodinase activity from pig cytosol. The method is 
described in the caption. It is obvious that almost all activity is 
precipitated in the broad range between 20%-40%. The apparent loss of 
activity is probably due to losses during dialysis. Visser et al. (1976) 
found total loss of activity on dialysis of microsomal enzyme but most 
activity is retained if DTT is added to the dialysis medium. Comparison 
between the fractions must also take into account that the activity was 
measured using 10 -7M T4 which is not a saturating substrate 
concentration. 
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FIGURE 4.3 Effect of Anti-Thyroid Drugs on Rat Kidney Cytosol 
Thyroxine 5'-Delodinase. 
Cytosol was prepared as shown in Figure 3.4. Each inhibitor was 
added in a volume of 25 pl,to give final concentrations shown in the 
figure, 30 minutes before the assay was commenced by the addition of 
25 pl of 125 I-T 4 to give a final concentration of 10 -7 M. 
Each value was determined in duplicate by butanol extraction after 
incubation at 37°C for 2 hours using a TCA control. 
	MES 	I 	HEPES 	I 	Gly 
5 	6 	a 	9 	10 
pH 
FIGURE 4.4 The Effect of pH on Pig Kidney Cytosol Thyroxine 
5'-Deiodinase. 
Pig kidney cytosol was prepared as in Section 3.3 using Sucrose/ 
EDTA/DTT 250/15/1 mM pH 7.4 as the homogenising buffer. Aliquots 
of the cytosol were then mixed with equal volumes of MES or HEPES 
or Glycine buffers of various pH values and incubated as described 
in Figure 3.2. The pH was checked after mixing. 
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TABLE 4.4 Ammonium Sulphate Precipitation of Thyroxine 5'-Deiodinase 
from Pig Kidney Cytosol. 
Fraction 
Volume 
(m1) 
Protein 
Concentration 
(mg/ml) 
Thyroxine '-Deiodinase 
Spec.Act.
a 
Tot.Act.
b 
Cytosol 100 7 1.31 1178 
20 0/ c sed 7.2 1.1 1.36 11 
30% sed 10.8 2.5 4.56 122 
40% sed 10.6 5.9 2.42 150 
60% sed 11.3 14.9 0.82 92 
60% S.N. 23.7 1.35 0.00 0 
a
Specific activity (pmol/mg/4h) as means of duplicates. 
b
Total activity (pmo1/4h) as means of duplicates. 
c
Per cent saturation of ammonium sulphate at 0°C. 
Pig kidney cytosol (100 ml) was prepared as shown in Section 3.3. 
• Saturated ammontum sulphate, dissolved in 15 mM citrate, 5 mM EDTA 
pH 6.5, was added at 0°C to make the cytosol 20% saturated with 
salt. The solution was allowed to mix for 20 min and was then 
centrifuged at 30,000 g for 20 min and the supernatant decanted and 
solid salt added to make to 30%, 40% and 60% saturation successively. 
with removal by centrifugation of sediments at each stage. The 
sediments and final supernatant were dialysed overnight against 
1 mM DTI, 25 mM citric acid adjusted to pH 7.4 with Na 2HPO4 . 
After dialysis the volume, protein concentration (Pelley et al., 1978) 
and T4 5'-deiodinase (ion-exchange method) were determined on each 
fraction. 
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A similar pattern of precipitation occurred with rat kidney 
cytosol as shown in Table 4.5, but in general, a higher concentration 
of ammonium sulphate was required to precipitate activity even though 
the cytosol had been made to 1000 mM with KC1 to help stabilise 
activity. 
4.3 Affinity Chromatography of Thyroxine '-Deiodinase Activity from  
Kidney Cytosol  
4.3.1 Introduction  
Affinity chromatography has been used by many workers in 
recent years as .a powerful technique for the purification of 
proteins. It has often given a major increase in the purity 
of the protein of interest. Although the idea of affinity 
chromatography, in which a ligand, fixed to a solid support matrix, 
binds specifically to the protein of interest has been known for 
many years, it was not until the use of agarose gel was developed 
as a support medium, together with methods of attaching the ligands 
to the agarose that affinity chromatography methods have become 
widespread (reviewed by Turkovi, 1978). 
Pensky and Marshall (1974) and Kagedal and Kallberg (1977) 
found that thyroid binding globulin (TBG) from plasma could be 
purified by attachment to a thyroxine-agarose affinity gel. 
This work suggested that thyroxine deiodinases might also be 
purified in a similar manner as they must bind to thyroxine at 
their active centres during the course of the catalytic 
deiodination of thyroxine. Therefore, a priori, a thyroxine 
affinity gel was a potential ligand for these deiodinase enzyme(s) 
111 
TABLE 4.5 Salt Precipitation of Thyroxine 5'-Deiodinase from 
Rat Kidney Cytosol. 
Fraction 
Volume 
(ml) 
Protein 
Concentration 
(mg/ml) 
Thyroxine 5'-Deiodinase 
Spec. Act.
a 
Tot. Act)b 
Cytosol 37 65 0.19 465 
20%c sed 20 2.3 2.87 132 
30% sed 20 8.1 1.67 270 
40% sed 20 18.2 1.38 504 
50% sed 20 54.8 0.09 99 
60% sed 20 10.5 0.00 1 
60% S.N. 33 19.1 0.01 8 
a
Specific activity (pmol/mg/2h) as means of duplicates. 
b
Total activity (pmo1/2h) as means of duplicates. 
cPercent saturation of ammonium sulphate at 0°C. 
Rat kidney cytosol was prepared as in Section 3.3 from 8 kidneys 
and then made to 1000 mM with KC1. Ammonium sulphate was added 
as in Table 4.4. Deiodinase activity was determined by butanol 
extraction method without prior dialysis nor removal of the salt. 
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and hence a means of purification by affinity chromatography. 
However the binding of thyroxine to the active site raised the 
possibility that it might also deiodinate the bound thyroxine. 
Kagedal and Kallberg (1977) improved the yield of TBG by 
using as a matrix Epoxy Activated Sepharose (Pharmacia) to 
covalently bind thyroxine through a moderately hydrophilic 
spacer arm 13 atoms long (Figure 4.5). They found that it 
gave a much better purification of TBG than the matrix used by 
Pensky and Marshall (1974) who employed cyanogen bromide- 
activation of agarose to couple it to thyroxine. The improved 
separation with a long hydrophilic spacer arm (as in this 
Pharmacia product) is thought to allow binding without steric 
hindrance from the agarose matrix (reviewed by Turkov.i, 1977 and 
by Lowe, 1979). 
4.3.2 Preparation of Thyroxine-Agarose Affinity Gel  
Coupling of thyroxine to epoxy activated Sepharose 6B 
(Pharmacia) was performed essentially as described by Kagedal 
and Kallberg (1977). In brief: the freeze dried gel was 
reswollen and washed repeatedly by the addition of distilled 
water (100 ml/gm gel) to the gel in 100 ml plastic centrifuge 
tubes. Decanting was performed immediately after Centrifugation 
at 1000 g. The use of plastic implements prevents the gel 
sticking (as it will to glass). One gm of dry gel gives about 
2.5 - 3.0 mls of swollen gel. 
Coupling of the gel was performed in the same centrifuge 
tubes in the dark at 25°C for 24-26 h by the gentle shaking of 
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FIGURE 4.5 Reactions of Epoxy Activated Agarose with Thyroxine 
(modified from Porath, 1974). 
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2 parts of a solution containing 3.6 mg sodium thyroxine 
(Calbiochem) to which a tracer amount 1 125 -thyroxine had also 
been added, 15 ml carbonate-bicarbonate buffer (50 mM, pH 9.5) 
and 5 ml dimethylformamide (Koch-Light) with one part of the 
swollen gel. The pH of the coupling solution is checked by 
pH paper to avoid damage to a , glass pH electrode. 
After coupling, the gel was centrifuged, decanted and 
then washed 2-3 times (depending on the amount of radioactivity 
in the washings) with the bicarbonate dimethylformamide solution 
without thyroxine and the decantings kept. Residual oxirane 
groups were then blocked by further incubation in the dark for 
24 hours at 25°C with 1 M ethanolamine (pH 10). The coupled gel 
was again decanted and then washed and stored in unbuffered 
10 mM Na 2 EDTA at 4°C. An approximate estimate of coupling 
is determined by measuring the radioactivity in the various 
solutions. A final and better estimate was made by counting an 
aliquot of the extensively washed coupled gel. A typical value 
is 0.35 umol thyroxine/ml of wet gel. 
4.3.3 The Elution of 5'-Deiodinase Activity from the Thyroxine  
Affinity Gel  
Pensky and Marshall (1974) successfully eluted thyroid 
binding globulin (TBG) from their T 4-gel by using the binding-
inhibitor 8-anilino-l-napthalene - sulphonic acid (ANS) or by 
using weak (2 mM) potassium hydroxide. 
Preliminary studies showed that whilst both KOH and ANS 
would elute cytosol proteins bound to the 1 -4 -gel, no activity 
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could be measured in the eluant. A lowered pH to 5.0 or 5.5 
is suggested as a general procedure (Porath, 1974) for eluting 
protein from affinity columns. A preliminary study found that 
5'-deiodinase activity from pig cytosol could be eluted by 
changing the pH from 7.4 to 5.5 so that a scaled up study was 
performed. The method and elution profile are shown in 
Figure 4.6 and its caption. 
From Figure 4.6 a single band of protein was seen to be 
eluted, however most of the 5'-deiodinase activity was spread 
in a broad band well beyond the main protein peak. This suggests 
that proteins other than the 5'-deiodinase are binding to the 
ligand and are eluted by the change in pH. 
Unfortunately, no more pig kidneys were available for 
further study. Therefore, all further studies were made on 
rat kidney cytosol even though it had proportionately less 
5'-deiodinase activity than the pig cytosol. 
As the rat cytosol 5'-deiodinase activity is labile 
when prepared, 2 mM DTT was maintained in all the solutions 
containing cytosol proteins which included the mobile phase 
buffers for affinity chromatography. The presence of DTT did 
not allow deiodination of the T4 ligand by the loaded enzyme 
as shown by the absence of any liberated 125 1 - after the enzyme 
preparation had been run on the thyroxine-gel into which 
a tracer amount of 125 1 T4 had been incorporated at the 
time of its preparation. 
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FIGURE 4.6 Thyroxine Affinity Chromatography of Pig Kidney Cytosol. 
The load protein consisted of the precipitate formed by making 180 ml 
of pig kidney cytosol containing 20 mg/ml protein to 40% saturation with 
ammonium sulphate. The precipitate was collected by centrifugation and 
dissolved in 40 mls of HEPES/EDTA 25/5 mM buffer pH 7.4. It was then 
'desalted' into the same buffer on several small Sephadex G-25 columns. 
(PD 10,Pharmacia) run in parallel. A final volume of 52.5 ml was 
collected and loaded by gravity flow onto a 12.0 x 1.5 cm column of 
T4-gel and fractions of 10 ml collected. Unbound protein was then 
washed off with HEPES buffer as the mobile phase until the protein 
concentration fell to 150 pg/ml by spot test using the method of 
Sedmark and Grossberg (1977). The mobile phase was then changed to 
MES/EDTA/DTT 25/5/2 mM pH 5.5 to elute the bound protein. 
T4-5'-deiodinase activity was estimated by combining 0.2 ml aliquots 
from each fraction with 0.8 ml of HEPES/DTT 100/2 mM pH 7.4 buffer. 
Thyroxine (10- 7M) substrate was added as in Chapter 3 and the iodide 
released during incubation at 37°C for 2 hours was then measured by 
the ion-exchange method. 
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The affinity chromatography of rat cytosol was then 
performed using the change in pH from 7.4 to 5.5 to elute the 
proteins. The results and method are described in Figure 4.7 
and its caption. 
Figure 4.7 shows that a relatively large amount of protein 
is not bound to the gel and is washed from the column and then it 
is some time before the change in pH leads to elution of the bound 
protein in a series of small peaks. This is quite a different 
•chromatogram in appearance to that of pig cytosol (Figure 4.6) 
in which the proteins were eluted as a single band even though 
the activity was spread out beyond this band. 
In view of the fact that the cytosolic 5'-deiodinase 
enzyme seems to be active and also stabilized in strong KC1 
solutions, the experiment in Figure 4.7 was repeated using as 
the mobile phase KC1/HEPES-TRIS/EDTA/DTT 1000/25/15/2 pH 7.4, 
however no protein was bound to the column so that changing 
the pH had no effect. This result was not unexpected, although 
Turkova (1978) and Pharmacia Technical Bulletin recommend a trial 
of 0.5 - 1.0 M salt to prevent non-specific binding of other 
proteins before more specific elution of the protein of interest. 
However the elution of deiodinase by 1000 mM KC1 suggested that 
KC1 could be used as a desorber. This was examined by using 
a linear gradient from 0 to 1500 mM KC1. The data and experimental 
method are given in Figure 4.8 and its caption. The figure shows 
a single protein peak eluted early (approx. 100-200 mM KC1) with 
the KC1 gradient, but possessing a trailed shoulder. Measurement 
of 5'-deiodinase activity shows again that there appear to be 
multiple peaks of activity. 
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FIGURE 4.7 Thyroxine Affinity Chromatography of Rat Kidney Cytosol 
with Elution by Decreased pH. 
A cytosol fraction was made fr6m two rat kidneys by the method in 
Figure 3.3 using sucrose/KC1/HEPES/EDTA/DTT 250/100/25/15/2 mM pH 7.4 
as the homogenising buffer. The cytosol was then made to 1 M with 
KC1 and then to 50% saturation (2.85 M) with (NH) 2S01 and the precipitate 
collected and desalted on two small Sephadex G-25 columns (PD 10 Pharmacia) 
which had been preequilibrated with HEPES-TRIS/EDTA/DTT 25/15/2 mM pH 7.4. 
The 5 ml of desalted protein solution was then loaded on to a 
10 x 1.5 cm column of thyroxine affinity gel prepared as in Section 4.3.2. 
The same buffer was then run as the mobile phase until the eluted protein 
concentration fell to less than 50 jig/ml. •The mobile phase was then 
changed to MES/EDTA/DTT 25/15/2 pH 5.5 to elute the 5'-deiodinase activity 
which was measured in each fraction by taking an 0.5 ml aliquot from each 
10 ml fraction and combining it with an equal volume of HEPES-TRIS/KC1/ 
DTT 100/100/2 mM pH 7.4 buffer and then assayed in duplicate using the 
butanol method with 10-7M thyroxine. Protein concentrations were 
measured by the method of Sedmark and Grossberg (1977). 
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FIGURE 4.8 The Elution of Cytosol 5'-Deiodinase from T4 Affinity-Gel 
by a Linear Gradient of KC1. 
An ammonium sulphate fraction was prepared from two rat kidneys and 
desalted and resuspended in homogenising buffer (see Figure 4.7). 
The desalted protein (10 ml) from the ammonium sulphate precipitate 
of the cytosol fraction was applied to a 12 x 1.5 cm column of affinity 
gel consisting of thyroxine linked to epoxy activated Sepharose 6B. 
After washing with 80 ml of HEPES-TRIS/EDTA/DTT 25/15/2 mM pH 7.4, the 
bound protein was eluted by changing the mobile phase to MES/EDTA/DTT 
25/15/2 mM pH 5.5 and simultaneously starting ,a linear KC1 gradient from 
0 to 1500 mM KC1 over 500 ml at 50 ml/hour. Each fraction was 10 ml 
and the whole apparatus was maintained at 10°C. 
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4.3.4 Polyacrylamide Gel Electrophoresis of the Eluted Protein  
from Affinity Chromatography  
For electrophoresis,a further batch of kidney cytosol was 
prepared from 6 rats, fractionated, and loaded on to the T4 
affinity column and washed free of unbound protein as before. 
The 5'-deiodinase activity was then eluted by 300 mM KC1 in 
MES/EDTA/DTT 25/15/2 mM pH 7.4 as an isocratic mobile phase rather 
than using a gradient of KC1 as was done previously. The fractions 
containing the eluted band of proteins were identified by the 
Coomassie Blue Spot test of Sedmark and Grossberg (1977), pooled, 
and then concentrated in dialysis tubing against Aquacide I (Sigma) 
and when reduced to less than 2 ml the protein was further 
concentrated in an Amicon BI5 concentrator to approx. 200 pl. 
Samples (30 pl) of the concentrate were prepared and then run in 
either 50 mu borate/phosphate buffer pH 8.0 or in 100 mM phosphate 
pH 7.2 containing 0.2% SDS on 3.3% polyacrylamide gels at 
7.5 mA/gel by the method of Weber et al. (1972). Photographs of 
the gels are shown in Figure 4.9. 
The normal disc electrophoresis showed a diffuse broad band 
from the origin to approximately two thirds along the gel. The stained 
gels run in SDS show at least 18 bands along their length and 
correspond to molecular weights ranging from approximately 2 x 10 7 
to 2 x 10 4 when compared to the migration of thyroglobulin (640,000), 
ferritin (440,000), albumin (67,000), ovalbumin (43,000), and 
myoglobin (17,600) as standards. The band migrations distances 
and their corresponding molecular weights are shown in Table 4.6. 
Of particular note is the very large range of molecular 
weights shown. The presence of very large protein units in SDS 
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FIGURE 4.9 The Appearance After PAGE-SDS of the T 4 -Affinity 
Chromatographically Purified Cytosol T4 5'-Deiodinase. 
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. TABLE 4.6 The Molecular Weights on PAGE-SDS of Cytosol Proteins 
Obtained after T 4 -Affinity Chromatography. 
BandNo.BandMigrationLog.Molecular 
(mm) 
 M. Weight 
(MO 
18 7 7.3222 21,000,000 
17 8 7.2620 18,280,000 
16 14 6.9011 7,964,000 
15 15 6.8410 6,934,000 
14 16 6.7808 6,037,000 
13 19 6.6004 3,985,000 
12 20 6.5402 3,469,000 
11 23 6.3598 2,290,000 
10 24 6.2996 1,940,000 
9 26 6.1793 1,511,000 
8 30 5.9387 868,400 
7 34 5.6981 499,000 
6 38 5.4575 286,700 
5 40 5.3372 217,400 
4 43 5.1568 143,500 
3 50 4.7358 54,430 
2 53 4.5553 35,910 
1 56 4.3749 23,710 
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suggests that the denaturing conditions of Weber et al. (1972) in 
which the sample is heated at 100°C in 2% SDS for 5 minutes is 
insufficient for their full denaturation and combination with SDS. 
To test this possibility, a further batch of cytosol protein was 
prepared by affinity chromatography and concentrated as above. 
Samples (60 111) of the concentrate were subjected to one of the 
following treatments in a microreaction vial. 
(i) extracted twice with CHC1
3
/CH
3
OH 50/50 (v/v) 
and the protein precipitate dissolved in 1% SDS 
and 1% mercaptoethanol with a further 10 mg . of 
SDS being added to the vial before boiling for 
5 min. 
(ii) Protein precipitated with 20% (w/v) trichloracetic 
acid and then dissolved in 1% SDS and 1% 
mercaptoethanol and boiled for 5 min. 
(iii) boiled for 5 min in 1% SDS and 1% mercaptoethanol 
to which was added 10 mg of SDS. 
Samples (30 pl) from each treatment were then separated by 
electrophoresis on polyacrylamide gels in SDS as described above. 
Photographs of the gels are shown in Figure 4.10 and the band 
migration distances together with the calculated molecular weights 
are shown in Table 4.7. 
It is apparent that all of the stronger denaturing conditions 
reduce both the number and intensity of the large molecular weight 
bands. This indicates that aggregates are present which can be 
reduced to three or four main bands of very much lower molecular 
weight under very strong denaturing conditions as shown by 20% TCA 
or CHC1
3/CH3OH combined with SOS. The data in Tables 4.6 and 4.7 
is further discussed in Section 4.6. 
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TABLE 4.7 The Molecular Weights on PAGE-SDS after Additional 
Denaturation of Cytosol Proteins obtained from T 4 -Affinity 
Chromatography. 
DenaturingCcmditionsBandMigrationLog 
(111111) 
i M  .Molecular 
Weight 
(Mi ) 
Excess SDS 0 6.0371 1,089,000 
9.5 5.6437 440,000 
16 5.3746 236,000 
19 5.2503 177,000 
31 4.7534 56,000 
. 36 4.5464 35,190 
40 4.3807 24,010 
50 3.9666 9,260 
52 3.8838 7,652 
TCA (20%) + SDS 32 4.7120 51,520 
35 4.5878 38,710 
40 4.3807 24,010 
CHC1 / H OH + SDS 32 4.7120 51,520 
36.5 4.5257 33,550 
41 4.3393 21,840 
47 4.0910 12,330 
* A broad band between 40 to 52 mm with maximum staining •at 50 mm. 
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4.4 Molecular Exclusion (Gel-Filtration) Chromatography of Cytosol  
Thyroxine 5'-Deiodinase  
The possibility of protein aggregation in a non-denatured 
preparation of the cytosol T4 5'deiodinase was examined by molecular 
exclusion (gel filtration) chromatography using crosslinked agarose 
(Sepharose CL-6B, Pharmacia) as the stationary phase. The data and 
method are shown in Figure 4.11 and its caption. Three broad bands of 
5'-deiodinase activity are seen at A (4 - 2 x 10 6 ), B (5 - 2 x 10 5 ) 
and C (19 - 6 x 10 3 ). This range of molecular weights agrees with the 
range of molecular weights found in a preliminary study published earlier 
(Colquhoun et al., 1981). They are consistent with aggregates of 
non-denatured subunits in solution. 
The protein bands A, B, C in Figure 4.11 were concentrated as 
before and run on either 3.3% (A, B) or 5% (C) polyacrylamide gels in 
SDS by the method of Weber et al. (1972). The band migrations are 
listed in Table 4.8. 
Inspection of Table 4.8 shows that band A is associated with 
protein of >3 x 10 6 mol. wt. which is consistent with the molecular weight 
obtained from elution volume on Sepharose CL-6B. Bands B and C after 
PAGE-SDS show not only protein bands of expected molecular weight 
but also of greater and lesser molecular weight than would be expected 
from their elution volume on Sepharose CL-6B. These observations are 
consistent with aggregation of non-denatured protein before running on 
Sepharose CL-6B as shown by peaks A and B. The widening of the range of 
molecular weights on PAGE-SDS suggests that denaturing aggregation can also 
occur by heating (during sample preparation for PAGE-SDS). 
250 
 
25 
Fraction Ng 
5b 
 
  
FIGURE 4.11 Chromatography of Cytosol 5'Deiodinase on Sepharose CL-6B. 
Desalted protein from ammonium sulphate precipitation of the 260,000 g 
supernatant (cytosol) fraction of rat kidney was applied in 4 ml of 
eluant buffer containing 100 mM IRIS, 15 mM EDTA, 1 mM DTT, pH 7.4 to 
an 81 x 2.5 cm jacketed column of Sepharose CL-6B and eluted in fractions 
of 10.5 ml over 16 hours. The column and fractions were maintained at 
10°C. Before removing 1 ml aliquots for incubation, 500 pl of 
2000 mM KC1 in eluant buffer was added to each fraction. Calibration 
of the column under running conditions was performed with thyroglobulin 
(640,000), ferritin (440,000), albumin (67,000), ovalbumin (43 1000), 
myoglobin (17,600) and cobalamin (1,200) as standards. Protein was 
assayed by the method of Sedmark and Grossberg (1978). 
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TABLE 4.8 Migration of Protein Bands on PAGE-SDS from Sepharose 
CL-6B Chromatography. 
Fraction No. DistanceofMigrationLog 
(mm) 
Mi  .Molecular Weight 
13-18 (A) 0 6.5127 >3.256 x 10 6 
(3.3%) 
22-26 (B) 1 6.4779 >3.00 x 10 6 
(3.3%) 42 5.5289 1.81 x 10 5 
50 5.0150 1.03 x 10 5 
64 4.5971 3.95 x 10 4 
33-40 (C) 0 6.2537 >1.8 x 10 6 — 
(5.0%) 26 5.5427 3.49 x 10 5 
41 5.1233 1.33 x 10 5 
60 4.5946 3.93 x 10 4 
The migration of the cytosol T4 5'-deiodinase was also examined by 
chromatography on Sephacryl 300 (Pharmacia) which is a cross-linked alkyl 
dextran. The method and elution profile are shown in Figure 4.12 and 
its caption. 
The migration of the main band of the T4 5'-deiodinase corresponds to 
a molecular weight of 45,000. This is markedly retarded when compared to 
the migration on Sepharose CL-6B. Hydrophobic proteins are often retarded 
when using Sephacryl as the stationary phase (Pharmacia literature) which 
implies there may be a hydrophobic site on the cytosol 5'-deiodinase. 
30- 
1 
2 
40 
Fraction N_ 
FIGURE 4.12 Chromatography of Cytosol T4 5'-Deiodinase on Sephacryl 300. 
Cytosol protein was prepared as in Chapter 3. The column was calibrated, 
pre-equilibrated, loaded, and run as described in the caption to Figure 4.11 
The column contained 75 x 2.5 cm of Sephacyl 300. Fraction volume was 
9.5 ml. 
130 
The effect of strong salt on the aggregation of T 4 5'-deiodinase 
activity was tested by running the same cytosol preparation in the 
presence and absence of 11 KC1 on parallel CL-6B gel columns at the 
same time to avoid loss of activity. The elution profiles are shown 
in Figure 4.13 from which it can be seen that the presence of KC1 spreads 
the 5'-deiodinase activity throughout the chromatogram. This is consistent 
with partial disaggregation to form a large number of smaller aggregates 
of differing molecular weights. The enzyme also remains active in 
strong KC1 as was expected from the stability studies conducted in 
Section 4.1. 
Confirmatory evidence for normal aggregation in solution of the 
cytosol 5'-deiodinase was obtained by applying the protein prepared by 
affinity chromatography to a Sepharose CL-6B gel column and finding that 
both the 5'-deiodinase activity and protein is spread throughout the 
elution profile as shown in Figure 4.14. 
The 5'-deiodinase activity values are for incubation at pH 7.4, 
uncorrected for non-enzymic deiodination. That deiodinase activity 
was indeed present, is shown by the activity levels falling to that of 
the free iodide already present in the substrate when no protein is 
present. 
Confirmation of considerable purification by either affinity 
chromatography or molecular exclusion chromatography is given by the 
specific activities shown in Table 4.9. 
4.5 Analysis of the Products Formed by Cytosol 5'-Deiodinase Using  
HPLC  
Cytosol and the cytosol proteins precipitated by ammonium sulphate 
were incubated separately at pH 7.4 for up to 4 hours with 
500 
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FIGURE 4.13 The Effect of KC1 on Aggregation Size of Cytosol T4 
5'-Deiodinase when Chromatographed on Sepharose CL-6B. 
The ammonium sulphate precipitate from rat kidney cytosol was halved 
and each half resuspended in either sucrose/HEPES/EDTA/DTT 250/50/15/0.1 
pH 7.4 or with the same buffer including 1000 mM1 KC1. Then each sample 
(9 ml) was applied to two 81 cm columns of Sepharose CL-6B pre-equilibrated 
with the respective buffer and then run overnight. Fractions of 9.1 ml 
were collected. To the fractions not containing 1 M KC1, 3 ml of 
411 KC1 were added to make it 1 M KC1. The activity plotted for zero KC1 
in the figure has been corrected for the dilution of the fractions. 
1 50 2;0 3b 40 
Fraction N9. 
FIGURE  4.14 Chromatography on Sepharose CL-6B of the Cytosol 
5'-Deiodinase purified by Thyroxine Affinity Chromatography. 
Cytosol was prepared and run on T 4 -agarose affinity column as in Section 4.3.4. 
The eluted protein was concentrated to 10 mls against aquacide and then run 
on Sepharose CL-6B as described in the caption to Figure 4.11. 
TABLE  4.9 Specific Activities of Purified Fractions of Cytosol 
5'-Deiodinase. 
Fraction 
Vol. 
(ml) 
Prot.Conc. 
(mg/ml) 
Tot.Act. 
(pmo1/4h) 
Spec.Act. 
(pmol/mg/4h) 
Purifi-
cation 
Homog. 185 4.32 ' 4958 6.27 1.0 
10,000 g sn. 165 4.32 4454 6.25 1.0 
260,000 g sn. 162 3.83 558 0.9 0.1 
amm.sulp.pt . 32 9.63 4022 1.29 2.0 
aff.chr.pk . 95 0.02 320 1900 303 
CL-6B pk.A 10.6 0.04 110 2750 440 
CL-6B pk.B 10.6 0.10 126 1260 200 
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[3,"-1251] - T 4 (3 x 10 -5 M, 120,000 cpm). The iodothyronines 
were extracted by the ion-exchange system and examined by the HPLC 
system described in Sections 2.2 and 2.4 using UV detection at 254 nm. 
Control extractions of both protein preparations shows strong UV 
interference obscuring the appearance of thyronine (T 0 ) and both the 
monoiodothyronines as well as the iodotyrosines. 
After extraction, T 4 was consistently seen on HPLC, but no di- or 
tri-iodothyronines could be identified at any time during the incubations. 
This included many samples in which there was greater than 10% 
deiodination of T4 'as measured by ion-exchange. This result was 
quite unexpected, as the T3 was the expected product of 5'-deiodination. 
T3 had earlier been shown to be deiodinated only very slowly by rat 
cytosol (Chapter 3). 
Assuming all the iodothyronine product was T3 (the iodine-125 was 
only in the outer ring) then 10% deiodination would give 3 nmol/ml of 
T3 which is three times the detection limit. If the deiodination were 
proceeding to either 3,5-T 2 or 3,3'-T 2 then 3nmol would be at least 
six times the detection limit. 
In an effort to resolve this problem of detection, the incubations 
of cytosol with T4 were repeated as above (0-2h). The HPLC was however 
coupled to a 120 tube fraction collector set at one tube per 10 seconds. 
• Each fraction was then transferred to the gamma counter for measurement. 
The fraction collection however blurs the separation of three pairs of 
iodothyronines, viz: TidrT 3 , 3,3'-T 2/3',5'-T 2 , and 3'-T 1/3-T 1 . 
No peaks other than T4 could be detected until the 1 and 2 hour 
incubations were examined when small peaks corresponding to 3,3'-T2/3',5%-T2, 
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3,5-T 2 , and 3'-T i were seen but which in total would account for <20% 
of the deiodination. 3-T 1 and T o would not be seen by this technique 
as they would have no iodine-125. 
4.6 Analysis for Carbohydrate  
In an attempt to relate 5'-deiodinase activity with the presence 
of glycoprotein, T4 5'-deiodinase enzyme was again prepared by affinity 
chromatography, concentrated, and then run overnight on a gradient 
polyacrylamide gel. The gel was then divided into three longitudinal 
sections as shown in Figure 4.15. The two smaller slices were stained 
for either protein (Coomassie Blue) or carbohydrate (PAS) and the third 
larger slice subdivided transversely and T4 5'-deiodinase estimated in 
each subdivision. The method and data are shown in Figure 4.15 and 
its caption. The figure shows that glycoprotein is present, and that 
5'-deiodinase activity is in part associated with the glycoprotein bands. 
It is of interest that some activity was still present in the TCA controls 
for bands 1 and 3. 
The property of the partially purified deiodinase in resisting the 
denaturing effect of trichloracetic acid when assayed on the gel 
suggested that it might either be a glycoprotein or be of unusual 
aminoacid composition. Such proteins manifest these characteristics 
(Young, 1963). This is especially so when they are not associated with 
other more easily denatured proteins such as those found in either kidney 
homogenate or cytosol. 
The protein derived from affinity chromatography was therefore 
examined for neutral carbohydrates and sialic acids as shown in Table 4.10. 
FIGURE 4.15 Pore Gel Electrophoresis of Affinity Chromatography 
Purified Cytosol 5'-Deiodinase. 
Cytosol protein was eluted from T 4 -affinity gel as described in 
Section 4.3.4. The concentrated protein was loaded onto a polyacrylamide 
gradient gel 2.5-13% (Gradipore, Sydney) and run overnight at 50 V and 
10 mA at 0°C. Protein was stained by the method of Weber et al. 
(1972), and glycoprotein by PAS method of Segrest and Jackson (1972). 
T4 5'-deiodinase activity was measured in 8 mm slices after homogenisation 
of each slice in 4 ml of HEPES/KC1/EDTA/DTT 100/100/15/1 pH 7.4 and 
incubated for 4 h at 37°C in 10 -7M thyroxine. 
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TABLE 4.10 Carbohydrate Composition of Affinity Chromatography 
Purified L 1 5'-Deiodinase. 
Protein Fraction Total Hexose 
(pg/m1) 
Fucose 
(pg/m1) 
Sialic Acid 
(pg/m1) 
Protein 
(pg/m1) 
Supernatant 
Precipitate 
690 
28 
100 
15 
0 
0 
112 
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Protein was determined by the method of Sedmark and Grossberg (1977), . 
total hexose and anthrone by the method of Roe (1955) using galactose 
as standard as modified by Spiro (1966); sialic acid by the thiobarbituric 
acid method of Svennerholm (1957) as modified by Spiro (1966); and 
by the cysteine/sulphuric acid method of Dische and Shettles for fucose 
as modified by Spiro (1966). 
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To prevent interference by the dithiothretiol, the protein was 
dialysed against water containing 0.001% sodium azide overnight at 
4°C in a bag made of 6000-8000 molecular weight cut-off dialysis tubing 
(SPettrOO'hdr). It was found that a White fluffy precipitate formed 
overnight. This was separated by centrifugation from the supernatant 
and the two fractions analysed Separately. No T4 5'-deiodinase 
activity in either of these purified fractions remained after dialysis. 
Activity was absent even in the presence of DTT during dialysis. 
Table 4.10 shows that both fractions contain large amounts of 
carbohydrate relative to the amount of protein. The soluble fraction has 
proportionately more carbohydrate than the sediment. It is of interest 
firstly, that the sediment precipitates even though it has so much 
carbohydrate and secondly, that neither fraction shows enzymic activity 
after dialysis in the presence of DTT. 
4.7 Discussion and Conclusions  
The properties of the thyroxine 5'-deiodinase in cytosol prepared 
from rat kidney can be summarised as follows: 
(1) It is prepared from kidney cytosol in variable yield 
which is in part dependent on the temperature of preparation, 
and on the KC1 concentration but not on the osmolarity of 
the suspending buffer. 
(2) It is labile and the activity is quickly lost on freezing. 
It is partially stabilized by strong KC1 solutions in the 
cold, and when frozen. 
(3) It has a broad pH optimum between 7.4 and 8.5. 
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(4) Analysis of the deiodination products from T4 by HPLC reveals 
only small quantities of di- and mono-iodothyronines. 
(5) The rat cytosol activity is precipitated through the broad 
range of 30-50% saturation by (NH)SO 4 in the presence 
of 1 M KC1. Pig cytosol activity is precipitated between, 
20-40% saturated (NH 4 )SO 4 without KC1. 
(6) Both pig and kidney cytosol are considerably purified 
by thyroxine affinity chromatography. The rat enzyme 
so produced is polydisperse in terms of molecular 
weight when examined by conventional PAGE-SDS. However 
the number of the bands could be considerably reduced by 
more vigourously denaturing the proteins prior to 
PAGE-SDS. 
(7) Aggregates of non-denatured protein were shown to exist 
in solution and migrated in a hydrophobic manner on 
Sephacryl. In solution the aggregates could be 
partially dispersed by strong KC1 without loss of deiodinase 
activity. 
(8) The more purified preparations of the enzyme (for example - 
after pore-gel electrophoresis), showed resistance to 
denaturation by trichloracetic acid. 
(9) The enzyme preparation after affinity chromatography was 
fractionated by dialysis into two glycoprotein containing 
fractions, one soluble and one insoluble in water. 
The fractions differed greatly in their carbohydrate 
to protein ratio. The soluble fraction had more 
carbohydrate. 
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(10) Part of the thyroxine 5'-deiodinase activity appeared 
to be associated with PAS staining protein on 
polyacrylamide pore gel electrophoresis. 
Strong evidence for the presence of only a small number of proteins 
in the aggregates after affinity chromatography can be deduced from the 
inspection of the log M i values taken from Tables 4.6 and 4.7 and which,•
for convenience, have been retabulated in Table 4.11. 
Considering first data from Table 4.6 of the logarithm of the 
molecular weights of any two adjacent bands, it can be seen that the 
values are integral multiples of a constant value; 
i.e. z = log M
+1 
. , = np (4.1) 1  
M. 
whereM i . = molecular weight of ith band 
p = 0.0602 
1, 2, 3, 4, 6, 7 
This data immediately suggests that any band is an aggregate of the 
preceding smaller bands. Equation 4.1 implies that the molecular 
weight of any band M i is given by 
m. = AlOmP (4.2) 
where A is a constant and equal to the molecular 
weight of band 1 
and m = n. 
It is thus possible to equate the measured molecular weight of each 
band with equation 4.2. 
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TABLE 4.11  
Denaturing 
Conditions 
Band 
Number Loa M - 	i L^ 	
m i+1 	_ 	1 p 	(p=0.0601) 
N
J
 I o- 
• 
'g M . 	' i
Table 4.6 
Normal SDS bl 4.3749 .1804 3.00 9 675.1 
b2 4.5553 .1805 3.00 9 587.8 
b3 4.7358 .4210 7.00 21 337.6 
b4 5.1568 .1804 3.00 9. 294.0 
b5 5.3372 .1203 	' 2.00 6 255.9 
b6 5.4575 .2406 4.00 12 168.9 
b7 5.6981 .2406 4.00 12 147.0 
, b8 5.9387 .2406 4.00 12 96.96 
b9 6.1793 .1203 2.00 6 84.41 
b 10 6.2996 .0602 1.00 3 63.97 
b 11 6.3598 .1804 3.00 9 36.75 
b12 6.5402 .0602 1.00 3 21.11 
b13 6.6004 .1804 3.00 9 12.13 
b14 6.7808 .0602 1.00 3 9.187 
b15 6.8410 .0601 1.00 3 6.061 
b16 6.9011 .3609 6.00 18 2.297 
b 17 7.2620 .0602 1.00 3 1.515 
b18 7.3222 1.00 
Table 4.7 f,. (p'=.0621) q , (q 	= 	p') 
Excess SDS bl 3.8838 .0828 1.33 4 
b2 3.9666 .4141 6.67 20 
b3 4.3807 .1657 2.67 8 
b4 4.5464 .2070 3.33 10 
b5 4.7534 .4969 8.00 24 
b6 5.2503 .1243 2.00 12 
b7 5.3746 .2691 4.33 13 
b8 5.6437 .3934 6.33 19 
b9 6.0371 
TCA + SDS b 1 4.3807 .2071 3.33 10 
b2 4.5878 .1242 2.00 6 
b3 4.7120 
CHC1 3 /CH OH b 1 4.0910 .2483 4.00 12 
+ SDS b2 4.3393 .1864 3.00 9 
b3 4.5257 .1863 3.00 9 
b4 4.7120 
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. 
Of great interest is that the values for M i derived from 
\A 
 relationship bear relationships to each other as two dimensional 
rectangular shapes. These relationships are shown in Figure 4.16 
and discussed below. 
If for ease of representation we let band 1 (bl) be a square of 
4 units of area, then to a very close approximation b2 = 6(6.06) units 
and b3 = 9(9.19) units when compared to the calculated values in 
brackets. 
Consideration of these areas suggests that b3 = 9 =(4 + 3 + 2)units 
which forms another square as shown in Figure 4.16. The model developed 
in the figure is based on the premise that the aggregation process uses 
blocks of 9 units (which are the most stable) and occasionally of 6 units 
to make larger squares or rectangles. 
Thus b4 = 24 =(9 + 9 + 6)= (2 x 63 + b2) 
b5 = 36 =(4 x 9)= (4 x b3) 
b6 = 48 = (b4 + b4) 
b7= 84= (b5 + b6) 
b8 = 147 = (b7 + 7 x 9) 
b9= 255 = (b8 + 12 x 9) 
b10 = 336= (b9 + 9 x 9) 
The possibilities for different shaped aggregates are obviously 
more numerous with increasing molecular weight. The models for b4 - b10 
shown in the figure are consistent with the postulate that the aggregates 
are made from two smaller blocks which join along a common border of the 
same length as a preceeding block. Although not shown in the figure, 
a linear end to end aggregate of 9 unit blocks is also quite possible. 
b8 
b7 
	
b10 
b6 
b5 
• b4 
b3 
b2 
bl b9 
FIGURE 4.16 A Geometric Model for the Structural Relationships Between 
the Cytpsol Bands on PAGE-SDS. 
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The model does not distinguish between several possibilities 
regarding subunit composition. They are firstly, that all bands 
consist of one subunit so that bl = 4, b2 = 6, b3 = 9 subunits, etc. 
and that these are stable and resistant to SOS in blocks of 9, 6,and 
4 or secondly, that three separate proteins are present which combine 
as shown in the figure and have molecular weights in the fairly 
precise ratio of 4:3:2. A third possibility is that there is a protein 
of 9 subunits in size and that the other smaller bands (bl and b2) are 
constant fragments of this protein. 
Confirmatory evidence for a small number of proteins is given 
by the small number of bands present in PAGE-SOS of the CHC1 3/CH 3OH 
and of the trichloracetic acid denatured cytosol proteins. Although 
in this data p' = 0.0621 rather than p = 0.0601 as in Table 4.6, 
completely integral values of n and m are obtained by using z = nq' 
where q' = . 
The CHC1
3
/CH
3
OH denatured protein shows only four distinct bands 
(apart from origin material) on PAGE-SOS, the largest of which (b4) at 
51,520 is within 5% of the molecular weight of band 3 in Table 4.7. 
This then implies that the other bands consist of 6 (5.86), 4 (3.81), and 
2 (2.15) subunits. Similarly for the TCA precipitated protein the 
bands represent 9, 7 (6.76),and 4 (4.2) subunits. The 7 unit band 
could consist of (4 + 3) units rather than (4 + 2) units previously 
encountered. 
The multiplicity of bands from the saturated SOS solution on 
PAGE-SOS confirms that aogregation is possible under the 
conditions of reaction with SOS. Interestingly, it also shows a band 
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at 52 mm (7650) which, although larger than the expected 6300 mol. wt., 
might represent the 1 unit peptide, as the resolution of small peptides 
on 3.3% PA gels is inaccurate. , 
On taking into account that the measurement of band migration is 
at best no better than + 0.5 mm the reproducibility of values of 
p = p', q = q' and of z = z' in both experiments is good and supports 
the above simple model to explain the aggregating bands on PAGE-SDS and 
implies a preparation containing only a small number of proteins (perhaps 
between one and three). 
Other experimental data is relevant regarding the number of different 
protein subunits present. The observed difference in protein to 
carbohydrate ratio after dialysis (Section 4.5) suggests at least two 
different proteins, one having a much higher proportion of carbohydrate 
than the other. Furthermore, it is unlikely that the deiodinase enzyme 
is of a molecular weight of 6000 as most enzymes are at least double 
this value (although it could be a proteolytic fragment) and this then 
implies several peptides to explain all the small bands. 
Considering the experimental observations and the deductions made 
from PAGE-SDS, I believe they are best explained by postulating that 
the enzyme in cytosol is derived from membranes within the kidney call 
or less likely, from within an enclosed cell compartment such as lysosomes 
or mitochondria. Such sites would explain the variable proportion of 
activity and would be consistent with the presence of glycoprotein. 
A soluble or 'latent' enzyme within lysosomes or mitochondria which is not 
part of a membrane is unlikely because there was no increase in 
5'-deiodinase activity in the cytosol when the kidney was homogenised in 
hypotonic medium. 
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Another and not mutually exclusive explanation for the low and 
varied cytosol activity comes from the repeated observation that the 
recovery of activity from the affinity or gel columns often greatly 
exceeds that of the total activity Of the loaded Protein. AlthoUgh this 
total activity is measured with non -saturating substrate concentrations, 
it does imply that other proteins in cytosol either strongly bind 
thyroxine such as the 'cytosol receptors' described by Tata (1975) 
or that there might be physiological protein inhibitors of the enzyme 
present. Either kind of protein might be separated from the enzyme 
during the chromatographic procedures. 
The property of aggregation can be explained by hydrophobic 
patches on the membrane protein which leads to their aggregation to 
quite large sizes in two dimensions (sheets). Helenius and Simons (1975), 
in their review on solubilisation of cell membranes, list seven membrane 
proteins which once solubilised, then remain as water soluble homogenous 
or dispersed aggregates after removal of detergent and which had molecular 
weights ranging from 3 x 10 5 to 3 x 10 6 . Hydrophobic induced 
aggregation would also explain the relative resistance to dispersion 
by SDS. 
In summary, the thyroxine 5'-deiodinase found in cytosol is 
characterised by the following properties: 
(1) It is unlikely to be found normally in cytosol in vivo  
but rather on homogenisation is liberated from a 
membraneous site within the kidney cell. 
(2) It is most likely to be a glycoprotein in composition 
with at least several subunits. 
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(3) It is aggregated in aqueous solution and partially 
dispersed by KC1. Part of it is precipitated when 
'dialysed against water. 
(4) It can be substantially purified by thyroxine as an 
affinity chromatographic iigand using agarose as a 
supporting matrix. 
(5) It deiodinates T to T o . Intermediary iodothyronines 
have short lifetimes. 
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CHAPTER 5  
Purification and Properties of Thyroxine 5'-Deiodinase  
from Rat Kidney Microsomes  
5.1 Introduction  
The purification of a membrane bound protein is complicated by the 
need to render the protein soluble in water, as most of the available 
puricifation techniques are dependent on the protein being in aqueous 
solution. Thus the successful solubilisation of the deiodinase was an 
essential step in the purification following preparation of the membrane. 
Microsomes were prepared from rat kidneys by using the 
homogenisation and centrifugation protocol shown in Figure 3.4. 
The 260,000 g particulate sediment was described as 'microsomes'. 
The measurement of thyroxine 5'-deiodinase activity employed the same 
substrate and trichloracetic acid control used in Chapter 3. 
5.2 The Properties and the Solubilisation of the Microsomal Deiodinase  
The pH optimum curve for deiodinase activity of microsomes was 
measured and is shown in Figure 5.1. The method is described in the 
caption. Maxima are present at pH 5.5 and at pH 7.5. 
The effect of storage, after freezing, on the microsomal 
5 2 -deiodinase activity was examined. The method and results are shown 
in Figure 5.2 and its caption. The figure shows a linear decrease of 
activity with time which was not stabilised by 100 mM KC1. 
The need for dithiothreitol in the assay for microsomal 
T4 5'-deiodinase was measured on washed microsomes and shown in 
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FIGURE 5.1 Effect of pH on Particulate Microsomal T4 V-DeiOdinaSe. 
Microsomes were prepared as in Figure 3.4 and resuspended in the 
appropriate buffers as described in Figure 3.3 to give the pH range 
shown in the figure. The pH values were checked with a pH meter 
after the addition of protein. 
FIGURE 5.2 The Effect of Freezing and Storage on Microsomal 
5'-Deiodinase Activity. 
Microsomes were prepared in HEPES/EDTA/DTT 50/15/1 mM pH 7.4 as in 
Figure 3.3. They were resuspended in the same buffer to give 
3.5 mg/ml and the solution divided in half. One portion was then made 
to 100 mM KC1 with solid salt, and the T4 5'-deiodinase activities 
measured in duplicate for both preparations. Both suspensions were 
then frozen in liquid nitrogen and stored at -20°C. Thereafter at 
various times, aliquots of each suspension were thawed quickly in a 
37°C shaking water bath and their T4 5'-deiodinase activities measured 
in duplicate. 
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Figure 5.3. The data in the figure generally agree with that of 
Visser et al. (1976), but maximal activity was obtained with a lower 
concentration of CITT (0.5 mM). 
Preliminary studies found that strong salt solutions would not 
solubilise the microsomal T4 5'-deiodinase. This suggested that the 
enzyme was an integral protein (Coleman, 1973) and would require 
detergent for its solubilisation. 
The effect of Triton X-100 on microsomal thyroxine 5'-deiodinase 
activity was measured and is shown in Figure 5.4, from which it can be 
seen that the detergent markedly inhibits the deiodinase at a concentration 
above 0.01% (v/v). This inhibition was shown to be reversible by 
dilution. 
Thus after the addition of Triton X-100, the assay of 5'-deiodinase 
was done only after the detergent concentration was either lowered by 
dilution to 0.01% (v/v) or reduced to values < 0.01% (v/v) by the method 
of Holloway (1973) in which the protein detergent mixture is passed 
through a small column of Biobeads SM-2 (Bio-Rad, California), a polystyrene 
-divinyl-benzene polymer. However this method can remove too much 
detergent and thus allow the protein to reaggregate. So that usually 
for deiodinase assay, dilution was employed to lower the final detergent 
concentration. 
The use of gel-filtration (molecular exclusion) chromatography 
was also tried for removal of detergent. With both Sephadex G.25 or 
Sephadex G 100, the Triton X-100 was not removed from the protein, but 
rather a protein-detergent micellar complex emerged in the void volume 
of each gel. 
• 
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FIGURE 5.3 The Effect of Dithitheitol (DTT) on Microsomal 
T4 5'-Deiodinase. 
Microsomes were prepared in Sucrose/HEPES/EDTA without DTT pH 7.4 
as in Figure 3.3, washed once and then resuspended in the homogenising 
buffer. Aliquots (1 ml) of the resuspension were taken and DTT added 
in a constant volume of 25 pl to give the concentrations shown. 
O'5 
Triton X-100 (°io viv) 
FIGURE 5.4 The Inhibition of Rat Kidney Microsomal 5'-Deiodinase 
Activity by Triton X-100. 
Microsomes were prepared as in Figure 3.3. Aliquots were assayed 
in duplicate using [3' 5.-1251  ]-thyroxine 10 -7 M in the presence of 
Triton X-100. 
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The concentration of Triton X-100 was measured by either UV 
spectroscopy at 283 nm (Technical Bulletin, Rohm and Haas, Philadelphia, 
1967) or by the method of Weber et al. (1964) which employs ammonium 
cobaltothiocyanate in dichloroethane. The latter method, though less 
sensitive, can be used after the precipitation of protein which then 
no longer interferes in the assays as happens with UV spectroscopy. 
The ability of Triton X-100 to solubilise T4 5'-deiodinase activity 
is shown in Figure 5.5 which employed the protocol shown in that figure. 
From Figure 5.5 it is clear that between 0.5 and 1.0% (viv) Triton X-100 
solubilises the T4 5'-deiodinase activity. The amount solubilised 
depends not just on the concentration of detergent but also on the 
detergent to protein ratio (Helenius and Simons, 1975). For this reason 
an approximate ratio of 5:1 of detergent to protein was always 
maintained during solubilisation procedures. 
The measurement of the pH optimum curve was repeated with the 
solubilised microsomal activity and is shown in Figure 5.6. The curve 
is more symetrical with a maximum at approximately pH 7.0, however a smaller 
maximum is still present at pH 5.5 when compared with Figure 5.1 which 
has maxima at pH 5.5 and 7.4. Thus the assay of particulate and 
solubilised microsomal 5'-deiodinase activity was performed at pH 7.4. 
The effect of ionic strength was measured on both particulate 
and solubilised microsomes as shown in Figure 5.7. The results in 
this figure are not strictly comparable because the solubilised microsomes 
were diluted to reduce the Triton X-100 concentration after preparation 
to 0.01% (v/v). This means that there will be an increase in activity 
of the - enzyme because the _substrate , concentration does not . give 
maximum velocity and the selective solubilisation of the enzyme removes 
inactive proteins. However it is clear that the activity of the 
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FIGURE 5.5 Protocol for the Step-Wise Solubilisation of Thyroxine 
5'-Deiodinase from Rat Kidney Microsomes. 
Microsomes (prepared as in Figure 3.4 
from four male rats) 
Make to 0.1% (v/v) with Triton X-100 
Mix at 4°C for 30 min 
Centrifuge 260,000 g for 30 min 
Resuspend the 30 ml pellet 
and repeat for 0.2, 0.5 and 
1.0% v/v Triton X-100 
successively. 
SN 
Dilute and assay for protein (a) 
and for T4 5'-deiodinase (b). 
Results shown in table below. 
SOLUBILISATION 
FRACTION 
VOLUME 
(ml) 
PROTEIN 
(mg) 
THYROXINE 5'-DEIODINASE 
ACTIVITY 
(pmo1/4 hours) 
Microsomes in 
0.01% Triton 
X-100 
0.1% 
supernatant 
0.2% 
supernatant 
0.5% 
supernatant 
1.0% 
supernatant 
30 
28 
31 
34 
38 
96 
83.32 
4.03 
9.52 
1.52 
326 
198 
79 
113 
18 
Footnotes  
(a) Pelley et al. (1976) 
(b) butanol extraction. 
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FIGURE 5.6 The Effect of pH on the Solubilised Thyroxine 5'-Deiodinase 
Activity from Rat Kidney Microsomes. 
Solubilised microsomal activity was prepared as described in 
Section 5.4 using 0.5% Triton X-100 and assayed at different pH after 
dilution using the protocol in Figure 3.3. 
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FIGURE 5.7 The Effect of Ionic Strength on the Microsomal T4 
5'-Deiodinase Activity from Rat Kidney. 
Microsomes were prepared and incubated with T4 in the presence of salt. 
The effect of KC1 was also examined on microsomes solubilized in 
0.5% (v/v) Triton X-100 and diluted to 0.01% (v/v). 
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solubilised deiodinase is much more subject to the effects of salt 
concentration with an optimum of 100 mM. 
5.3 Affinity Chromatography of the Thyroxine 5 -Deiodinase from  
Microsomes  
The absorption and desorption of the solubilised microsomal 
protein and 5'-deiodinase was first investigated under the conditions 
found suitable for the affinity chromatography of the 5'-deiodinase of 
cytosol. The elution profile is shown in Figure 5.8. This figure 
shows that protein and activity were bound to the column at pH 5.5 and 
both could be eluted by strong KC1 solution. 
As the increase in specific activity between the load protein and 
the eluted protein peak was small, other ligands were sought which might 
give a more specific binding, and hence a higher purification. In this 
regard various known inhibitors of the 5'-deiodinase were examined for 
their suitability as ligands on the assumption that their ability to 
inhibit was dependent on enzyme binding. They were first tested as 
inhibitors using microsomes and assaying by the butanol method. The 
results are shown in Figure 5.9. The data in Figure 5.9 agrees closely 
with that of Chopra et al. (1980) who used RIA to measure the inhibition. 
Propylthiouracil and iopanoic acid were selected for further 
trial because they were the most effective inhibitors and because they 
have functional amino groups with which to couple to the supporting 
agarose gel. Their structures and their absorption spectra are shown 
in Figure 5.10. 
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FIGURE  5.8 Affinity Chromatography of -Solubilised Microsomes on a 
Thyroxine-Sepharos6 6B Affinity Gel. 
Microsor2s were prepared and then resuspended in 10 ml of homogenising 
buffer (Sucrose/KC1/HEPES/EDTA/DTT 250/100/50/15/1 mM at pH 7.4) and 
made to 0.5% v/v with Triton X-100. After stirring for 1 hour at 4°C 
the microsomes were centrifuged at 260,000 g for 1 hour and the supernatant 
was diluted to 0.05% Triton X-100 and applied in a volume of 30 mls 
to a 1.5 ml 1-4-gel affinity column prepared as in Chapter 4 and pre-
equilibrated in the same buffer. The column was then washed with 
MES/EDTA/DTT 25/15/1 mM pH 5.5 containing 0.02% v/v Triton X-100 until 
no protein could be detected by the 'spot' method of Sedmark and 
Grossberg (1977) and then eluted by the same MES buffer with the 
addition of 500 mM KC1. Protein was then measured in duplicate by the 
method of Sedmark and Grossberg (1977) and T4 5'-deiodinase activity 
in duplicate by the butanol method with readjustment of pH to 7.4 and 
KC1 to 100 mM by dilution with HEPES/EDTA/DTT 100/15/1 mM pH 7.4 buffer. 
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FIGURE 5.9 The Effect on Rat Kidney Microsomal 5'-Deiodinase 
by Various Inhibitors. 
Microsomes were prepared as in Figure 3.4 and assayed in duplicate 
using 10-7 M thyroxine as substrate by the butanol method. 
Abbreviations: In ,inhibitor; T3, 3,5,3' triiodothyroxine; PTU, 
propylthiouracil; IPA, iopanoic acid (Telepaque-Stirling Winthrop); 
ANS, 8-anilo-1-napthalene-sulphonic acid, Sal, sodium salicylate. 
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FIGURE 5.10 The Structures and the Absorption Spectra of Iopanoic 
Acid (IPA) and of Propylthiouracil (PTU). 
Spectra were performed on aqueous solutions (7 x 10 -7 M) in 1 cm 
quartz cells using a water blank in a Pye Unicam split beam scanning 
spectrometer. 
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The absorption spectra gave several possible wavelengths for 
spectroscopic assay of PTU and IPA, however it was decided to use the 
lesser maxima at 315 nm for IPA and 307 nm for PTU in the measurement 
of coupling to the Sepharose 6B because the other wavelengths could be 
subject to interference by the absorption maxima of protein (280 nm), 
or the affinity gel matrix (230 nm). Beer's Law was found to hold 
in the range 8 to 140 nmo1/1. 
Iopanoic acid and propylthiouracil were then coupled to epoxy-
activated Sepharose 6B (Pharmacia) by the same protocol as used in 
Chapter 4 but using a reaction time of 42 h at 30°C. Unreacted oxirane 
groups were again blocked with ethanolamine. A control gel in which 
all the oxirane groups were reacted with ethanol'aminewas also made. 
The amount of ligand bound was determined by suspending a sample of the 
reaction product in glycerol and was read against standards of IPA or 
PTU made up in glycerol. 
The amounts of each ligand bound were IPA 2.04 pmol/m1 gel; 
PTU 0.55 pmol/m1 gel. This compares to T4 0.39 umol/m1 of gel. 
Under the reaction conditions it is expected that IPA will bind through 
its primary amino group, but PTU might bind through either its secondary 
amino group or through the hydroxyl or sulphydryl groups that a tautomeric 
isomer of PTU can adopt. 
The ability of the four affinity gels: IPA, PTU, T4 and blank 
to separate the microsomal T4 5'-deiodinase was examined in parallel 
experiments with the same starting material. The data for each column 
are shown in Table 5.1. The table shows that the IPA-Gel is the best 
affinity gel as it retains 2-3 fold the activity retained on T4 or PTU 
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TABLE 5.1 Comparison of T4 5'-Deiodinase Purification by Various 
Affinity Gel Columns. 
• FRACTION VOLUME 
(ml) 
TOTAL 
PROTEIN 
(mg) 
TOTAL ACTIVITY 
(pmo1/2 h) 
SPECIFIC ACTIVITY 
(pmol/mg/2 h) 
Load Protein 20 4.00 .256 64 
Ethanolamine 
(Blank) Gel Eluant 10 1.35 63 .47 
T4 -Gel Eluant 10 0.65 34 52 
PTU-Gel Eluant . , • 	 10 0.80 38 47 
IPA-Gel Eluant • 10 0.95 91 96 
Microsomes from the kidneys of four rats were prepared and solubilised 
in 10 ml as before (Sections 5.1, 5.2) and the supernatant prepared by 
centrifugation at 260,000 g for 1 hour. 
The supernatant was then diluted 10 fold, and 20 mls applied to each of 
the four columns containing 5 ml of their respective affinity gels. 
The protein was run on, and then the unbound protein eluted by washing 
with Hepes/EDTA/DTT 25/15/1 mM pH 7.4 buffer containing 0.02% Triton X-100 
until the protein in the eluant was undetectable by the spot test of 
Sedmark and Grossberg (1977). The bound protein was then eluted in a 
volume of 10 mls by the addition of 500 mM KC1 to the elution buffer. 
Protein and 5'-deiodinase activity was determined as in Figure 5.9. 
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gels. Interestingly, the ethanolamine gel is superior in its performance 
to both PTU and T 4 gels but not to the IPA gel. 
The elution of 5'-deiodinase activity from the IPA-agarose was 
further examined by the stepped elution with KC1 by using 100, 500 and 
1000 mM KC1. The method and results are shown in Table 5.2. The table 
shows that the IPA bound protein is in part further fractionated by 
elution with differing KC1 concentrations. The difference in specific 
activity suggests that there is still some non-enzymic protein bound to 
IPA which tends to elute earlier with the lower KC1 concentration. 
Comparison by PAGE-SDS (Weber et al., 1972) of the proteins from 
solubilised microsomes and of the proteins in the 100 and 500 mM eluants 
for the IPA-agarose gel showed a marked reduction in protein bands (see 
Figure 5.11). Of those proteins found in the eluant, no integral 
logarithmic relationship was apparent between their molecular weights such 
as was found with the cytosolic enzyme. The detergent SDS is sufficiently 
strong to solubilise almost all proteins and displaces Triton X-100. 
5.4 Discussion and Conclusions  
Coleman (1973) has suggested that the membrane proteins can be 
roughly described as either integral or peripheral. Integral proteins 
are tightly bound to, or within the membrane and can only be solubilised 
by disrupting the membrane with detergents or organic solvents. 
Peripheral proteins are less tightly bound and are solubilised by less 
drastic measures such as the disruption of homogenisation or by solutions 
of strong salt. 
Detergents have been used extensively for the solubilisation of 
cell membrane components, although a delicate balance often exists 
Microsomes(sol.) 	100mM KU etuant 
500 mM KU eluant 
FIGURE 5.11 The Appearance on PAGE-SDS of the Triton X-100 Solubilised 
Microsomes and of the Protein in the KC1 Eluants from the 
IPA-Affinity Gel. 
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TABLE 5.2 Elution of Thyroxine 5'-Deiodinase Activity from Iopanoic 
Acid Affinity Gel. 
FRACTION VOLUME 
(ml) 
PROTEIN 
(mg) 
TOTAL ACTIVITY 
(pmo1/2 h) 
SPECIFIC ACTIVITY 
(pmol/mg/2 h) 
Load Protein 50 10.7 704 66 
100 mM KC1 10 500 97 194 
Eluant 
500 mM KC1 10 100 61 610 
Eluant 
1000 mM KC1 10 0 0 0 
Eluant 
Microsomes from the kidneys of six rats were prepared as in Sections 
5.1 and 5.2. The solubilised microsomal protein (50 ml) was loaded 
into the column and was treated as in Table 5.1. The bound protein 
was successively eluted by 100, 500 and 1000 mM KC1 in the buffer 
containing 0.02% Triton X-100. 
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between solubilisation and denaturation of the protein. In general, 
Coleman (1973) suggests that the potency for inactivation of proteins 
by different detergents occurs in the following order: 
ionic » bile salts > non-ionic. 
In fact most membrane proteins are denatured by ionic detergents 
such as sodium dodecyl sulphate (SDS), however the bile salts, the 
glycoside digitonin and the non-ionic detergents esliecially, such as 
Triton X-100 (Rohm and Haas) have often been used successfully to 
solubilise integral proteins (reviewed by Helenius and Simons, 1975). 
Initial studies on solubil ising the microsomal 5'-deiodinase were 
made with Triton X-100 because of: (a) its previous successful use 
with many other different enzymes and (b) the successful use of affinity 
chromatography in the presence of Triton X-100 by Dawson and Crane (1974) 
during the purification of acetylcholine receptor proteins. Triton X-100 
is a non-ionic octylphenoxyethanol detergent having a chain length of 
9-10 units (Technical Bulletin, Rohm and Haas, Philadelphia). 
During solubilisation the detergent binds to membranes at low 
concentrations resulting in a change in a number of their properties 
• including increases in both membrane area, and in membrane permeability 
and a reduction in buoyant density (Helenius and Soderlund, 1973). 
Most membrane bound enzymatic activities are affected in some way or 
another (Coleman, 1973). As the detergent concentration is further 
increased, macro-molecules are able to pass through the membrane, 
a process known as lysis. After lysis of a membrane there is evidence 
(Deamer, 1973) of increased binding of the detergent to membranes with 
increasing detergent concentration until a concentration is reached when 
the membrane begins to disintegrate, i.e. solubilise. 
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The final step in solubilisation occurs when the Triton X-100 
concentration reaches a sufficient value such that separate lipid and 
protein micelles are formed. These different micelles have been 
separated by ion exchange chromatography (Jacobs et al., 1966), density 
gradient centrifugation (Engelman, et al., 1967) and also by phase 
partition separation (Albertson, 1973). 
The criteria for solubilisation is operational. It is common for 
workers to define solubilised material as that which does not form a 
100,000 a sediment after 1 h. For the purpose of this thesis, 
solubility was taken as the inability to form a 260,000 g sediment 
after 30 min. 
The free equilibrium concentration of Triton X-100 has been shown 
to be below or equal to the CMC* in the presence of membranes (Helenius 
and Simons, 1974). The extent of solubilisation can best be correlated 
with the ratio of bound detergent to membrane. As this ratio is often 
laborious to determine, the effects of the Triton X-100 correlate well 
with the total detergent/membrane ratio (Helenius and Simons, 1975) if 
the membrane concentration is relatively high (approximately 2 mg/ml) 
as was done in this thesis. 
Triton X-100, although a useful detergent for membrane 
solubilisation, is difficult to remove from samples by the usual methods 
such as dialysis, because of its very low CMC *(0.015, v/v). Triton X-100 
has been reported to have been removed from solubilised membranes by gel 
filtration (Roltem et al., 1968), and Bio-Gel A5m (Loach et al., 1970), 
but most authors have found that the detergent behaves as a large 
molecular weight aggregate (approximately 100,000) as was found for the 
critical micelle concentration. 
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microsomal T4 5'-deiodinase and hence these methods are not generally 
applicable. Bio-beads SM-2 (a neutral, porous styrene-divinylbenzene 
co-polymer) were used in a small column as a simple, rapid and mild 
procedure for the removal of Triton X-100 (Holloway, 1973). However in 
practice it was found that the Bio-beads could remove too much Triton X .-100 
allowing the protein to come out of solution (Section 5.2). 
The solubilised microsomes displayed little change in the pH optimum 
for T4 5'deiodinase activity, but they did display a much greater 
activity in the presence of 100 mM KC1. 
Although the purification achieved by affinity chromatography, 
using iopanoic acid as a ligand, appears modest in terms of the increase 
in specific activity (3-10 fold) and by the decreased number of bands 
on PAGE-SDS, it compares quite favourably with the purification achieved 
by other workers. 
Kohrle et al. (1980) solubilised the 5'-deiodinase in deoxycholate, 
followed by either gel filtration or ion-exchange chromatography to 
separate 5'-deiodinase activity and obtained to give a 1.5 to 2 fold 
purification. They found no increase in purification using T4 as an 
affinity ligand. Fekkes et al. (1980) used polyoxyethylene ether W.1 
followed by covalent chromatography using activated thiol-Sepharose to 
give 3 fold purification. They found no increase in purification using 
glutathione as an affinity ligand. Both groups found marked variation 
in the molecular weight of 5'-deiodinase, as judged by molecular exclusion 
chromatography with different detergents in the mobile phase, indicating 
variation in the protein-detergent micelle size with the different 
detergents. Thus affinity chromatography has the advantage of isolating 
5'-deiodinase by mechanisms which do not depend on molecular size. 
Different workers (see Section 1.2.4.2) have localised the 
microsomal thyroxine 5'-deiodinase to either or both the plasma 
membranes and the endoplasmic reticulum of the rat liver and kidney. 
Therefore it was felt important,to carefully evaluate by the assay 
methods used in this thesis the plasma membrane and endoplasmic 
reticulum as sites of the 5'-deiodinase activity because this might 
allow a better purification prior to affinity chromatography. This 
work is discussed in Chapter 6. 
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CHAPTER 6  
Further Examination of the Subcellular Sites of 
5'-Deiodination  
6.1 Introduction  
As was discussed in the conclusion to Chapter 5, it was decided 
to examine both the plasma membrane and endoplasmic reticulum to assess 
their relative contributions to the microsomal 5'-deiodinase activity 
using the deiodinase assays established earlier in the thesis employing 
iodine-125 labelled substrates. 
Similarly, the strong likelihood that the soluble 5'-deiodinase 
found in cytosol after cell fractionation comes from a location other than 
cytosol implies that it might be coming from an enclosed cell organelle 
containing soluble enzymes such as the lysosome. Further circumstantial 
evidence was that the crude mitochondrial fraction had substantial 
activity (Chapter 3), even though homogenisation in hypotonic medium 
(Chapter 4) did not increase either the total homogenate or the cytosol 
activity as is characteristic of the latent soluble enzymes of lysosomes 
(de Duve, 1965). 
Accordingly it was decided to conduct parallel studies both on lysosomes, 
plasma membranes and endoplasmic reticulum. 
The strategy adoped for these studies was firstly, to use highly 
selective methods for the preparation of cell organelles from the above 
fractions and secondly, to use marker enzymes which were as unambiguous as 
possible to identify the cell organelle in each prepared fraction, rather 
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than depending on centrifugational criteria. On one occasion, mitochondrial 
and lysosomal fractions were identified by electron microscopy. 
6.2 Methods for the Preparation and Identification of Cell Fractions 
6.2.1 Preparation of Lysosomes  
Lysosomes can be separated from mitochondria and peroxisomes 
of both liver and kidney cells by utilising the cells' ability to 
take up and store the detergent Triton WR-1339 in their lysosomes 
which then leads to a change in lysosomal density (Wattiaux et al., 
1963). This observation was employed by Trouet (1964) for the 
isolation of highly purified lysosomes in high yield from rat liver 
on a discontinuous sucrose gradient, and by Wattiaux-De Coninck et al., 
(1965) for the isolation of lysosomes in lower yield but in highly 
purified form from rat kidney on a continuous sucrose gradient. 
Such preloaded lysosomes are often called "tritosomes". 
The lysosomes prepared by the above methods are easily 
ruptured by mechanical or osmotic stress so that the method of 
Trouet (1964) was modified for both liver and kidney lysosomes as 
follows: 
(i) The method of homogenisation was changed from a 
Potter-Elvehjem device to a tissue press with a plate 
containing 1 mm holes 2 mm apart followed by 8 passages 
in a hand held glass Dounce homogeniser. 
The homogenising buffer was Sucrose/TRIS-HC1/KC1/EDTA/DTT 
250/100/15/1 pH 7.4 rather than just sucrose 250 mM. 
(iii) Chloroquine 2 x 10 -5 M was added to all solutions, as it 
is known to stabilize lysosomal membranes in vitro  
against rupture (Miller and Smith, 1966). 
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6.2.2 Preparation of Plasma Membranes and Endoplasmic Reticulum  
Plasma membranes were prepared from kidney and liver either by 
the method of Booth and Kenny (1976) or by the Wisher and Evans (1975) 
modification of the hypotonic bicarbonate method of Neville (1960). 
Both methods were modified to use the same homogenisation method and 
buffer described in Section 6.2.1. 
6.2.3 Marker Enzymes  
The following enzymes were used as markers for cell components 
of rat liver and kidney: glucose-6-phosphatase (EC 3.1.3.9) for 
endoplasmic reticulum was assayed by the method of Swanson (1955) 
as modified by Evans (1978); 5'-nucleotidase (EC 3.1.3.5) for 
plasma membrane was assayed by the method of Evans (1978) using 
AMP as substrate and measuring the liberated phosphate by the method 
of Le Bel et al. (1978); succinic dehydrogenase (EC 1.3.99.1) for 
mitochondria (inner membrane) was assayed by the method of Holdsworth 
(unpublished) in which 0.1 ml of fraction was combined with 0.4 ml 
of 0.2 M NaH2PO4 pH 7.4, 0.3 ml of 0.2 M succinate pH 7.4 and 
0.1 ml 1% 3,(4,5 dimethyl thiazole) 2,5 diphenyl tetrazolium bromide 
(MTT, Sigma), the reaction was stopped after 15 minutes with 
1 ml 1% w/v trichloracetic acid and the colour extracted into 4 ml 
of tetrahydrofuran and read at 550 nm; galacturonidase (EC 3.2.1.31) 
and N-acetyl-P-glucosaminidase (EC 3.2 . .1.30) for lysosomes were 
assayed by the methods of Gianetto and de Duve (1955) using the 
p-nitrophenol derivative (Calbiochem) and of Peters et al. (1972) 
using the 4-methyl umbelliferone derivative (Boehringer) respectively. 
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N-acetyl-P.-glucosaminidase is an almost completely latent 
lysosomal enzyme, hence its assay has the advantage of allowing 
assessment of lysosomal integrity (Peters eta]., 1975). 
6.3 T-Deiodinase Activity of Lysosomes  
Rat liver and kidney homogenates and their lysosomal fractions were 
prepared after the prior injection of Triton WR-1339. The marker 
enzymes (section 6.2.3) and the different 5'-deiodinase activities were 
then determined on these fractions. The methods and the values obtained 
are shown in Table 6.1 and its caption. 
The values in the table show that the yield of lysosomal protein is 
about 4-5% of homogenate which is slightly greater than normally obtained 
(Beaufay, 1969). This is probably due to microsomal contamination as 
shown by the presence of glucose-6-phosphatase and 5'-nucleotidase. 
However the lysosomal enzymes f3. galacturonidase and N-acetyl-f3- 
glucosaminidase are selectively increased in this fraction and suggest 
substantial enrichment of lysosomes. Of great interest is the marked 
increase in T4 and rT 3 5'-deiodinase. There is very little increase 
in T3 outer-ring deiodination. As the concentration of T4 is tenfold that 
of rT
3' the specificity of the lysososomal 5'-deiodinase enzyme appears 
to be rT 3 > T 4 > T 3 . 
As tritosomes, prepared by the method of Trouet (1964), usually 
have about 20% contamination of microsomal elements (Beaufay, 1969), 
it was necessary to ascertain if the rT 3 5'-deiodinase activity was 
a microsomal contaminant. This was done in the next experiment as shown 
in the protocol of Figure 6.1 and Table 6.2. At the same time an 
175 
TABLE 6.1 Iodothyronine 5'-Deiodinase and Marker Enzyme Activities . 
of Kidney and of Liver Homogenates and Lysosomes Prepared 
from Triton WR-1339 Pretreated Rats. 
Protein 
or 
Enzyme 
Activity 
Liver 
homogenate 
Kidney 
homogenate 
Liver 
lysosomes
a 
Kidney 
lysosomes
a 
Protein 
(mg/ml) 3.1 1.4 0.168 0.058 
5'nucleotidase 
(pmol/mg) 14 28 357 30 
Succinic
b 
 
dehydrogenase 
(units/mg) 10 13 53 0 
Glucose-6- 
phosphatase 
(pmol/mg) 
t3-ga1acturonidase 
(umol/mg) 
26 
27 
45 
13 
173 
107 
759 
35 
N-acetyl-13
b 
glucosaminidase 
(units/mg) 2.2 
. 
6.1 18 13 
T 4 -5' deiodinase 
(pmol/mg) 
rT 3 -5' deiodinase 
(pmol/mg) 
3.1 
3.3 
11 
7.3 
80 
55 
107 
185 
T3-5' deiodinase 
(pmol/mg) 0.2 0.4 0.8 1.2 
a 
lysosomes made to 0.1% then diluted to 0.01% Triton X-100 before assay. 
arbitary units. 
Two male hooded Wistar rats (180 gm) were pretreated with Triton WR-1339. 
Homogenates and their lysosomal fractions were prepared from both livers 
and kidneys as in Section 6.2.1 modified to increase the yields of 
lysosomes by loading a combined particulate fraction (260,000 g), rather 
than a heavy mitochondrial fraction, on to the discontinuous sucrose 
gradient. Marker enzyme activities were determined in duplicate as 
described in Section 6.2.3 and 5'-deiodinase activities were measured 
in triplicate by the butanol extraction method using T4 (10 -7 M), 
rT 3 (10-8 M) and T3 (10-8 M) as substrates incubated for 1.5 hours. 
Protein was measured by the method of Sedmark and Grossberg (1977). 
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FIGURE 6.1 Protocol for Extraction of Lysosomes by KC1 and Triton X-100. 
Prepared tritosomes (Trouet, 1964) 
diluted 1:6 with 25 mM TRIS pH 7.2 
frozen in liquid nitrogen 
thawed 37°C 
centrifuged at 260,000 g for 30 min 
sediment resuspended in 1M KC1 supernatant 
centrifuged at 260,000 g for 30 min 
sediment taken up in 
Triton X-100 0.1% (v/v) 
then diluted to 0.01% 
supernatant 
centrifuged 260,000 g for 30 min 
sediment supernatant 
Fractions were assayed for both rT 3 5'-deiodinase and 
N-acetyl-a-glucosaminidase as described in Table 6.2. 
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TABLE 6.2 Extraction of Lysosomes with KC1 and Triton X-100. 
Fraction rT 3 5 1 -deiodinase a ! N-aceiy1- .0-g1utOsaminidaSe 
Liver Kidney Liver Kidney . 
tritosomes 
tritosomes after 
freeze-thaw 
freeze thaw 
supernatant 
100 
135 
10 
100 
117 
7 
100 
108 ' 
60 
100 
128 
43 
. KC1 supernatant 6 19 23 23 
Triton X-100 
supernatant 41 84 6 16 
Triton .X-100 
sediment ' 14 13 2 10 
a Enzyme activities are the total for each fraction (mean of 
duplicates) expressed as a percentage of the value for tritosomes. 
All activities were measured after making each fraction to 0.1% (v/v) 
Triton X-100 and then diluting to 0.01%. 
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assessment was made as to whether the enzyme was soluble or membrane-
bound. 
Table 6.2 shows that most of the N-acetyl-6-glucosaminidase is released 
by osmotic shock and the single freeze-thaw cycle, although as expected, 
the kidney lysosomes, because of their smaller size, are more resistant 
to this process. The lysiS is virtually complete after exposure to the 
strong salt. On the other hand, very little rT 3 5'-deiodinase is released 
until the membrane fraction is treated with 0.1% Triton X-100. In a 
parallel experiment, KC1 and NaCl (0-500 mM) were found to have no effect 
on either rT 3 or T4 5'-deiodinase of tritosomes. 
As the use of strong salt removes most of the endoplasmic reticulum 
contamination from lysosomes (Beaufay, 1969, Thines-Sempoux, 1976), this 
implies that the rT 3 5'-deiodinase is a membrane bound lysosomal enzyme. 
The requirement for dithiothreitol (DTI) as a cofactor for rT 3 
5'-deiodinase was examined wtih tritosomes prepared from both liver and 
kidney in media without DTT. The results in Figure 6.2 show an obligatory 
requirement with maximum activity for the deiodinase of either tissue 
at about 10 mM DTT. Consequently subsequent assays were performed at 
10 mM DTT rather than at 1 mM DTT. 
Since many of the enzymes of lysosomes have pH optima in the acid 
range, the effect of pH on r1 3 5'-deiodinase was determined. Liver 
tritosomes were used because of the much higher yield of lysosomal 
protein from liver. Preliminary experiments showed possible inhibition 
by various buffer ions such as cacodylate, barbiturate and citrate so that 
the pH of the incubation media was adjusted using only sodium phosphate 
buffers which appear not to inhibit the deiodfnase. As certain values 
KIDNEY 
LIVER 
• 
30 
5 	10 100 
EDIT] (rnM) 
FIGURE 6.2 The Effect of Dithithreitol on Lysosomal 5'-Deiodination 
of rT 3 . 
Tritosomes were prepared (section 6.3.2) and made to 0.1% (v/v) 
Triton X-100 and then aliquots were diluted to 0.01% Triton 
X-100. At the same time DTT was added to give the final 
concentrations shown. Reverse 13 5'-deiodinase was assayed 
as in Table 6.1. 
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of pH are more than one pH unit removed from the three pK a of the 
phosphate buffers, the pH was measured during the reaction and no change ' 
was observed, but as expected, the addition of lysosomal protein did 
on occasion shift the nominal pH of the buffer. The results and 
method are shown in Figure 6.3 and its caption. 
Figure 6.3 shows a sharp maximum for rT 3 5'-deiodinase at about 
pH 7.2, with a broader maximum at pH 7.2 for T4 5'-deiodinase. It also 
confirms the lack of activity against T3. 	Enzyme activities (not shown) 
were similar with both IRIS and HEPES buffers between pH 7 to 8. Thus 
subsequent lysosomal 5'-deiodinase activities were performed at pH 7.2 and 
37°C. 
6.4 The Intracellular Localisation of the Microsomal Thyroxine  
5'-Deiodinase  
Plasma membranes were prepared by both the modified methods described 
in Section 6.2.2. From the 7000 g supernatant of the Booth and Kenny 
method, a 10,000 g (20 min) and then a 260,000 g (30 min) sediment were 
successively prepared. The latter sediment was taken as the endoplasmic 
reticulum component of the microsomal fraction. The T4 5'-deiodinase, 
5'-nucleotidase,and glucose-6-phosphatase activities of these fractions 
were then determined and are shown in Figure 6.4. 
Figure 6.4 allows a comparison between the methods of Booth and Kenny 
(1976) and Wisher and Evans (1975). With the former method, a clear 
separation of 5'-nucleotidase and glucose-6-phosphatase with the plasma. 
membrane and endoplasmic reticulum fractions was achieved. T4 
5'-deiodinase was present in both fractions but was of higher relative 
activity in the plasma membrane fraction. The results from the 
FIGURE 6.3 The Effect of pH on Liver Lysosomal 5'-Deiodination of 
Iodothyronines. 
Tritosomes from liver were prepared as in Section 6.3.1 and 
assayed for T4, rT 3 and 13 5'-deiodinase activity as in 
Table 6.1. The pH was adjusted by tenfold dilution of 
tritosomes with the appropriate phosphate buffer (200 mM) 
and DTT after the addition of 0.1% Triton X-100. The actual 
pH was measured before and after with a glass pH electrode. 
Protein 
5-nucleotidase 
glc.-6-phos'ase 
-o 
(An g g 
t-- 	CNA VI 	 r-- 
0 	 .4 	co cn _J I I o 
N NJ 	NJ 
0 
"0 200 
0 
>PN 
—I-- 100 
• — 
Li 0 
200 
Li 
• •■■••• 
0 
T4 5-deiodinase 
	• 
100 
0 
Booth &Kenny 	Wisher& Evans 
FIGURE 6.4 Enzyme Activities in Microsomal Fractions of Rat Liver. 
Enzyme activities were measured as described in the text. 
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fractionation by the Wisher and Evans method were less differentiated 
and show that T4 5'-deiodinase was spread into the two poorly separated 
5'-nucleotidase and glucose-6-phosphatase fractions. 
6.5 Iodothyronine 5'-Deiodinases of Microsomes  
In view of the known rapid deiodination of reverse T3 by microsomes 
(Chapter 1), the 5'-deiodinase activities of the plasma membrane- and 
endoplasmic reticulum fractions were measured using rT 3 , 13 and 14. 
Marker enzyme activities were also determined. 
The method and results are shown in Table 6.3 and its caption. 
It can be seen from the table that both fractions had rT 3 and 14 
5'-deiodinase activities with very little T3 5'-deiodinase activity. 
The order of specificity of the 5'-deiodinases for the substrates is 
rT 3 > T4 > T3 which is similar to the order for lysosomal 
5'-deiodinase activity. 
6.6 Kinetic Analysis of the Iodothyronine Deiodinase Activities of  
Rat Liver  
The uncertainty in assessing both the specific activities and the 
substrate specificities when using non-saturating substrate concentration 
PP 
was brought out after a kinetic analysis in which the K
APP 
 and VA 
max 
PP 
and KA were determined for each substrate and enzyme source. This 
cat 
method and results are shown in Figure 6.5 and its caption. The 
• APP 
calculated values for Km
APP 
 and are shown in :Table 6.4. 
CdL 
Figure 6.5 shows the initial enzyme velocities for each enzyme 
source. The data for T3 and T4 5'-deiodinase is only approximate because 
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TABLE 6.3 Iodothyronine 5'-Deiodinase and Marker Enzyme Activities of 
Rat Liver Homogenate and Microsome Fractions. 
Enzyme Homogenate 
(100 ml) 
Plasma Membranes
a 
(25 ml) 
Endoplasmic 
Reticulumb 
(25 ml) 
Protein 
(mg/m1) 1.55 1.20 1.60 
5'-nucleotidase 
(pmol/mg) 21 26 18 
Succinic , 
dehydrogenase' 
' (units/mg) 21 0 42 
Glucose-6- 
phosphatase 
(pmol/mg) 16 30 65 
13-galacturonidase 
(pmol/mg) 29 24 38 
N-acetyl-ii- _ 
glucosaminidase' 
(units/mg) 26 23 16 
T4 	5'-deiodinase 
(pmol/mg) 
rT 3 5'-deiodinase 
(pmol/mg) 
17 
12 
25 
14 
13 
13 
13 5'-deiodinase 
(pmol/mg) 1.2 1.5 1.1 
a
7,000 g sediment 
b
260,000 g sediment 
c arbitary units 
Protein and enzyme activities were determined as in Table 6.1. 
The plasma membrane and endoplasmic reticulum fractions were prepared 
by the modified method of Booth and Kenny (1976) as described in 
section 6.4, except that the 7,000 g sediment was not recentrifuged 
at 4,000 g. 
150i E.R. 
90 
o 
ct. 
30 
T3 
2 	3 o so (Jim) 
FIGURE 6.5 Initial Velocities of the 5'-Deiodinase Activities Found 
in Different Cell Fractions of Rat Liver. 
Cell fractions (endoplasmic reticulum, plasma membranes 
from the same homogenate) and tritosomes (from preinjected 
rats with Triton WR-1339) were prepared from rat liver as 
in sections 6.2.1 and 6.2.2. Protein were measured by 
Sedmark and Grossberg (1978). 5'-deiodinase activity was 
measured in the presence of 0.01% (v/v) Triton X-100 and 
10 mM DTT. Samples of enzyme preparation pre-warmed at 
37° for 5 min and then added to the radioactive substrate 
to give the final concentrations shown. For each of the 
substrates there was approximately 40,000 cpm/ml. At 
measured intervals (0, 1, 2, 5, 10, 20 mins for rT 3 and 
0, 5, 10, 15, 30, 60 nuns for T4, T3) duplicate 0.5 ml 
aliquots were removed and added immediately to TCA and the 
liberated iodide measured by butanol extraction. Initial 
velocities were determined by drawing tangents to the curve 
at the origin. 
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TABLE 6.4 Apparent Kinetic Constants for Iodothyronine 5'-Deiodinases 
of Rat Liver. 
Substrate Kinetic 
Parameters 
Plasma 
Membrane 
Endoplasmic 
Reticulum 
Lysosomes 
Vol(m1) 200 200 200 
rT 3 
Protein conc.(mg/m1) 
KAPP pmo1/1 
m 
V
APP  pmol/min/m1 
max 
• 
KAPP pmol/mln/mg 
cat 
0.3 
0.22 
12.7 
42 
0.3 
0.57 
94 
313 
0.09 
0.53 
18.8 
208 
Vol (ml) 200 200 200 
T4 
Protein conc.(mg/m1) 
KAPP pmo1/1 
m 
VAPP pmol/min/ml 
max 
P 
KAP 
 pmol/min/mg 
cat 
0.3 
0.24 
2.4 
0.3 
1.9 
11.5 
38 
0.09 
0.5 
5 
56 
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their much lower deiodination rates made the measurement of the initial 
velocities difficult. As the specific activity was different at each 
concentration the expected statistical error was also different, therefore 
APP APP 
Km 	and Vmax were determined by the direct plot method of Eisenthal and 
Cornish-Bowden (1974) which is less affected by the variable expected 
error. The calculated values are tabulated in Table 6.4. Values for 
13 are not shown because of the very low activity and associated large 
error in the measurements. 
6.7 The Use of HPLC in the Assay of Deiodination  
As a qualitative study, the experiment in Figure 6.5 was repeated but 
the timed aliquots were added to four volumes of ice-cold ethanol to 
which had been added 4 pg of isopropyl diiodothyronine as an internal 
standard. 125 I-labelled tracer was omitted. Iodothyronines were then 
extracted as a group by the ion-exchange method (Section 2.2) and taken to 
dryness under air at 56°C. Samples were then redissolved in 120 pl of 
mobile phase, of which 100 pl was injected into the HPLC system described 
in Section 2.4. 
Two important problems emerged with this qualitative HPLC assay of 
the iodothyronine products of deiodination. Firstly, the modified 
method of Tajuddin and Elfbaum (1973) described in Section 2.2 extracts a 
band of strongly U.V. absorbing material from endoplasmic reticulum, 
plasma membrane and cytosol which elutes early in the chromatogram and 
which thus obscures the presence of mono- and di-iodothyronines. With 
assay of lysosomal deiodinase activity only the mono-iodothyronines were 
obscured. See Figure 6.6. 
Thus with the present methods, the use of HPLC was generally only 
of use to give a qualitative indication of the deiodination products. 
2'5 
min 
FIGURE 6.6 HPLC appearance of lysosomal extract after incubation with 
rT3. 
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When a combination of highly active deiodinase and substrate could be 
studied, as with the lysosomal enzyme and rT 3 , then quantitative 
results could be obtained. 
Figure 6.7 shows a comparison between the measurement by HPLC of the 
release of 3,3'-T 2 from r1 3 and of the measurement of the release of I -
from rT 3 by ion-exchange assay in the same experiment. No other 
iodothyronine was detected by HPLC. As the correspondence between l - 
and 3,3'T 2 is very nearly one to one, it indicates that no other product 
is formed over the 20 minute period of incubation. 
Observation and kinetic analysis of both curves in Figure 6.7 
suggests that substrate inhibition occurs at higher substrate 
concentrations. Analysis of both sets of data by the method of 
APP 
Eisenthal and Cornish-Bowden (1974) gives values for K m of 0.54 pM, 
which agrees closely with the value of 0.53 pM obtained in Table 6.4. 
6.8 Discussion and Conclusions  
The heterogeneity of the various cell fractions as judged by their 
marker enzymes activities needs to be recognized, but nevertheless, 
a substantial separation of endoplasmic reticulum and plasma membranes 
from the same homogenate was achieved using the method of Booth and 
Kenny (1976). A very substantial purification of lysosomes (tritosomes) 
was also achieved. However there was still residual contamination of the 
lysosomes as judged by the marker enzymes indicative of plasma membrane and 
endoplasmic reticulum. This is in agreement with Beaufay (1969) and 
more recently with Waltiaux et al. (1978). These authors prepared 
highly purified normal lysosomes in a metrizamide gradient and still 
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FIGURE 6.7 Comparison of the Measurement of Initial Velocity by 
Ion Exchange ( 125 r) and HPLC (3,3'-T 2 ). 
Lysosomal protein was incubated with rT 3 including 
[3 1 5 1 - 125 1] - rT 3 as tracer by the method described in 
Figure 6.5. The iodothyronines and iodide were extracted 
and assayed by ion exchange and HPLC as described in 
Sections 2.2 and 2.4. 
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found significant plasma membrane markers .g. 5'-nucleotidase) present. 
This might well be explained by the normal endocytotic transfer of 
plasma membrane to lysosomes. 
In the presence of saturating concentrations of dithiothreitol, the 
data obtained in Figure 6.3 and Table 6.5 suggests that the 5'-deiodinase 
activities from each of the three sites in the liver cell deiodinates 
the substrates tested in the following order: rT3 > T4 > 13. 
The presence of Triton X-100 alters the relative activities of 
plasma (PM) membrane and endoplasmic reticulum (ER). Before detergent: 
PM > ER for T4 and rT3, after detergent: ER > PM for T4 and rT3. 
APP 
The much lower K
m 
(after detergent) suggests that the PM maybe more active 
at lower concentrations of T4 and rT3(which may also be more in the 
physiological range) than the ER. 
The activation of ER enzyme activities by detergents is well known 
(reviewed by Evans, 1978). In this particular case, activation may occur 
for two reasons: firstly, by solubilising the enzyme and thus allowing 
free access of substrate from any direction; secondly, by an increase in 
the activity in solution of the poorly soluble substrates which bind 
non-specifically to protein and glass. 
Thus on the basis of centrifugation and marker enzymes and of the 
different kinetic parameters, there appear to be at least three different 
5'-deiodinase activities in rat liver. Whether the different sites 
represent the one enzyme at a different site, or different isoenzymes, 
or quite different enzymes of different protein composition is not obvious 
and might not be known until each of the activities is purified and their 
properties and composition determined. The interaction of these 
enzymic sites is further discussed in Chapter 7. 
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The activation of enzyme activity by detergent in plasma membrane (PM) and 
endoplasmic reticulum (ER), suggests that much of the activity is latent. 
This latency may explain in part the differing conclusions of Leonard and 
Rosenberg (1978) who found a PM site for 14 5'-deiodinasein kidney, 
whereas Maciel et al. (1979) found both a PM and ER site, and Fekkes et al. 
(1979) and Auf demhBrinke et al. (1979) who found only an ER site in liver. 
The identification of a lysosomal 5'-deiodinase has not previously 
been made. Although Auf dem Brinke et al. (1979), using the Leighton 
et al. (1968) modification of Trouet (1964) technique to prepare 
lysosomes by preloading with Triton WR-1339,did suggest that there might 
be a 14 5'-deiodinase associated with lysosomes. The definite presence 
of a highly active rT3 5'-deiodinase remained undetected as the use of 
rT 3 as a substrate was not examinedby these authors. 
Thus the work in this chapter agrees with that of Maciel et al. 
(1979) in that there is 5'-deiodinase activity in both endoplasmic reticulum, 
and plasma membranes, but also finds a membranous_5'-deiodinase activity 
in the lysosomes of the liver cell. 
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CHAPTER 7 
Discussion and Summary  
7.1 Introduction  
In this chapter, the experimental techniques which were employed 
in this thesis are critically reviewed. The results obtained from these 
techniques are then integrated into a model which describes the metabolism 
of the iodothyronines by the liver and kidney during stress and starvation. 
The model makes several predictions which could be tested by experiment. 
7.2 Review of Analytical Methods  
7.2.1 Butanol Extraction  
The use of 125 I-labelled substrates and their subsequent 
extraction by the butanol/petroleum spirit mixture has proved to be 
a reliable and rapid means for the assay of 5'-deiodination by broken 
cell systems in vitro. 
The assay does however have two disadvantages. The first is 
that it measures only iodide which is only one of the reaction 
products. Thus it is unable to distinguish how many deiodination 
steps occur. The use of substrate labelled with iodine-125 in one 
ring reduces the number of possible reactions. 
The second disadvantage is that the accuracy of the technique is 
dependent on the radioactive specific activity. This means that 
when large concentrations are used, in kinetic analysis, and a fixed 
amount of radioactive tracer is used for each concentration, the 
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accuracy of measurement of initial velocity (V 0) decreases. •This 
is compensated in part by the V o remaining constant for a much longer 
period of time so the disadvantage is not overly restrictive. 
The need for the addition of a fixed amount of tracer is mostly 
a problem of the financial restraints imposed by a limited research 
budget. It does also have an experimental justification, in that 
the amount of ethanol or propanol solvent for the tracer is kept 
well below values which will inhibit the deiodinase reactions. 
The measurement of the release of 125 1 - from labelled substrates 
has the advantage of being more easily applied to study in vitro  
deiodinase reactions than radio immuno assay (RIA). This is because 
no antibody is required and the response metameter is linear and not 
sigmoidal as it is in RIA (Ekins et al., 1967). 
By suitable labelling of substrates, most of the deiodinating 
pathways shown in Figure. 1.2 could be monitored by the butanol 
extraction. At present however, only 1- 4 , rT 3 and 1 3 labelled in the 
outer or phenolic ring are commercially available. 
The use of concentrations of substrate (i.e. T 4 10-7 M, T 3 and 
r1 3 10 -8 M) which were close to physiological values not only 
indicated physiologically relevant deiodinase activities but ensured 
the use of high specific activity of tracer% This allowed consistent 
determinations of deiodination by gamma counting. 
The technique also allowed 5'-deiodination of cytosol to be 
detected by the I - produced, even though the iodothyronine intermediates 
were short-lived. 
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7.2.2 HPLC  
The use of HPLC to separate the iodothyronines after their 
preliminary ethanolic extraction and their isolation as a grOup 
on AG50W-X2 sulphonic ion-exchange resin has complemented the 
butanol technique. 
HPLC wAh detection at 254 nm using a mercury lamp light source, 
has provided confirmation that the main iodothyronine deiodination 
product catalysed by lysosomes of rT 3 , is 3,3'-T 2 and that further 
deiodination does not occur within the 20 minute period of the assay. 
However U.V. detection has not yet been useful in measuring the 
deiodination products of T4 because of the much slower deiodination 
and because of the strongly absorbing band of interference which 
obscures the mono- and di-iodothyronines when ethanolic extracts 
are made from the tissue fractions. 
As the substances present in the absorbing band migrate very 
early in the chromatogram they are either more polar or of smaller' 
molecular weight than the iodothyronines. •This means that potentially 
a preliminary group separation on a polar stationary phase such as 
silica or alumina might eventually prove successful. Preliminary. 
separation by paper chromatography or by thin layer chromatography. 
on cellulose or silica was not successful because of the intrinsic • 
U.V. contaminating substances in these phases. Prolonged washing 
with Solvents removed most, but not all contaminants. 
When iodine-125 labelled substrates were used, a fraction 
collector was used to collect, identify and measure each band. 
However the collection into tubes blurs the separation of the 
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difficult pairs viz: T 4 /rT 3 , 3'5'-T 2/3,3'-T 2 and 3'-T 1 /3-T 1 . 
As well, the technique is very slow because of the need to count 
120 fractions for each chromatogram. Despite these difficulties, 
the fractioh collection technique was used to show that the deiodination 
of T4 by cytosol proceeds via either or both 3,3'-T 2 or 3',5'-T 2 and 
either or both 3-T 1 and 3'-T 1 . Cytosol had been previously thought 
to completely deiodinate T4 without producing measurable quantities 
of any of the lesser iodothyronines (Colquhoun et al., 1980). 
Thus as the cytosol deiodinates rT 3 much more rapidly than -r 3 
(Chapter 3), and Cavalieri et al. (1977) have reported 5-deiodination 
of T4 to rT 3 by cytosol, the most likely route for T4 deiodination 
by cytosol is firstly 5-deiodination to rT 3 then 5'-deiodination to 
3,3'-T 2 with further deiodination to 3 or 3'-T 1 . 
In conclusion, the separations of iodothyronines achieved by 
HPLC must be considered to be far superior than the means of their 
detection yet available. 
7.3 The Purification of Deiodinase Enzymes  
Several authors (e.g. Kiihrle et al., 1980; Fekkes et al., 1980) 
have experienced difficulty in attempting to purify microsomal deiodinase 
enzymes. The thiol covalent gel chromatography technique of Fekkes et al. 
(1980) which gave a three-fold increase in activity appears to be the 
most successful technique previously published. 
Similar difficulties in purifying the microsomal enzymes were 
encountered during the work described in this thesis. Nevertheless, the 
successful use of affinity chromatography as a purification step for the 
deiodinase enzymes has not been reported by other workers (reviewed in 
Chapter 5). 
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The use of affinity chromatography in the purification of the 
deiodinases is therefore a significant experimental advance and suggests 
that ligands other than those already used might provide better 
purifications in the future. 
The successful use of thyroxine (which is a substrate) for the cytosol 
5'-deiodinase suggests that reverse 13 might be a more successful ligand 
for the purification of all of the 5'-deiodinases as all of the 
5'-deiodinases tested have a greater activity towards rT 3 as a substrate. 
Reasoning in a similar manner, the successful use of the 5'-deiodinase 
inhibitor iopanoic acid, suggests that other inhibitors, e.g. iodipate, 
may be of use, especially for the purification of the endoplasmic 
reticulum and plasma membrane enzymes. 
Another group of ligands which may be of use in affinity chromatography 
of the deiodinases, are the thyromimetic analogues, e.g. isopropyl-
diiodothyronine, which bind strongly to thyroid hormone receptors and by 
analogy may well bind to the deiodinase enzymes. 
The use of thyroxine as the ligand in affinity chromatography, has 
shown that its coupling to the support matrix prevents its deiodination by 
the enzymes in both cytosol and microsomes. This indicates that the 
normal binding of the amino group near the active centre is an essential 
prerequisite for deiodination. Furthermore, other parts of the thyroxine 
molecule must bind to the enzyme for it to be retained on the column. 
This raises the possibility that coupling of T4 or other ligand to the 
matrix via a different group than the amino group used in this thesis, 
may provide an improved retention of the membrane bound 5'-deiodinases 
and hence an improved purification. 
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That binding of different deiodinase enzymes to a ligand can be 
different, is shown by the substantial purification of the cytosol 
5'-deiodinase activity using T4 as the ligand. This degree of purification 
was not obtained with the microsomal activity even though a substantial 
amount of deiodinase activity bound to the ligand. 
7.4 The Number, Location and Function of the 5'-Deiodinase Enzymes  
The work described in this thesis clearly suggests three of possibly 
four different subcellular sites in rat liver and kidney cells which have 
5'-deiodinase activities. They are the plasma membrane, the endoplasmic 
reticulum, the lysosomes and perhaps the cytosol. 
As discussed in Chapter 4, the  is suggestive evidence that in vivo, 
the cytosol activity may normally reside elsewhere in the cell and that it 
enters the cytosol during the homogenising process. 
On the other hand, the properties of the cytosol 5'-deiodinase enzyme 
are in part different to those of the membrane bound enzymes. Thus it is 
not yet possible to nominate the putative site of origin for the cytosol 
enzyme. 
Previous research had found deiodinase activity in the cytosol. 
Cavalieri et al. (1977) found a T4 5-deiodinase which produced rT 3 although 
its activity was low. Sinsheimer et al. (1977) have described a glutathione 
(GSH) dependent and a GSH independent deiodinating activity in cytosol, 
which were active against synthetic iodinated compounds. 
Recently, Smallridge eta]. (1981) have described a deiodinating enzyme• 
in cytosol and in microsomes of rat kidney which is specific for 3',5'-T 2 
as a substrate. These observations of deiodinase activity in cytosol 
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raised the possibility that there might be a deiodinase enzyme normally 
present in cytosol which has different substrate specificities to those 
deiodinases found elsewhere in the cell. 
With respect to the other more definitely established membrane sites 
of 5'-deiodinase activity, it is difficult to see the biological advantage 
of having the three sites in kidney and liver cells. The explanation for 
the number of sites may lie at several levels. 
Firstly, the various sites may simply reflect both the site of 
synthesis of the enzyme on the rough endoplasmic reticulum together 
with its destinations (after its synthesis and subsequent incorporation) 
in the plasma membrane or the lysosomes. This explanation is perhaps 
less likely as Maciel et al. (1978) found no 5'-deiodination activity in 
the golgi apparatus. The golgi apparatus is thought to be responsible 
for the incorporation of the carbohydrate into the glycoproteins of 
plasma membrane and lysosomes. 
Transport of protein between cell sites might explain multiple 
membrane sites for the 5'-deiodinase in another manner. Membrane transfer 
between plasma membranes (PM) and lysosomes occurs via the processes of 
pinocytosis, and the fusion of the pinocytotic vesicle with the lysosome 
would provide a route from plasma membrane to lysosome. This process is 
thought to explain the normal presence of 5' nucleotidase and other 
PM maker enzymes in lysosomes (Wattiaux et al., 1978). Reverse transport 
of membranes also occurs in which there is externalisation of lysosomal 
enzymes (Hasilik, 1980). This two-way traffic might explain the 
simultaneous presence of the 5'-deiodinase in both sites. However one 
would expect similar Km values for the iodothyronines, which is not the 
case (see Table 6.4). 
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In fact, the two 5'-deiodinase activities with similar K m values are 
the lysosomal and the endoplasmic reticulum 5'-deiodinase activities. 
This might suggest that it is the same enzyme in ER and lysosomes. 
Novikoff (1973) has shown in general that the GERL complex normally gives 
rise to the lysosomal proteins during the life of the cell. 
A second level of explanation may lie in there being a functional 
necessity for the various sites of the 5'-deiodinase enzyme to achieve 
normal thyroid hormone homeostasis. This possibility will be discussed 
in the following section. 
Given that T3 is the active thyroid principle necessary for the 
elicitation of most, if not all, thyroid hormone effects (Chapter 1), then 
any cell that has adapted, during the evolution of specialisation, so that 
T 3 controls part of its metabolism thus has only two options for the 
supply of T3. 	It can either actively synthesise T3 by deiodinating T4 
in situ, or it can depend on other cells to synthesise 13 and import it 
from plasma. The options are not mutually exclusive so that it may do  both. 
The latter combined method would allow local control in response to local 
factors and systemic control in response to systemic or whole-body 
factors. There is evidence that pituitary and liver which have active 
5'-deiodinases,in fact, do both in different proportions (reviewed by 
Hesch, 1981). 
Regardless of how a given cell type acts in the thyroid hormone 
economy of the body, it would be difficult to believe that a control 
mechanism does not operate. Indeed, it would seem unlikely that the 
feed-back or servoloop which involves the hypothalamus, the adenohypophysis 
and the thyroid and which so tightly controls the release of T4 does not 
in some way control the conversion of T4 to T3 and of T4 to rT3. 
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Support for this assertion comes from the studies of Loos et al. (1980) 
who confirmed that in athyreotic patients receiving a constant infusion 
of T4, there was a diurnal fluctuation in rT 3 and T3.' The rise in rT 3 
preceeded that of T3 in time by about 2 hrs. In normal people given 
intra venous TRH, there is a fall in rT 3 within 45 mins and it preceeds the 
rise in T3 which occurs at about 45-60 minutes (Gaitan et al., 1980). 
These latter workers also showed that the release of prolactin may have an 
effect on the rT 3/T 3 ratio. 
Any hypothesis to explain the different plasma levels of the 
tri-iodothyronines must take into account the kinetic studies performed 
in the low T3 state (see Chapter 1). These studies suggest that in man 
the rate of production of T3 falls and the rate of catabolism of rT 3 
(which is normally rapid) also falls with little change in its production 
rate (reviewed by Chopra, 1981). 
The observed plasma changes in T and rT , together with the in vitro  
studies showing markedly different pH optimum values for the production of 
T 3 and rT 3 from T4, suggests that the production of T3 and rT 3 is a controlled, 
non-random process carried out by at least two enzymes (Visser, 1980; 
Chopra et al., 1978). As yet however, no worker has successfully 
separated or purified either of the 5- or 5'-deiodinases of thyroxine. 
Although recently, in human placenta, Roti et al. (1981) have described 
a T4 5-deiodinase which deiodinates T4, T3 but not rT 3 . With the two 
enzyme hypothesis, the changes in the low 73 states would be due to an 
inhibition or decrease in the 5'-deiodinase activity in the cell and thus 
a decrease in T3 synthesis and decrease in r1 3 degradation would occur 
simultaneously (Kaplan and Utiger, 1978). 
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Several authors have attempted to explain the control of production 
T 3 and rT 3 using either alterations in other metabolites such as 
glutathione, NADPH, or pH, which either stimulate or inhibit their 
production, or by the direct inhibition of the synthesis of T3 by 
regulatory iodothyronines such as rT 3 or 3',5'-T2 (Chopra et al., 1978; 
Chopra, 1981; Visser, 1980; Visser, 1981; Hesch eta]., 1980; 
KOhrle, 1981). 
The discovery by Visser et al. (1976) of the necessity for a reduced 
thiol compound as a co-factor has lead several workers to try and link 
changes in T3 and rT 3 production toeither reduced glutathione (GSH) or to 
oxidized glutathione (GSSG) or to the ratio of GSH to GSSG (e.g. Visser, 
1980; and Chopra, 1981). 
The model of GSH control of the production of tri-iodothyronines 
has some deficiencies. Firstly, dithiothreitol (DTT) is much more 
effective than GSH at any molar concentration in stimulating 5'-deiodinase. 
Secondly the response curve of liver homogenates to GSH is very much 
lower than for OTT (Chopra, 1978). Thirdly, the possible physiological 
changes in the intracellular concentrations of GSH in starvation from 
5.3 to 2.7 mM (Vina et al . , 1978) would therefore only elicit a small 
response (< 10% using the data of Chopra, 1978) in 5'-deiodinase activity. 
It would also be necessary to postulate that 5'-deiodinase enzyme was more 
sensitive to GSH than the 5-deiodinase enzyme to cause decreased T3 but 
not rT 3 production. No such evidence has yet been obtained. 
Visser (1978; 1981) has argued that the decreased glucose concentration 
in liver during fasting leads to decreased production of NADPH from the 
pentose phosphate shunt and hence of GSH. Whilst decreased production of 
NADPH during starvation is generally accepted, elevated levels of GSSG in 
liver to account for the fall in GSH have not been found. Rather, the levels 
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of GSH relate to protein intake and degradation rates which provide 
sulphydryl aminoacids to the liver (Tateishi and Higashi, 1978). 
In the starved rat, GSH values return to fed levels by about day 4 
to 5 of the fast, yet 5'-deiodinase activities remain depressed. This 
is especially so for the rT 3 5'-deiodinase activity. However its activity 
can be restored with large concentrations (20 mM) of DTT (Chopra, 1980). 
This study of Chopra provides strong evidence for factors other than the 
nett intracellular concentration of'GSH in the control of deiodination. 
The study does not exclude a localised low concentration in a cell 
compartment which requires a high concentration outside to promote the 
entry of GSH through a relatively impermeable membrane. 
The localisation of the rT 3 5'-deiodinase to the lysosomal membrane 
1 
is the less common site for lysosomal enzymes but still occurs for a 
significant number of lysosomal enzymes (Lucy, 1969; Thines-Sempoux, 1973; 
Yamamoto et al., 1980). The membrane site raises the question of whether 
the active site of the enzyme faces the cytoplasm or the lysosomal matrix, 
1.e. whether it is on the inner or outer face. 
On the basis of protein labelling experiments, most lysosomal membrane 
proteins have part of their peptide chain exposed to the cytoplasm 
(Schneider et al., 1978). However no information is available regarding 
the orientation of the active site of the rT 3 5'-deiodinase. Thus it is 
unclear whether the concentration of the thiol co-factor GSH in the cytoplasm 
is relevant or whether it is the intra-lysosomal concentration of GSH. 
No figures are available for the intra-lysosomal concentration of GSH, 
but the lysosomes have a proven reductive system which reduces cystine to 
cysteine residues (Griffiths, 1979). The measurement of GSH or reducing 
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power inside lysosomes in different states would be an important step in 
further assessing the role of lysosomal 5'-deiodinase and might explain 
the finding of Chopra (1980) of decreased rT 3 5'-deiodinase during 
starvation, which is restored with high concentrations of OTT. 
Thus the requirement for high concentrations of DTT, which is a 
much stronger reducing agent than GSH, is a serious impediment to 
believing that in vitro activities of deiodinases described in the 
literature reflect those occurring in vivo. When using ruptured lysosomes, 
80% of the maximal activation for rT 3 5'-deiodinase was achieved between 
0.1 and 0.5 mM DTT, which was much closer in reducing power to equivalent 
physiological values of GSH. However future studies on intact lysosomes 
will be important, not only for assessing the access of GSH to the lysosomal 
deiodinases but also of the access of substrate to the lysosomal enzyme. 
Goldman (1975) has reviewed the permeation of amino acids into the interior 
of intact lysosomes. Single aminoacids and other molecules of molecular 
;weight up to 200 are freely permeable but oligopeptides of 2 or 3 aminoacids 
are retarded. It would be of great interest to measure permeation of 
iodothyronines into intact lysosomes. 
Hesch and co-workers (Hesch et al., 1980; Kohrle, 1981) have argued 
strongly that the intracellular pH is the main determinant of whether 
T4 5 or 5'-deiodinase is most active within the liver cell. Their model 
couples pH control together with the inhibition of T4 to T3 deiodination 
by rT 3 and 3',5'-T 2 which has been shown in vitro using broken cell 
preparations by Hoffken et al. (1976) and by Chopra (1977), and using 
intact renal tubules by Heyma et al. (1980b). 
Whilst the model of Hesch and co-workers has the potential to explain 
many of the changes in iodothyronine metabolism seen in illness, it is 
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severely hampered by its proponents' inability to show either a relation 
between change in pH and change in rT 3 or T3 in severely ill patients with 
either acidosis or alkalosis or to show in the perfused liver changes 
consistent with the model (Kiihrle, 1981). 
As no worker has yet separated, nor purified, the T4 5 or 5'-deiodinases, 
and as their properties are very similar (Chopra and Teco, 1981), an 
alternative explanation to the two deiodinase hypothesis would be to 
postulate a single T4 deiodinase which produces both 13 and rT 3 . Once 
produced, the tri-iodothyronines are then deiodinated at very different 
rates, i.e. T3 would be slowly deiodinated and rT 3 would be very rapidly 
deiodinated. Thus, rather than just controlling the enzymic production 
of the tri-iodothyronines, their catabolism could also be controlled. 
Rapid deiodination of rT 3 and very slow deiodination of T3 were in 
fact observed for all the renal and hepatic 5'-deiodinase activities described 
in this thesis, especially with the lysosomal 5'-deiodinase. Thus, using 
the results of this thesis, it is possible to construct a fairly pragmatic 
working hypothesis. The model is based on the hypothesis of different 
rates of metabolism of T3 and rT 3 and on the inhibition by rT 3 of the 
production of T3 (and rT 3 ). Control of production and catabolism of 
tri-iodothyronines are not necessarily mutually exclusive. 
Before discussing the model, certain chemical properties of the 
iodothyronines need to be reviewed. Iodothyronines are aminoacids 
with markedly hydrophobic and bulky iodinated aromatic side chains. 
They have a phenolic ring in which the pK a varies depending on the number 
of iodines present in phenolic ring, i.e. for T4 (and? rT 3 ) pKa = 6.73, 
for T3 (and ? 3,3'-T 2 and 3'-T 2 ) pKa = 8.47, and for T o (and ? 3,5-T 2 and 
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? 3-T 1 ) pKa - 10.00 (reviewed by Cody, 1981). The iodothyronines are 
poorly soluble in aqueous or saline solutions (Gemmill, 1955). Their 
solubilities are markedly temperature dependent and also pH dependent 
when the pH is above that of the pK a of the phenolic group (Evert, 1960). 
They form insoluble complexes with many divalent ions (Kendall and 
Osterberg, 1920). The Mg2+ complex has been used by Sterling and 
Brenner (1966) to precipitate free thyroxine for its assay. 
The intra cellular concentration of Mg 2+ is relatively high at about 
10 mM (Gamble, 1954) of which about 1 mM is the free ion (Walser, 1967). 
This means that any cell will require protein carriers for the iodothyronines 
to prevent their precipitation as magnesium complexes. This would explain 
the finding of many binding sites in the cell (Tata, 1975) without the 
proteins necessarily being receptors for initiating thyroid hormone action. 
The model proposed is shown schematically in Figure 7.1. Because 
of the considerations in the previous paragraph, no binding proteins are 
shown in order to simplify the diagram. The figure shows a plasma 
membrane (PM) enzyme which produces both T3 and rT 3 . Both hormones are 
either imported into, or exported from the liver cell. Some T4 may also 
enter the cell. The T3 which enters the cell is only slowly metabolised 
and can thus interact with its receptors in the nucleus, the mitochondria 
and possibly the plasma membrane. The rT 3 which enters the cell is in 
equilibrium between production at the PM and its degradaiion by lysosomes 
and to a lesser extent by endoplasmic reticulum (ER). The r1 3 in the 
cytosol adjacent to the PM will inhibit or control the production of T3 
Reverse T3 might also be metabolised by PM, ER and cytosol (not shown). 
Further degradation di-iodothyronines may occur in either the cytosol or 
on the ER. • 
insulin 
tamino  acids 
FIGURE 7.1 Speculative Model for the Control of 73 and rT 3 Function 
in Rat Liver and Kidney. 
207 
Thus in situations giving rise to low T3 states, the decrease of 
the lysosomal rT 3 5'-deiodinase activity will cause a rise in cytosol rT 3 , 
which in turn will inhibit T3 production by the PM. The same chronological 
sequence of a rise in rT 3 then a fall in T3 was observed in vivo by 
Loos et al. (1980) and by Gaitan et al. (1980) in thyroidectomised and normal 
people respectively. 
The evidence for choosing a PM site as being the more important site 
for T3 production, rather than an ER site in the model is two-fold but by 
no means certain. Firstly, the PM site is exposed to the circulating 
plasma (via extracellular fluid) which would allow export of T3 without 
it entering the liver cell and secondly, the data in Table 6.3 suggests 
that in their particulate forms, the PM is more active than the ER in 
5'-deiodination of T. 
The large latency of the deiodinase of the ER, as revealed when 
exposed to Triton X-100, together with its similar Km 
value and 
specificities as the lysosomes, suggests that some of the activity is 
vesicular and may be destined for the lysosomes, i.e. it is synthesised 
on the RER and transported to the lysosomes where the enzyme becomes 
active. 
Catabolism of rT 3 by its deiodination in the lysosome could have 
the advantages of compartmentalisation for the cell. Thus it is of 
interest that many of the low 13 states are characterised by hormonal 
changes or are induced by drugs which are known to have marked effects on 
lysosomal structure and function. For example, propranolol and 
dexamethasone which are associated with low T3 and elevated rT 3 (Chapter 1) 
are known to interact and stabilise the lysosomal membrane (Weiman, 1979; 
Weissman, 1969). Such a structural alteration due to the rearrangement of 
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membrane phospholipid might well decrease the activity of the 
5'-deiodinase enzymes embedded in the lysosomal membrane and thus cause 
a rise in intracellular rT 3 which would spill over into the plasma. 
The rise in rT 3 inside the cell would then inhibit 13 production. In 
addition these drugs also interact with PM and therefore might have a 
direct effect on the PM deiodinase. 
The model would predict therefore, that lysomotrophic drugs (de Duve 
et al., 1974) which are known to stabilize lysosomes, e.g. chloroquine 
and chlorpromazine (Weissman, 1969; Chien et al., 1977),would inhibit 
rT 3 deiodination and might be associated with elevated rT 3 /low 13 in the 
plasma and that drugs such as reserpine (Pfeiffer et al., 1980) which 
labilise lysosomes might lower rT 3 and raise 13. 
Physiological and pathological stress states characterized by low 13 
and elevated rT 3 such as starvation, surgery/anaesthesia, untreated 
diabetes mellitus, and other acute and chronic illnesses (Chapter 1) are 
also characterised by a rise in counter regulatory hormones which oppose 
the action of insulin, i.e. cortisol, glucagon and adrenalin (reviewed by 
Allison et al., 1976). 
Glucocorticoids and glucagon have marked effects on gluconeogenesis 
in the body by increasing mobilisation of aminoacids from muscle to 
provide increased aminoacid substrates for gluconeogenesis in the liver. 
Both cortisol and glucagon are known to have marked effects on 
lysosomal function. Philip and Kurup (1978) have shown that chemical 
adrenalectomy in the rat leads to increased lability in vitro of 
lysosomes in liver and aorta. Thus corticosterone in the rat may have 
a background stabilising effect on lysosomes when present in physiological 
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concentrations, especially when elevated during times of stress and 
hence may have an effect on the degradation of rT3 by lysosomes. This 
effect may well be accentuated in the presence of glucagon because of 
the effects of glucagon on lysosomal autophagy. 
In the presence of glucagon, low amino acid levels (which are required 
for hepatic gluconeogenesis) markedly stimulate autophagy of intracellular 
proteins by lysosomes in the perfused rat liver. The process of autophagy 
begins within a short period of exposure to the combination of low levels 
of amino acids and glucagon (Neely et al., 1977; Ward et al., 1977; and 
Schworer and Mortimore, 1979). 
Segelen et al. (1980) have found that mixtures of amino acids will 
inhibit lysosomal autophagy. In particular a mixture of the seven amino 
acids: leucine, phenylalanine, tyrosine, tryptophane,histidine, asparagine - 
and glutamine are most effective. Of these, asparagine and Plutamine 
were the most effective alone, and were especially effective in inhibition 
of autophagy when in combination with leucine. The combination of 
gluconeogenic (Asn, Gln) and anabolic (Leu) amino acids might therefore 
be a biological signal that there is sufficient amino acid mobilisation or 
dietary intake for the maintenance of blood glucose and hence there is no 
need for autophagy. 
The inhibition of rT 3 _5'-deiodination could occur by an intralysosomal 
decrease of glutathione or other reducing compounds as discussed earlier. 
There are,however, a number of other possibilities, viz: competitive 
inhibition of the 5'-deiodinase by the proteolytically released amino acids; 
binding of rT 3 to proteins inside the autophagic vacuoles; allosteric 
control of the 5'-deiodinase by amino acids or peptides and membrane lipid 
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changes affecting the 5'-deiodinase or the permeation of rT 3 through the 
lysosomal membrane. 
An important possibility not listed above for the control of lysosomal 
rT 3 deiodination is that of the effect of pH on the rT 3 r'-deiodinase. 
Examination of Figure 6.3 shows a marked increase of the lysosomal 
deiodinase activity between pH 5 and 7. This range is in good agreement 
with many estimates of the prevailing pH within lysosomes (reviewed by 
Reijingoud and Tager (1977). 
The pH inside phagocytic vacuoles of polymorphonuclear leukocytes 
falls rapidly when proteolysis is occurring (Jensen and Bainton, 1973) so 
that during autophagy the pH inside liver lysosomes could be expected to 
fall and thus inhibit the rT 3 5'-deiodinase. Recently Ohkuma and Poole 
(1978) have measured in vitro the intralysosomal pH in living macrophages. 
They found a resting pH of about 4.5-4.7. When ammonia or weak bases 
were added, the pH rose immediately up to pH 6.5. 
Thus, as the aminoacid levels are raised inside the liver cell, 
either as a consequence of feeding, or of mobilisation from muscle, 
increasing quantities of ammonia, of the basic urea-cycle amino acids 
and of glutamineandlasparagine from transamination, will be produced 
during gluconeogenesis. 
A proportion of these bases will be trapped within the lysosornes 
(de Duve et al., 1974), and raise the intralysosomal pH as shown by 
Ohkuma and Poole (1978). The rise in pH will then stimulate the 
rT 3 5'-deiodinase. 
Thus the control of the rate of rT 3 deiodination by lysosomes might 
well be a balance between the fall in intralysosomal pH due to autophagy, 
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and the rise due to the liberated amino-bases formed during 
gluconeogenesis. 
Autophagy would decrease the amount of endoplasmic reticulum 
protein within the liver and might therefore reduce both the catabolism 
of rT 3 and the production of T3. 	The greater protein degradation 
involving endoplasmic reticulum which occurs in liver, when compared 
to kidney, might also explain the greater changes in 13 production by the 
liver which have been shown by Kaplan (1979) to occur in Starvation. 
Thus the control of lysosomal autophagy by aminoacid levels, which 
are in turn strongly controlled by insulin, glucagon and the glucocorticoids, 
may provide the final common pathway for metabolite control of 13 and rT 3 
during starvation. Low intracellular levels of aminoacids in liver, 
especially when combined with elevated glucagon and low insulin, would 
stimulate autophagy, whereas elevated levels of aminoacids and insulin 
would inhibit lysosomal autophagy. 
This pathway would explain how a small amount of oral carbohydrate 
and larger amounts of oral protein but not lipid would reverse the rise 
in rT 3 and the fall in 13 in serum, by inhibiting the lysosomal rT 3 
5'-deiodinase. The findings of Westgren et al. (1977) of the reversal of 
dietary changes in the tri-iodothyronines would be consistent with this 
hypothesis because of the well known effect of increased insulin release by 
oral glucose and the insulin's subsequent increase of aminoacid transport 
into liver. Similarly, the findings of Richmand et al. (1980) that 
septicaemic patients required both intravenous glucose and aminoacids to 
reverse the tri-iodothyronine changes are consistent with the lack of insulin 
response and therefore the requirement of both glucose and aminoacids to 
be given together to raise intracellular aminoacid levels. 
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The failure of lipid to reverse the changes in tri-iodothyronine levels 
when given during starvation would be explained on the model by the catabolism 
of fatty acids since during a oxidation of fatty acids, the only product is 
acetyl-CoA which is converted in each cycle of the tricaboxylic acid 
cycle to carbon dioxide. This means that fatty acids do not normally 
give rise to significant nett synthesis of glucose or glucogenic ketoacids 
or aminoacids. 
The model allows a further prediction which could be tested. The 
drug propylamine inhibits the formation of autophagic vacuoles (Segelen 
et al., 1980) and thus would be predicted to inhibit the changes in rT and 
T3 induced by starvation in rats or perfused livers. 
7.5 Summary and Conclusions 
Assay systems involving iodine-125 labelled iodothyronine substrates 
have been established which can detect deiodination with high sensitivity. 
A HPLC separation has also been established which complements •the radio-
chemical assays. 
Using these assays, 5'-deiodinase enzyme activities have been 
localized to the plasma membranes, to the endoplasmic reticulum and to the 
lysosomes prepared from liver and kidney homogenates. A further activity 
in the cytosol of these tissues was also found, but evidence suggested, 
in part, that its presence there may be due to an artefact of the 
homogenisation procedures. 
Purification studies were performed on the cytosol 5'-deiodinase 
(because of its solubility) and on the combined microsomal 5'-deiodinase 
activity. Substantial purification (300 fold) of the 5'-deiodinase from 
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cytosol was achieved using thyroxine as the ligand in affinity chromatography. 
Gel electrophoresis of this purified product suggested the presence of only 
a small number of proteins which combine in a regular fashion to produce 
aggregates of related structures. 
The combined plasma membrane and endoplasmic reticulum microsomal 
activity was significantly purified (3-10 fold) using iopanoic acid 
(which is a 5'-deiodinase inhibitor) as the ligand in affinity 
chromatography. The degree of purification compares favourably to that 
achieved by other workers. 
A model for deiodination of T4 is suggested in which the production 
of both T3 and rT 3 occurs predominantly at the plasma membrane. The rT 3 
produced is then subject to rapid catabolism by deiodination in the lysosome. 
The rate of rT 3 deiodination by lysosomes is controlled by the inhibition 
or stimulation of lysosomal autophagy or changes in the lysosomal membrane 
or both by drugs, hormones or aminoacids. This leads to alterations in 
the intracellular levels of rT 3 which in turn feeds-back negatively on the 
plasma membrane enzyme (and also perhaps the endoplasmic reticulum 
deiodinase) to inhibit the production of 13. 	This then lads' to a rise 
in plasma rT 3 followed soon after by a fall in plasma 13. 
It is further postulated that the final common pathway for dietary 
changes of rT 3/T 3 levels is via the intracellular levels of aminoacids 
in the liver, especially those (e.g. Asn, Gln, Leu) which are gluconeogenic 
or anabolic. 
Finally drugs which are known to be lysomotrophic and markedly affect 
the stability of lysosomes are predicted to have effects on the ratio of 
rT 3 to 13 found in plasma. 
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